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The intention of the work described in this thesis was to identify whether 
extremely high dilutions of antigen can induce changes in dendritic cell 
maturation and dendritic cell ability to initiate immune responses. Basic 
research performed trying to address whether such ultra-high, homeopathic, 
dilutions of antigen have a biological role is limited, while clinical investigations 
into this matter are inconclusive. Homeopathy is, however, gaining popularity, 
and is very often at the epicentre of intense scientific and medical debate. We 
hypothesised that dendritic cells, being an excellent APC, might be a good 
candidate cell to investigate this controversial topic. While dendritic cells are 
excellent APCs, capable of inducing T cell responses 100 times more effectively 
than other lymphocytes, there is mounting evidence suggesting that they might 
also be involved in bacterial dissemination during Salmonella infections. We 
investigated the role of dendritic cells in the development of protective immune 
responses against Salmonella typhimurium infections. Furthermore, we assessed 
whether the APC derived cytokine, IL-23, which shares the common p40 
subunit with IL-12 p70, is required for the development of primary, memory as 
well as protective immune responses against Salmonella typhimurium. While IL-
23 has been shown to be important for the maintenance of IL-17 responses by T 
cells, its role during Salmonella induced pathology remains elusive. Our work 
identified some interesting aspects of this cytokine in immunity against 
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1.1 The need for immunity 
Competition and natural selection has driven species to inhabit a vast array 
of different niches, including ones within other organisms. While many examples 
of symbiosis are beneficial for both parties, such as in the case of commensal 
bacteria residing at the lumen of the intestinal tract (Yan and Polk, 2004), there are 
a number of organisms whose survival is detrimental to the health of their host, or 
even the community a host is a member of. The need to maintain physiological 
numbers of beneficial symbiotic organisms, and to defend against the invasion and 
colonisation by pathogenic organisms, while avoiding aggression against self-
derived cells, has lead to the development of intricate chemical and cellular 
immune networks. These can be divided into two main categories; innate 
immunity and adaptive immunity. While both those “arms” of immunity have 
evolved to prevent from, and combat, pathogenic invasion, they have amongst 
others one fundamental difference; adaptive immunity has the unique ability to 
become “educated” and “remember” each specific pathogen.  
 
1.1.1 Innate immunity 
The evolutionary older form of immunity, innate immunity is characterised 
by being the first line of defence against pathogenic organisms. It includes (but is 
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not restricted to) physical barriers such as the skin, chemical, such as the acidic 
environment of the stomach or proteolitic enzymes, and cellular, such as 
macrophages (MΦs), neutrophils and dendritic cells (DCs) that can recognise a vast 
range of proteins, sugars and lipids from pathogens that share evolutionary traits, 
and either directly kill them or instruct other cells to perform this task.  
 
1.1.2 First line of defence 
 Some of the primary functions of the skin are the isolation and provision of 
a mechanical barrier between the interior and the surrounding environment, 
thermoregulation, immunosurveillance and prevention from dehydration. The 
intestinal tract and the lung serve for the intake of nutrients and gas exchange 
respectively. In a normal person measuring 1.5 meters height, these three tissues 
expose together an area of around 400 m2 to the environment (Hooper and 
Macpherson; Mosteller, 1987; Roughton and Forster, 1957). As such, the rapid 
elimination of micro-organisms, dust particles, allergens and toxins that are 
encountered constantly is of prime importance. Ciliary action on the trachea 
actively removes dust particles and unwanted micro-organisms, while absorptive 
villus enterocytes residing at the gut surface prevent entry of pathogens through 
the epithelial layer (Negus, 1949; Srikanth and McCormick, 2008). Both gut and 
lungs are covered in mucus, which prevents tissue damage and provides an 
additional barrier against invading pathogens (Bergofsky, 1991; Srikanth and 
McCormick, 2008). 
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The keratinisation of the skin is important in providing immune protection 
as well as prevention of water loss. However, many pathogens such as bacteria, 
can produce proteases and thus penetrate the outer layer of the epidermis. 
Commensal bacteria living on the skin and gut contribute towards immunity by 
outcompeting unwanted pathogens. Furthermore, a number of anti-bacterial 
peptides and proteins (AMPs) are found on the surface of the skin, the gut lining, 
and alveolar spaces (Srikanth and McCormick, 2008). These proteases have been 
found to play important roles in direct pathogen elimination, recruitment of white 
blood cells to the sites of infection, as well as the maintenance of physiological 
levels of commensal bacteria (Niyonsaba et al., 2009; Schroder and Harder, 2006). 
Examples of AMPs include dermicidin, cathelicidin LL-37, psoriasin and RNase-7. 
Dermicidin is an AMP produced under physiological conditions by eccrine 
gland cells on the skin and shows antimicrobial activity against Staphylococcus 
aureus, Enetrococcus faecalis, Escherichia coli as well as fungal pathogens such as 
Candida albicans (Harder and Schroder, 2005). The antimicrobial peptide 
cathelicidin (LL-37) is expressed in eccrine and duct cells in the skin as well as mast 
cells and respiratory epithelial cells in the lung and gut, under inflammatory 
conditions (Doss et al.; Harder and Schroder, 2005). It shows activity against S. 
aureus and C. albicans as well as viruses, while it is also chemotactic for neutrophils, 
monocytes, mast cells, eosinophils and T cells (Doss et al.; Harder and Schroder, 
2005). Psoriasin, which is produced constitutively by keratinocytes in areas with 
high bacterial colonisation on the skin, such as hair follicles, is a potent E. coli 
bactericidal AMP (Bevins, 2005), while it is also believed to be important in 
maintaining healthy numbers of commensal bacteria and recruit neutrophils and T 
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cells to the sites of infection (Harder and Schroder, 2005). RNase 7 is an inducible 
AMP produced by keratinocytes and neutrophils residing at the epidermis. It is 
chemotactic for neutrophils, mast cells and dendritic cells (Harder and Schroder, 
2005). β-defensins are found on the skin, in the lumen of the intestinal tract as well 
as the lungs. They are highly cationic, inducible peptides that have antimicrobial 
properties against bacteria, viruses and eukaryotes (Schutte and McCray, 2002). 
They attract mast cells, DCs, neutrophils, monocytes and T cells to the site of 
infection. Some forms are found to be constitutively expressed by skin 
keratinocytes while others are induced during inflammation in response to pro-
inflammatory cytokines and bacterial cell wall components, and are produced by 
keratinocytes, epithelial cells, neutrophils and mast cells (Schutte and McCray, 
2002).  
Taken together, AMPs play a very important role not only in direct 
pathogen elimination, but also in initiating a cascade of events that leads to the 
recruitment of highly specialised cells to the site of infection.  
While AMPs provide a formidable chemical barrier against pathogen 
invasion, cytokines, a group of specialised signalling molecules play a crucial role 
in co-ordinating immune responses against such invading pathogens. Innate and 
proinflammatory cytokines such as IL-1, IL-6, IL-12, type 1 interferons and TNF-α 
as well as chemokines such as CXCL8 (IL-8) are secreted by innate cells in response 
to AMPs, bacterial products, host cell death products as well as stress such as 
injury. They play a crucial role not only in the recruitment of innate and adaptive 
cells to the site of infection, but are also required for the activation and polarisation 
of cells of the adaptive immunity.  
 5 
Tumour necrosis factor-α (TNF-α) is secreted in response to bacterial, viral 
and protozoan infections. It stimulates the hypothalamic thermoregulatory centre, 
resulting in fever which is thought to inhibit bacterial growth (Kluger, 1991; Small 
et al., 1986), it causes vasodilatation (Hollenberg et al., 1991), and actively enhances 
migration of cells through vascular endothelial cells to the periphery (Smart and 
Casale, 1994), it is a chemoattractant for neutrophils and stimulates phagocytosis 
(Roilides et al., 1998). IL-1β and IL-6, similarly to TNF-α, have also been found to 
act on the hypothalamic thermoregulatory center (Lesnikov et al., 1991; Morgan et 
al., 2004). IL-1 (IL-1α and IL-1β) is secreted by MΦs, fibroblasts and DCs. It 
increases the expression of adhesion factors on endothelial cells allowing for 
transmigration of leukocytes to the periphery (Dangerfield et al., 2005). Recent 
work has also shown that IL-1 may also play an important role in polarising 
adaptive immune responses (Chapter 1.4, 1.5). IL-6, similarly to TNF-α and IL-1, 
acts on the hypothalamus to cause fever (Sundgren-Andersson et al., 1998). Recent 
work has shown that this innate cytokine is also involved in polarising adaptive 
immune responses, discussed further on (Chapter 1.4, 1.5). IL-12 p70 is a 
heterodimeric cytokine secreted by innate cells such as MΦs and DCs, in response 
to viral, bacterial and protozoan infections. It plays a pivotal role in the 
polarisation of adaptive immune responses (discussed in Chapter 1.4, 1.5). IL-10 is 
an anti-inflammatory cytokine secreted by both innate and adaptive cells in 
response to bacterial, viral, protozoan and nematode infections. It inhibits the 
synthesis of pro-inflammatroy cytokines such as TNF-α and regulates adaptive 




1.2 Cells of the innate immune system 
Mechanical barriers as well as chemical defences provide formidable 
protection against the vast number of pathogenic organisms that vertebrates 
constantly encounter. Nevertheless, the “first line of defence” does not always 
ensure protection. A number of pathogens are able to colonise their hosts by 
exploiting naturally occurring tissue damage such as in the case of Clostridium 
tetani, a Gram-positive rod shaped anaerobic bacterium which is the causative 
agent of tetanus (Cooke, 2009). Alternatively, pathogens can invade their hosts by 
outcompeting commensal bacteria and avoid killing by AMPs such as in the case of 
Salmonella enterica, a Gram-negative rod shaped bacterium that causes typhoid 
fever (Pilonieta et al., 2009). Some pathogens possess methods that allow them to 
directly transverse mechanical barriers and evade detection such as in the case of 
the circariae of Schistosoma mansonii, a trematode that causes schistosomiasis 
(McKerrow and Salter, 2002). Immediately after pathogen invasion, the host has a 
number of cellular and chemical means by which it deals with the foreign 
organism. 
 
1.2.1 Dendritic cells 
DCs reside at almost every tissue in the body. However, they are 
strategically enriched at sites of pathogen entry such as the skin, mucosal surfaces, 
airways, intestinal lining, female reproductive tract and uterus (Iwasaki, 2007). 
They constantly sample their environment by receptor mediated endocytosis, 
phagocytosis and macropinocytosis. These processes are well-characterised 
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methods of bacterial clearing by phagocytes in general (such as DCs, neutrophils 
and MΦs). However, recognition and internalisation of pathogens by DCs are the 
means by which they acquire antigen (Ag) in order to educate the adaptive 
immune system about the nature of the invading pathogen. Their phagocytic 
capacity in conjunction with their ability to educate cells of the adaptive arm of 
immunity places DCs at the interface between innate and adaptive immune 
responses. As such, work performed on DC biology aims to understand how this 
phagocyte translates “signals”, received in the periphery, to “message”, for the 
initiation of adaptive immune responses. 
Upon pathogen or “danger” signal recognition through pattern recognition 
receptors (PRRs), DCs internalise pathogens or pathogen-associated products. The 
internalised pathogen is contained in the phagosome, which in turn is enriched 
with vacuoles containing lytic enzymes and reactive oxygen species, creating the 
lysosome (Luzio et al., 2007). Extracellular proteins are processed within the 
lysosome and transported via transporter associated proteins (TAP) for loading 
onto major histocompatibility complex class II molecules (MHC class II) 
(Mukherjee et al., 2001). While this process occurs, DCs migrate through the 
lymphatics to the respective draining lymph node or spleen (Faure-Andre et al., 
2008). The migration process is characterised by the downregulation of CCR6 and 
upregulation of CCR7, which ligates to CCL21 and directs DCs towards secondary 
lympoid organs and T cell areas (Page et al., 2002). During migration, DCs lose 
their phagocytic and endocytic capacity, load degraded, pathogen-derived Ag on 
to MHC molecules, upregulate co-stimulatory molecule expression on their 
surface, and secrete pro-inflammatory cytokines (Cella et al., 1997). Once they 
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reach secondary lymphoid organs, DCs transverse T cell areas where they present 
processed Ag, in the context of MHC, to naïve CD4+ T cells (Cella et al., 1997).  
The role of DCs in immune response development is thought to mainly be 
the activation of naïve T cells or memory cells via MHC-T cell receptor (TCR) 
interactions, there is evidence, however, suggesting that DCs are also able to bind 
unprocessed Ag for presentation to B cells, playing an important role in direct 
initiation and regulation of antibody (Ab) responses (Wykes et al., 1998).  
DCs also play a key role during the T cell negative selection process in the 
thymus, and establish T cell tolerance in the periphery (Hawiger et al., 2001; 
Proietto et al., 2008) (Discussed in more detail in Chapter 1.4). They regulate 
ongoing immune responses against pathogens by homing to infected sites and 
recruiting T cells, neutrophils and other leukocytes. Recirculating DCs have been 
reported to home to sites of inflammation sustaining infiltration of T cells (van Rijt 
et al., 2005). In addition, DCs can receive information from T or B cells via co-
stimulatory molecules or cytokines, affecting their activation state and 
subsequently the way they prime T cells (Alpan et al., 2004; Bayry et al., 2005; 
Orabona et al., 2004). During ongoing infections, DCs establish cross-talks with 
resident and infiltrating immune cells, resulting in the fine-tuning and regulation 
of the ongoing immune response (Bennouna et al., 2003; Rimoldi et al., 2005). The 
fact that DCs occupy sites with different immunological challenges and needs, 
together with their ability to perform a vast range of tasks, has posed them as a 




MΦs are bone marrow derived cells, and ontogenically similar to DCs since 
those two APCs are thought to share common precursors (Geissmann et al., 2010). 
Similarly to DCs, they can acquire Ag in the periphery, process that Ag and load it 
on MHC molecules and, consequently, present it to naïve CD4+ T cells for 
activation (Chang et al., 2005). However, they are thought to be less efficient at 
antigen presentation and activation of naïve T cells than DCs (Steinman and 
Witmer, 1978). Furthermore, bone marrow derived MΦs have been shown to 
preferentially migrate to sites of infection, where they release cytokines and recruit 
other lymphocytes, rather than to secondary lymphoid organs, where naïve T cells 
naturally reside (Zhao et al., 2006). Nevertheless, MΦs are excellent at eliminating 
pathogens as well as “debris” in the form of dead bacteria and dead neutrophils, 
which accumulate during infection and inflammation (Martin and Leibovich, 
2005). As such, the role of MΦs in infection is thought to be immunolodulation 
through cytokine secretion, microbial killing and lymphocyte recruitment 
(Fujiwara and Kobayashi, 2005; Martinez-Pomares and Gordon, 2007; Seljelid and 
Eskeland, 1993).  
Recent advances in MΦ biology have revealed some intriguing functions of 
this cell type that differentiate them from DCs. MΦs activated through cytokines 
associated with allergy, asthma and helminth infections (Taylor et al., 2005) 
(discussed in more detail in Chapter 1.4) have been found to play important roles 
in wound healing and muscle regeneration (Loke et al., 2007; Tidball and Wehling-
Henricks, 2007). Such “alternatively” activated MΦs are characterised by the 
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expression of Ym1, REALMα and arginase (Hesse et al., 2001; Nair et al., 2003; Raes 
et al., 2002). The accumulation of these MΦs in response to platelet derived growth 
factors at injured sites is followed by the release of transforming growth factors 
which activate fibroblasts and keratinocytes to produce collagen (Wahl et al., 1989). 
Additionally, the hypoxic environment at injured sites, where MΦs accumulate, 
activates them to promote angiogenesis (Luft, 2008). The role of MΦs in muscle 
regeneration is poorly understood, however, it is clear that in the absence of 
infiltrating MΦs, myocytes regenerate slowly and incompletely (Tidball and 
Wehling-Henricks, 2007).  
MΦs and DCs share many phenotypical and functional similarities, often 
blurring the image we hold of them as two distinct cell populations. Whether they 
are a single cell population that performs distinct tasks under different 
enviromental stimuli, or two distinct populations is an intriguing question which 
advances in DC and MΦ biology might soon answer!  
 
1.2.3 Neutrophils 
Neutrophils constitute around 60-70% of circulating white blood cells in 
humans and in an adult they are produced at a rate of as many as 1011 cells daily 
(L.J Witts, 1967; Textbook of Haematology). Under physiological conditions they have 
a lifespan of 12 hours. They are one of the first white blood cell recruited to the site 
of infection and in many cases also the last one a pathogen will “see” before 
elimination. Neutrophils become activated by AMPs, complement factors such as 
C5, cytokines such as interleukin 8 (IL-8 or CXCL8) and IFN-γ (Interferon gamma), 
 12 
as well as bacterial products such as N-formyl-peptides (Nathan, 2006). Upon 
activation, they migrate to the site of infection, a process that takes 15-45 minutes, 
and is mediated by the binding of L-selectin found on neutrophils to E- and P-
selectin on endothelial cells (Burns et al., 1999). Upregulation of lymphocyte-
function-associated antigen (LFA) on endothelial cells promotes binding to 
intracellular adhesion molecules (ICAMs) on neutrophils, establishing a tight 
adhesion that arrests migration and enables extravasation through chemotaxis, 
mediated mainly by IL-8 (DiVietro et al., 2001).  
Phagocytosis, oxygen dependent and oxygen independent killing 
mechanisms, and neutrophil extracellular traps (NETs) are some of the methods 
that this cell type employs in order to achieve pathogen elimination (Nathan, 2006). 
Phagocytosis (first described by Metchnikoff in 1901) is mainly mediated through 
Fcγ Receptors (CD32 and CD16) and complement receptors CDR1 (CD35), and is 
the process by which neutrophils and other phagocytes, such as DCs and MΦs, 
engulf microorganisms into the phagosome (Witko-Sarsat et al., 2000). There, 
pathogens are exposed to antimicrobial peptides, proteolytic enzymes and reactive 
oxygen species (ROS). Once killing is completed, neutrophils go through apoptosis 
in a process that involves CD11b/CD18 and the activation of caspases (Nathan, 
2006). The oxygen independent killing mechanism, is characterised by the 
degranulation of neutrophils (as well as MΦs and DCs) and the release of peptides 
such as defensins, cathelicidins and bactericidal permeability-increasing proteins 
(BPIs) (Yang et al., 2001a).  
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Oxygen-dependent killing is initiated with the assembly of the NADPH 
oxidase enzyme complex at the membrane of the phagosome. The oxidation of 
NADPH results in the formation of hydrogen peroxide, which is converted to 
hypochlorite (HOCl) (Hampton et al., 1998). Killing is achieved by the reduction of 
pathogen related proteins and nucleic acids by hypochlorite (Hampton et al., 1998).  
An interesting and recently identified feature of neutrophils is their ability 
to form extracellular traps. These are extracellular structures composed of 
chromatin, which can bind to extracellular bacteria (Brinkmann and Zychlinsky, 
2007). Upon IL-8 or TLR activation, neutrophils utilise the same cascade to the one 
described for the oxidative killing mechanisms. This pathway, however, can also 
lead to the rearrangement of chromatin in the nucleus, followed by the 
degradation of the nuclear envelope, resulting in the chromatin coming into direct 
contact with the cytoplasm (Brinkmann and Zychlinsky, 2007). When neutrophils 
get instructed to undergo apoptosis they release NETs to the surrounding 
environment creating a web that can bind to bacterial proteins and kill microbes 
directly (Brinkmann and Zychlinsky, 2007). The role of NETs in disease are yet 
unclear since it is a novel field of research, but it has been found that strains of S. 
pneumoniae capable of degrading NETs by DNAse activity can escape killing and 
are more pathogenic than strains lacking DNAse activity (Beiter et al., 2006). 
Similarly to DCs and MΦ, neutrophils express PRRs and upon activation 
produce IFN-γ, TNF-α, IL-1, IL-6 as well as AMPs (Nathan, 2006). This enables the 
recruitment of DCs, mast cells, T cells, MΦs and more neutrophils to the site of 
infection. Furthermore, recruited cells come in direct contact with neutrophils, 
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getting information about the nature of the invading pathogen. Direct cell-cell 
contact of neutrophils with DCs has been described and is thought to play an 
important role in fine-tuning immune responses (Bennouna et al., 2003; Ludwig et 
al., 2006). 
 
1.3 Dendritic cell, the main antigen presenting cell 
DCs were first described in the skin in 1868 by Paul Langerhans. However, 
it took more than 100 years before they were characterised as DCs by Cohn and 
Steinman in 1973 (Steinman and Cohn, 1973) and as veiled cells (human immature 
DCs) by  Balfour and Knight in 1982 (Balfour et al., 1982). Their function was not 
understood till mixed leukocyte reaction (MLR), T-dependent antibody responses, 
and graft rejection studies established them as a very potent antigen presenting cell 
(Inaba and Steinman, 1984; Inaba et al., 1983; Inaba et al., 1984; Steinman and 
Witmer, 1978), capable of inducing T cell responses 100 times more efficiently than 
MΦs or other leukocytes. Isolation of DCs from blood or secondary lymphoid 
organs was an arduous process since DCs constitute between 1-2% of total 
leukocytes. However, the generation of monoclonal antibodies against DC surface 
molecules, technological advances in flow cytometric techniques and the discovery 
of methods for the in vitro generation of DCs from bone marrow precursors in 
large numbers, provided the necessary tools to accelerate work on the function of 
these cells, and thus further our understanding of DC involvement in the initiation 
and regulation of immune responses (Crowley et al., 1989; Inaba et al., 1992; 
Nussenzweig et al., 1982).  
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1.3.1 Dendritic cell subsets 
Dissecting immune responses against different pathogens, revealed 
functional differences between initially DCs and MΦs. Advances in DC biology 
revealed functional and ontogenical differences between DCs. Patterns linking 
expression levels of cluster of differentiation numbers (CD numbers) with tissue 
residence and function became apparent, leading to the emergence of DC subsets. 
While widely accepted as CD11c+ -the integrin-α subunit thought to play a role in 
the adherance of monocytes to endothelium cells and phagocytosis of complement 
coated particles (Stewart et al., 1995) - MHC class II high, CD40 low and CD80 low, 
DCs were initially divided into two broad groups, DC1 and DC2. These subsets 
reflected their ability to drive Th1 or Th2 responses respectively (Rissoan et al., 
1999). Attractive as this paradigm might have been due to its neat categorisation of 
DC subsets according to the type of adaptive immune responses they elicited, it 
was short lived. Further work using a wide range of surface markers showed that 
DCs exhibited more plasticity than that proposed by the DC1/DC2 identification 
system.  
Today, murine DCs are typically identified by their levels of CD11c, MHC 
II, CD4, CD8a, CD11b and CD205 expression (Sato and Fujita, 2007). Different DC 
subsets have been identified including CD4+CD8α-, CD4-CD8α+, CD4-CD8α- and 
CD11c+B220+ plasmacytoid DC (pDC) (Shortman and Liu, 2002). The T cell marker 
CD8 is expressed as an αα-homodimer by DCs rather than an αβ-heterodimer as is 
the case on T cells (Sato and Fujita, 2007). Both CD8α+ and CD8α- DC subsets 
appear equally competent at driving T cell proliferation. However, CD8α+ DCs 
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secrete greater quantities of IL-12 upon ligation of CD40 and are thought to be 
better at skewing responses towards a Th1 profile, whereas CD8α- DCs, are 
considered to be better at driving T helper type 2 responses (Maldonado-Lopez et 
al., 1999; Pulendran et al., 1997; Pulendran et al., 1999). For a period of time CD8α+ 
and CD8α- DCs were thought to be of either myeloid or lymphoid origin, 
respectively, however, we know today that both myeloid and lymphpoid DC 
populations can give rise to CD8α+ or CD8α- DCs (Chicha 2004, Manz 2001, Traver 
et al. 2000). 
Characterisation of DC subsets has also revealed links between their 
preferential homing capacity and expression levels of surface markers. Ongoing 
research will certainly improve our understanding of DC function and homing 
capacity. However, we could divide DC subsets into two main populations (Figure 
1.1), a) non-lymphoid tissue resident DCs and lymphoid migratory DCs, and b) 
plasmacytoid DC (pDC). Non lymphoid resident DCs are further subdivided into 
those present at sterile organs such as the heart and pancreas, filtrating sites, such 
as the kidney and liver as well those found in the skin and mucosal tissues such as 
lungs and gut (Naik et al., 2007). Lymphoid DCs, which have been studied 
extensively in the mouse model, and of which little is known in the human, are 
found in the spleen and lymph nodes (Naik et al., 2007). Plasmacytoid DCs are 
circulating blood DCs, but have been described to be present in mucosal surfaces, 
secondary lympoid organs and gut (Naik et al., 2007).  
Understanding to which tissues different DC subsets preferentially home to 
as well as what type of immune responses they bias might prove to be a very 
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useful tool for the generation of targeted vaccination techniques. However, it is 
worth bearing in mind that despite the fact that the nature of different DC subsets 
may bias the type of response elicited, it does not necessarily determine the 
resulting profile of the adaptive immune response developed (Manz et al., 2001; 
Wu et al., 2001).  
 
1.3.2 Dendritic cell precursors 
DC precursors originate in the bone marrow. So far three different types of 
DC precursors and progenitors have been identified and classified according to 
their cell surface markers. Hematopoietic stem and progenitor cell (HSPC), 
characterised by CD45+, Lin- (Lineage), c-Kit+ (CD117) and Sea-1+ (Mouse 
haematopoietic Stem cell antigen 1) expression, is thought to be the precursor for 
tissue resident non-lymphoid DCs (Massberg et al., 2007; Wright et al., 2002). MΦ 
DC precursor (MDP) characterised by CD34+, Lin-, c-Kit intermediate and CD11b-, 
is thought to be involved in the generation of spleen resident DCs and MΦs, 
conventional DCs (cDCS) , pDCs and monocytes, including Gr1+(Granulocyte) 
inflammatory monocytes, that develop into TNF-α - and Inducible Nitric Oxide 
Synthase-Producing DCs (TIP DCs) during infection (Auffray et al., 2009; Fogg et 
al., 2006). Common DC progenitor (CDP) or clonal DC precursor (pro-DC), 
characterised by CD34+, Lin-, c-Kit intermediate and Flt-3+ expression, have been 
described to drive the generation of conventional and plasmacytoid DCs residing 
at secondary lymphoid organs (Onai et al., 2007). A detailed schematic of the 
different fates of DC precursors is found at Figure 1.1.  
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Despite the identification of different DC subsets and their implication in 
generating tissue specific DCs, increasing amount of evidence suggests that the fate 
of DC progenitors is equally dependent on chemokine, cytokine, and growth factor 
presence. For example DC precursors that do not express the receptor for GM-CSF 
or Flt3, are thought to develop into the DC subpopulation predicted according to 
their cell surface markers described above (Kingston et al., 2009). However, there is 
evidence suggesting that a common DC precursor expressing GMCSF ligand and 
Flt3 can develop into a cDC or a pDC in the presence of either GM-CSF or Flt3 
ligand (Naik et al., 2007; Xu et al., 2007).  
DC precursors exhibit a great deal of plasticity, while no master regulator 
responsible for the generation of distinct DC subtypes has yet been identified. 
Additionally, mounting evidence suggests that the cytokine and growth factor 
milieu in the bone marrow, blood or secondary lymphoid organs, as well as 
physiological or pathological conditions may play an important role in the fate of a 
DC precursor. Ultimately, DCs and their precursors have demonstrated 
remarkable functional plasticity and are able to differentiate into different types of 
DCs after encounters with various stimuli (Banchereau and Palucka, 2005). 
 
1.3.3 Recognition of pathogens and “danger signals” 
The concept of a pattern recognition receptor (PRR) was first envisaged by 
Charles Janeway in 1989, when he proposed that the host possesses a number of 
receptors that can recognise pathogenic components and trigger antimicrobial 
responses to a number of diverse infectious organisms (Janeway, 1989). While this 
hypothesis established the foundations of the discrimination of self from non-self, 
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it was later recognised that the host can also recognise host-derived “danger” 
signals (Matzinger, 1998). Innate recognition of pathogenic organisms and self-
derived “danger” signals - usually intracellular components - is a crucial stage of 
immune development.  
Antigen presenting cells have a large array of pattern recognition receptors 
(PRRs) that recognise evolutionary conserved molecular patterns (called pathogen 
associated molecular patterns or PAMPs) expressed by infectious organisms such 
as bacteria, viruses, helminths, yeast and protozoa, as well self-derived Ags. 
Examples of known PRRs include the the toll like receptors (TLR’s, 1-11 in humans, 
1-13 in mice), C-type lectins, CARD helicase receptors such as retinoic acid-
inducible gene 1 (RIG-1) like receptors (RLRs), and nucleotide-binding 




1.3.4.α Bacterial recognition 
Ligation of bacterial components such as LPS or peptidoclycan to TLR-4 or 
TLR-2, respectively, are known to induce classical activation of DCs (Michelsen et 
al., 2001), characterised by production of cytokines such as IL-12 p40 and p70, 
TNF-α and IL-6, as well as up-regulation of MHC class II and surface expression of 
co-stimulatory molecules. CpG unmethylated DNA, which is characteristic of 
bacterial but not eukaryotic DNA, has been shown to classically activate DCs in 
vitro by ligation to TLR-9 (Boonstra et al., 2003). Lipoproteins, such as OspA, an 
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outer surface lipoprotein from Borrelia burgdoferi, can bind to both TLR-2 and TLR-
1 while bacterial flagellins bind to TLR-5 inducing classical DC activation 
(Alexopoulou et al., 2002). 
 
1.3.4.β Viral recognition 
Binding of single stranded RNA such as that from influenza virus or 
vesicular stomatitis virus (VSV) to TLR-7 induces type 1 interferons and IL-1 
production by pDC (Lund et al., 2004). Double stranded (ds) synthetic 
polyriboinosinic:polyribocytidylic acid (polyI:C), the synthetic analogue of viral 
dsRNA or encephalomyocarditis virus (EMCV) binds to TLR-3 inducing DC 
activation and cross presentation (discussed in 1.3.7) for CD8+ T cell activation 
(Schulz et al., 2005). 
 
1.3.5 Other PRRs 
NLRs constitute a cytoplasmic PRR family, containing more than 20 
members. The first NLRs to have been described are NOD-1, which recognises γ-d-
glutamyl-meso-diaminopimelic acid on gram negative bacteria and NOD-2, which 
is a bacterial and single stranded RNA virus sensor, recognising muramyl 
dipeptide (MDP) (Lee and Min, 2007; Murray, 2009). Flagellin from Salmonella and 
Legionella, which as discussed earlier can bind to TLR-5, can also bind to NLRs, 
IPAF and NAIP5, activating the caspase-1 signaling pathway, which leads to the 
production of IL-1β and host cell death (Mariathasan et al., 2004; Zamboni et al., 
2006). Extracellular ATP (adenosine triphosphate) and uric acid, both released 
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following stress in the form of physiological exhaustion, or during bacterial or 
viral- induced cell death, bind to NALP3, leading to the activation of caspase-1 as 
well as secretion of IL-1β and IL-18 (Mariathasan et al., 2006; Martinon et al., 2006), 
suggesting that NLRs might be important in sensing “danger” signals. 
Cytoplasmic CARD helicases, such as RIG-I and MDA-5 receptors, bind to poly I:C 
synthetic RNA and viral double stranded RNA (Thompson and Locarnini, 2007; 
Yoneyama et al., 2004), inducing type 1 interferon responses (Gitlin et al., 2006).  
C-type lectin receptors, such as DC (DC)-specific ICAM-grabbing 
nonintegrin (DC-SIGN) (CD209) in humans and SIGN-R1 in mice, and 
DC‑associated C‑type lectin 1 (DECTIN-1) receptor are found on MΦs, DCs as 
well as B cells (Geijtenbeek and Gringhuis, 2009). They are extracellular receptors 
that bind a range of glycans (mannose, fucose) on viruses, bacteria, fungi, protozoa 
and helminths (Geijtenbeek and Gringhuis, 2009). C-type lectin binding promotes 
phagocytosis, endocytosis and antigen presentation by DCs (Bonifaz et al., 2004; 
Gazi and Martinez-Pomares, 2009; Zhang et al., 2005). They have also been found 
to be involved in secretion of type 1 interferons by APCs (Chen et al., 2008), 
driving allergic and type 2 responses (Barrett et al., 2009; Sato et al., 2006; Shreffler 
et al., 2006) as well as inducing IL-10, in response to probiotic (commensal) bacteria 
(Smits et al., 2005), possibly involved in regulation. 
 
1.3.6 PRR interplay 
 Characterising the importance of individual PRRs in pathology and in 
pathogen recognition has proven useful in understanding how APCs recognise 
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pathogens and “danger” signals in the periphery, and subsequently how they 
become activated and drive immune responses. A single infectious organism, 
however, will simultaneously present a number of different PAMPs to PRRs on 
APCs. While, some PRRs work synergistically, amplifying APC activation, it is not 
uncommon for others to counter-regulate each other. 
Ligation of TLR-4 via LPS has been shown to upregulate TLR-4, TLR-2 and 
TLR-9, possibly enhancing APC sensitivity to bacterial cell wall components and 
CpG unmethylated DNA (An et al., 2002; Gautier et al., 2005; Napolitani et al., 
2005). On the other hand, ligation of TLR-2 has been found to alter DC 
responsiveness to TLR-4 and TLR-3, by blocking their ability to induce type 1 
interferons, possibly through an IL-10 dependent manner, since TLR-2 ligation 
drives strong IL-10 responses by DCs (Re and Strominger, 2004). The importance of 
TLR interplay has also been investigated in pathologic conditions. Double, TLR-2 -
/- TLR-9 -/-, deficient mice were shown to be much more susceptible to aerosol 
mycobacterial infections than the respective TLR-2 -/- or TLR-9 -/- single gene 
deficient mice, suggesting that TLR synergy is important for optimal immune 
response development (Bafica et al., 2005).  
There is limited evidence that CARD helicases also interplay with TLRs. 
MDA-5 has been shown to be expressed and translocated to the cytosol upon IFN-
β stimulation, a process which is facilitated upon TLR activation (Kang et al., 2002). 
NLRs such as NOD-1 and NOD-2 have been found to act synergistically with TLR-
4 for the induction of TNF-α and IL-6, while activation of NODs allows for 
maturation of human DCs with sub-activating doses of LPS, suggesting the 
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synergy between NODs and TLR-4 allows for DC activation at lower bacterial 
concentrations.  
Counter regulation between TLRs and other PRRs has also been reported. 
RIG-1 is negatively regulated by A20, an LPS-inducible regulator of TLR-4, 
suggesting that TLR-4 may indirectly inhibit signalling through RIG-1 (Lin et al., 
2006). CLR’s have been shown to modulate TLR signalling. For example, DC-SIGN 
ligation by mycobacterial glycans in human DCs acts to modulate TLR-3, TLR-4 
and TLR-5 signalling, by inducing IL-10 production, and concomitant reduction of 
IL-12p70 (Geijtenbeek et al., 2003; Gringhuis et al., 2007). 
 
1.3.7 Antigen processing and presentation 
Following pathogen recognition, APCs internalise pathogens and process 
them for presentation to T cells. Antigen processing and antigen presentation by 
APCs is a crucial part of T cell homeostasis and immune response development. 
Two distinct pathways of antigen processing are recognised today. The 
endogenous pathway, which results in presentation of cellular and viral peptides 
on MHC class I molecules, or human leukocyte antigen (HLA in humans). And the 
exogenous pathway, which results in presentation of extracellular derived antigen 
on MHC class II molecules.  
Select cell types, in particular DCs, can use the exogenous pathway for 
presentation of extracellular derived Ag on MHC class I molecules in a process 
termed “cross-presentation” (Heath et al., 2004). Similarly DCs can utilise the 
endogenous pathway for presentation of intracellular derived Ag on MHC class II 
molecules (Nuchtern et al., 1990). 
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Endogenous pathway  
Missfolded or worn out proteins are ubiquitinated and targeted for 
proteasomal degradation within the cytosol and endoplasmic reticulum. 
Proteasomes such as leucine aminopeptidase, puromycin-sensitive aminopeptidase 
and bleomycin hydrolase degrade proteins to 8 to 10 amino acid length in size 
(Towne et al., 2008; Towne et al., 2007). The transporter associated with antigen 
protein (TAP), which spans the membrane of the endoplasmic reticulum binds to 
the degraded peptides and transports them to the lumen of the E.R (Shepherd et 
al., 1993). There, further degradation takes place, reducing the peptides to the right 
size for MHC I loading. A series of chaperone proteins facilitate the folding of class 
I MHC molecules and its association with β2-microglobulin (Ortmann et al., 1994). 
The partially folded MHC I molecule associates with TAP, a process catalysed by 
tapasin, which loads the peptide on to the MHC I molecule and stabilising it. This 
induces the transport of the MHC I-peptide complex to the cell membrane via the 
Golgi coplex (Banchereau et al., 2000). 
 
Exogenous pathway 
 Extracellular bacteria or Ag are internalised into the phagosome, which 
after fusing with lysosomes, forms the phagolysosome (or late endosome) 
(Banchereau et al., 2000). Protein degradation and MHC II loading is performed 
within this compartment. Nascent MHC II is formed in the E.R by α and β chains 
as well as an invariant (Ii) chain, which serves to block the MHC docking site from 
endogenous and cellular peptide loading, as well as to transport the MHC II 
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molecule to the late endosome (Banchereau et al., 2000). The MHC-Ii complex is 
transported to endosomal vesicles where lysosomal proteases degrade the 
invariant chain leaving behind a small fragment called CLIP. HLA-DM, an MHC II 
like protein, removes CLIP and replaces it with a peptide from the phagolysosome 
(Watts, 2004). The Ag loaded MHC class II is then transported to the cell 
membrane for presentation to naive CD4+ T cells. 
 
1.4 Adaptive immune responses 
The importance of the adaptive arm of immunity has been clearly 
demonstrated in animal models such as those of thymectomised or severe 
combined immunodeficiency (SCID) mice, as well as in humans, such in the case of 
acquired immunodeficiency syndrome (AIDS) or hyper IgM syndrome. Humans 
and mice lacking T or B cells succumb much more rapidly than normal hosts to 
pathogenic infections. Moreover, they are prone to opportunistic infections by 
agents that are otherwise non-invasive, such as pulmonary infections with 
Cryptococcus neoformans, Aspergillus fumigatus and Histoplasma capsulatum as seen in 
HIV-1 infected humans (Antinori et al., 1996), and Pneumocystis carinii in both HIV-
1 infected humans and SCID mice (Rapaka et al., 2007). It is thus clear that 
adaptive immune responses are integral to the effective elimination of pathogens 
by the host.  
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1.4.1 T cells 
The activation and subsequent involvement of T cells in immune responses 
is a critical step towards the elimination of infectious organisms. Animal 
experiments addressing the importance of T cells in immunity have shown that T 
cell deficient mice are severely immunocompromised and, similarly to humans 
suffering from AIDS, succumb to infections caused by opportunistic pathogens, 
rapidly. T cells amplify immune responses by recruiting leukocytes to the sites of 
infection by activating MΦs, neutrophils and natural killer cells (NK cells), by 
providing help to B cells for Ab switching and clonal expansion, and by direct 
killing of infected cells.  
T cell lineages include αβ T cells γδ T cells. αβ T cells are further divided 
into CD4+, CD8+ and NKT cells. These subtypes of T cells are selected for early, 
during thymic development, and show no plasticity. CD4+ αβ T cells are the most 
abundant T cell subset and responsible for most of the functions described below. 
CD8+ T cells are essential for eliminating viral and intracellular pathogen infected 
cells. γδ CD4+ T cells represent a very small proportion of the total T cell 
population. They home to mucosal and dermal tissues and are thought to be 
involved in localised immune responses. NKT cells show limited diversity of αβ 
TCR in comparison to CD4+ T cells, and recognise glycolipids presented on CD1d.  
Groundbreaking work in T cell immunology by Mossman and Coffman in 
1986 recognised distinct subpopulations of T cells according to their ability to 
secrete either IL-4 or IFN-γ (Mossman & Coffman, 1986). Soon after, it became 
apparent that T cell populations exert specific effector functions against the vast 
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range of pathogens encountered by the host. Today, we recognise the existence of 4 
such subpopulations of T helper cells: T helper 1 (Th1), T helper 2 (Th2), inducible 
T regulatory cells (Treg), and T helper 17 cells (Th17) (Figure 1.2). Recent work has 
proposed the existence of two more subsets, T helper 9 and T helper 22 cells, for 
which, however, no master transcriptional regulator has yet been identified. 
Understanding how distinct T cell subsets combat pathogens and prevent or cause 
autoimmune disease may lead to improved vaccination, cancer therapy strategies 
as well as graft rejection and autoimmune disease prevention strategies (Mariotti et 
al., 2008a; Sredni et al., 1996; Weaver et al., 2005). It is worth bearing in mind that 
distinct pathogens may require a range of different T cell subsets to be eliminated. 
Furthermore, it is not uncommon during pathology for individual T cells to secrete 
a number of different cytokines, blurring the somewhat artificial division we 
ascribe to them.  
 
1.4.2 Th1 
Th1 responses are characterised by the secretion of IFN-γ and expression of 
the transcription factor T-bet by T cells (Szabo et al., 2000). Th1 responses are 
associated with clearing bacterial, viral, fungal and protozoan infections such as 
Salmonella typhimurium, hepatitis C virus, Candida albicans and Leishamania major 
(Cenci et al., 1997; Davis et al., 2008; Ferlin et al., 1998; Mittrucker et al., 2002). They 
are also involved in eliminating cancer cells, in graft rejection and pathology 
during autoimmune disorders such as multiple sclerosis (Disis and Park, 2009; 
Mariotti et al., 2008b; Selmaj et al., 1991). Th1 responses augment the infiltration of 
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MΦs, NK cells and neutrophils at the sites of infection. Responses against Th1 
polarising pathogens are characterised by high levels of IFN-γ, lymphotoxin-α and 
IL-2.  
IFN-γ is an important cytokine for the activation of MΦs, inducing NO 
synthesis and microbial killing, lymphocyte recruitment, virus infected cell-killing, 
enhancement of Ag uptake and presentation, and inhibition of cell division 
(Schroder et al., 2004). Lymphotoxin-α is thought to play a role in clearing viral 
infections through the activation of CD8+ T cells (Kumaraguru et al., 2001). IL-2 is 
important for the expansion of both CD4+ and CD8+ populations as well as the 
generation of memory CD8+ populations (Williams et al., 2006). CD4+ T cells play a 
major role in providing help to B cells for Ab switch via CD40-CD154 interactions 
(Lederman et al., 1992), and induction of memory CD8+ T cells through CD27 
ligation and provision of IL-15 (Oh et al., 2008; Xiao et al., 2008). Furthermore, 
CD4+ and CD8+ T cells can directly kill lymphocytes, infected cells, as well as 
cancer cells, via the Fas-Fas ligand and perforin-granzyme route (Canaday et al., 
2001; van den Broek et al., 1996; Zheng et al., 2007).  
 
1.4.3 Th17 
Early experiments on experimental autoimmune encephalomyelitis (EAE) 
attributed disease pathology to IFN-γ secreting CD4+ T cells (Miller and Karpus, 
1994). Later work using either IL-12 blocking antibodies or IFN-γ deficient mice 
showed that IL-12 is necessary for EAE induction, whereas the absence of IFN-γ 
contributed to pathology (Krakowski and Owens, 1996; Leonard et al., 1995). 
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Strikingly, it was found that IL-12p35 deficient mice were susceptible to EAE, 
suggesting that a different IL-12 member than IL-12p70 was responsible for the 
induction of an autoreactive T cell repertoire (Gran et al., 2002). IL-23  (composed 
of IL-12 p40 and IL-12 p19) was later shown to be responsible for the induction of 
EAE pathology. Furthermore, mounting evidence suggested that IL-23 was also 
responsible for the induction of IL-17A (IL-17) responses, suggesting that CD4+ IL-
17 producing cells are responsible for disease pathology (Cua et al., 2003; Park et 
al., 2005) in the EAE setting. Today we know that Th1 CD4+ T cells and CD8+ T 
cells are in fact also necessary for establishing disease pathology in the EAE setting. 
Nevertheless, the link of IL-17 to this autoimmune disease model provided the 
impetus for addressing the role of Th17 cells in immunity.  
The generation of Th17 cells in mice is dependent on the presence of TGF-β 
and IL-6 (Mangan et al., 2006; Veldhoen et al., 2006), while human studies have 
found that Th17 differentiation is dependent on IL-1β plus IL-6 or IL-1β plus IL-23 
(Acosta-Rodriguez et al., 2007a; Wilson et al., 2007), and is under the control of the 
transcriptional factor RORγT (Ivanov et al., 2006). Th17 responses are described by 
the secretion of IL-17, IL-21 and IL-22.  
IL-17 is thought to play a role in the induction of proinflammatory cytokines 
and chemokines as well as participating in the disruption of endothelial cell tight 
junctions at the blood-brain barrier (Kebir et al., 2007; Khader et al., 2007). IL-21 
acts on T cells to further expand Th17 populations (Korn et al., 2007), while IL-22 is 
thought to play a role in promoting microbial killing by inducing the secretion of 
AMPs (described in Chapter 1.1.2) (Liang et al., 2006). Recent work on the EAE 
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model has shown that IL-17 secreting T cells home to inflamed tissues with 
established lesions (O'Connor et al., 2008), while work on the Mycobacterium 
tuberculosis disease model has suggested that perhaps Th17 cells may be important 
in recruiting CD4+ T cells to infected sites (Bettelli et al., 2008; Khader et al., 2007). 
Ongoing research is aiming to understand the role of this relatively novel cytokine 
in protective immunity and autoimmune disease 
 
1.4.4 Th2  
Th2 responses are characterised by the production of IL-4 by T cells and the 
expression of the transcription factor GATA-3 (Zheng and Flavell, 1997). Th2 
responses have been described in the resolution of helminth infections and 
pathology associated with allergic inflammation and asthma (Else and Finkelman, 
1998; Ngoc et al., 2005). Evidence suggests that skewing transplant recipients from 
Th1 to Th2 responses can prolong graft survival (Qin et al., 2001), however, Th2 
responses have also been shown to induce chronic graft rejection (Mhoyan et al., 
2003). Th2 responses are characterised by the secretion of IL-4, IL-5, IL-9, IL-10, IL-
13, IL-25 (IL-17 E), IL-33 and amphiregulin by T cells (Zhu and Paul, 2008).  
IL-4 is a positive feedback cytokine for Th2 differentiation. It also promotes 
B cells to class switch to IgE (Kopf et al., 1993), which binds to basophils and mast 
cells, resulting in the secretion of active mediators such as serotonin and histamine 
(Prussin and Metcalfe, 2003). IL-5 is a powerful chemoattractant for eosinophils 
(Coffman et al., 1989).  IL-13 is involved in the expulsion of helminths (Wynn, 
2003), while amphiregulin is an epithelial cell growth factor that has been shown to 
also be involved in the expulsion of Trichuris muris (Zaiss et al., 2006). IL-10 inhibits 
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DC maturation, as well as directly inhibiting Th1 differentiation (Fiorentino et al., 
1989). IL-25 acts as an IL-4, IL-5 and IL-13 positive regulator, and is secreted by 
non-T or B cells at mucosal sites (Fallon et al., 2006). 
 
1.4.5 Regulatory T cells 
The notion that regulation is involved in immunity was introduced in the 
1970s (Katz, 1972). It was not, however, until 1995 that the revolution in immune 
regulation began, with work by Sakaguchi who demonstrated that IL-2 receptor 
(CD25) depleted T cells transferred into athymic mice resulted in autoimmune 
disorders (Sakaguchi et al., 1995). Today, we have identified a number of different 
regulatory T cell populations that can be broadly divided into naturally occurring 
T regs, which are of thymic origin, and inducible T regs, which are generated in the 
periphery. In addition, regulatory populations have been further subdivided 
according to their cytokine-secretion profiles into Treg and Th3 populations. Work 
on scurfy mice and X-linked neonatal diabetes mellitus, enteropathy and 
endocrinopathy syndrome (IPEX) on humans recognised that forkhead/winged-
helix protein (Foxp3) is the master transcriptional regulator for the generation of 
regulatory T cells (Brunkow et al., 2001; Fontenot et al., 2003; Wildin et al., 2001). 
TGF-β, in the absence of other proinflammatory cytokines, is thought to be the 
primary inducer of regulatory T cells (Chen et al., 2003).  Naturally occuring T regs 
modulate immune responses by killing autoreactive T cell clones that escape into 
the periphery via the Fas/Fas ligand and granzyme/perforin routes, while 
inducible T regs modulate ongoing immune responses by killing effector 
 32 
lymphocytes (Banz et al., 2002; Gondek et al., 2005; Weber et al., 2006). 
Additionally, Tregs modulate the ability of APCs to activate T cells by secreting 
cytokines such as IL-10 and by cell-cell interactions involving CTLA-4/CD80 that 
downregulates costimulatory molecule expression on DCs (Fehervari and 
Sakaguchi, 2004; Wing et al., 2008).  
 
1.4.6 B cells 
B lymphocytes are best known for their antibody producing capacity, 
making them the prime cell providing humoral immunity. B cell precursors are of 
bone marrow origin. They recirculate in the blood and reside in germinal centres, 
where, with the provision of T cell help, they clonally expand and switch antibody 
isotype production (Allman et al., 2004). Many infectious models as well as human 
conditions such as hyper IgM syndrome, have established the importance of 
humoral responses in improved prognosis (Lougaris et al., 2005). Antibodies bind 
to pathogens such as bacteria and can initiate the complement pathway or 
opsonise phagocytosis by DCs and MΦs (Kelly et al., 2005; May and Frank, 1973). 
In mucosal tissues such as the gut, IgA Ab can bind to pathogenic bacteria, 
impairing their ability to attach to epithelial cells, while it also impedes bacterial 
motility required for host invasion (Vaerman, 1984).  
Although, the consensus is that the main contribution of B cells in immunity 
is Ab production, without which disease clearance is severely impaired, B cells 
have been described to also play important roles in Ag presentation and provision 
of help T cells. B cell deficient models, addressing the contribution of this cell type 
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in initiating and sustaining immune responses, have shown that B cells enhance T 
cell numbers and immune response development (Kleindienst and Brocker, 2005), 
infection settings, such as the Salmonella typhimurium model in mice, have shown 
that full clearance of the pathogen is achieved only when both T and B cells are 
present, while pathology can not be overcome in the absence of B cells, whether 
antibody is present or not (Mastroeni et al., 2000a). Naive B cells are weak antigen 
presenting cells, however when clonally expanded, they exhibit excellent antigen 
presenting capacity, possibly contributing to the rapid clearance of pathogens later 
in infection, or even during early stages of concomitant invasions by the same 
pathogen (Ugrinovic et al., 2003). Furthermore, B cells are essential for the recovery 
from experimental autoimmune encephalomyelitis (Lyons et al., 2008). Provision of 
the IL-10 regulatory cytokine by autoreactive B cells is essential for EAE recovery 
(Fillatreau et al., 2002). B cells have recently been described to be crucial for the 
generation of memory T cells both in mice and humans by providing them with 
the right survival signals, most probably through the ligation of CD40 to CD154 
(Crawford et al., 2006; Morales-Aza et al., 2009; Whitmire et al., 2009). Although 
their importance as an Ab-producing cell is immense, often overshadowing other 
key roles they may play during infection or autoimmune disease, it is obvious that 
B cells have a wide range of immunologically important functions during both 
primary and memory responses. 
 
1.5 Dendritic cells bridge the innate with the adaptive immune responses 
Pathogen derived components and host derived “danger” signals are 
recognised and taken up by DCs in the periphery. DCs then migrate to secondary 
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lymphatic tissues where they present parts of the internalised material in the 
context of MHC class II to naïve CD4+ T cells (Reis e Sousa and Germain, 1999). A 
crucial factor deciding the fate of immune response development (discussed in the 
previous chapter - Chapter 1.4) during pathogen invasion is the context in which 
DCs present Ag to T cells. The signal DCs receive in the periphery via PRR ligation 
becomes translated into a message for T cells in the form of MHC-antigen 
presentation, co-stimulatory molecule upregulation and cytokine secretion. 
Different pathogens leave an “imprint” on DCs, which following maturation will 
initiate pathogen-specific T cell responses (Banchereau and Steinman, 1998; de Jong 
et al., 2002; MacDonald et al., 2002b; Mangan et al., 2006).  
The activation and polarisation of naïve CD4+ T cells is determined by three 
signals provided by DCs in secondary lymphoid tissues.  The first signal is 
provided via the presentation of short peptides (epitopes) that originate from 
pathogenic proteins acquired in the periphery by DCs on MHC molecules, which 
are bound by the appropriate TCR of naïve CD4+ T cells. The second signal is 
thought to be co-stimulation mediated primarily via CD28 on the T cell and 
CD80/CD86 on the APC, in whose absence T cells become anergic (Kapsenberg, 
2003). The third signal provided by DCs, is a combination of cytokines and surface 
molecules on DCs that determine the polarisation state of the T cell (Kalinski et al., 
1999; Kapsenberg, 2003). 
 
Signal 2 
The best characterised co-stimulatory molecules on DCs are two members of 
the B7 family, CD80 and CD86, which bind to CD28 and CTLA-4 (Cytotoxic T 
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Lymphocyte Antigen-5 or CD152) found on T cells. CD28 is expressed 
constitutively on T cells while CTLA-4 is upregulated upon activation  (Carreno 
and Collins, 2002; Wang and Chen, 2004). Ligation of CD80 and CD86 to CD28 
provides a powerful signal to T cells, which, in conjunction with the signal 
provided by TCR ligation to peptide-loaded MHC (signal 1) induces the 
upregulation of CD25 (IL-2 receptor) on T cells as well as the production of IL-2, 
resulting in T cell entry into the cycle and subsequent proliferation  (Alegre et al., 
2001; Carreno and Collins, 2002; Greenwald et al., 2005). Ligation of CD152 to CD80 
or CD86, however, is thought to transmit an inhibitory signal to T cells (Carreno 
and Collins, 2002; Wang and Chen, 2004).  
In addition to signal transduction via CD28 to T cells, some evidence 
suggests that CD80 and CD86 ligation to CD28 provides a retrograde signal to 
the APC (Khan et al., 2007). Recent work has revealed five new members of the 
B7 family, including inducible costimulator (ICOS) ligand, PD-L1, PD-L2, B7-H3 
and B7-H4 (Greenwald et al., 2005). All of these have been shown to be 
expressed on APCs and provide a potential new mechanism for regulating T cell 
activation and tolerance.  
 
Signal 3 
The subset naïve CD4+ T cells develop into is, to a great extent, determined 
by the molecular signals provided during antigen presentation by APCs known as 
“signal 3” (Kapsenberg, 2003). The cytokine milieu naïve CD4+ T cells are found in, 
together with surface molecules expressed on APCs instruct T cells to become 
polarised towards the various different profiles described earlier (Chapter 1.4).  
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APC-derived IL-12 p70 polarises CD4+ T cell responses towards a Th1, IFN-γ 
secreting profile (Orabona et al., 2004; Van Gool et al., 1996). Nevertheless, the 
requirement for this cytokine has been found to not be restricted to DCs, since in 
the absence of DC derived IL-12, other cell sources of IL-12 p70 are sufficient to 
drive Th1 responses (MacDonald and Pearce, 2002; Soares et al., 2007). IL-23 
secreted by APCs has been found to play a crucial role in the generation of IL-17 as 
well as IFN-γ responses, however it is yet unknown whether it is required for the 
instruction of CD4+ T cells to become IL-17 or IFN-γ producers or the activation of 
previously polarised CD4+ T cells (Aggarwal et al., 2003; Langrish et al., 2005). IL-6 
secretion by APCs is thought to be important for activating T cells by inhibiting T 
regulatory cell-mediated responses (Pasare and Medzhitov, 2003). Regulatory T 
cell response development is known to be dependent on the presence of TGF-β, 
while IL-6 in conjunction with TGF-β is known to instruct CD4+ T cells to become 
IL-17 producers (Mangan et al., 2006). As such, IL-6 may be involved in averting 
the activation of naïve CD4+ T cells away from an undesirable regulatory 
phenotype, by directing them towards a Th17 one (Bettelli et al., 2006; Stockinger et 
al., 2007; Veldhoen et al., 2006). Low surface expression of co-stimulatory molecules 
on DCs coupled with reduced or absent IL-12 p70 production and elevated 
secretion of IL-10 and can lead to a T helper 2 (Th2) phenotype (Jankovic et al., 
2004). IL-10, which is secreted by APCs as well as activated CD4+ T cells acts in a 
retrograde fashion back on APCs to inhibit MHC class II expression, CD86 
expression, IL-12, TNF-α and IL-1β secretion (Liu et al., 2004; Steinbrink et al., 
1997), a process thought to play an important role for controlling inflammation. 
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In addition to cytokines, a range of surface molecules are also involved in 
the provision of signal 3 to naïve T cells. CD40 is a cell surface receptor on APCs, 
which ligates to CD154 on T cells, a process thought to be essential for immune 
regulation as well as activation and function of APCs (Grewal and Flavell, 1998; 
van Kooten and Banchereau, 2000). Ligation of CD40 to CD154 has been shown to 
be crucial for the development of optimal Th1 as well as Th2 immune responses 
(al-Ramadi et al., 2006; MacDonald et al., 2002a; MacDonald et al., 2002b).  
In addition to CD40, signal 3 can also be provided via OX40L. Expression of 
OX40L by DCs, as well as other APCs, has been shown to be induced following 
activation, while its expression can be enhanced following CD40 signalling (Croft, 
2003; Gramaglia et al., 1998; Murata et al., 2000). OX40L associates with OX40 
(CD134), on T cells, which is induced following TCR/CD3 signalling (Gramaglia 
et al., 1998). Interestingly, OX40L has been shown to be particularly important for 
the generation of Th2, but not Th1 responses (Jenkins et al., 2007). 
 
1.6 Salmonella 
Salmonella is a facultative Gram negative bacteria that infects humans and 
animals through the faecal-oral route. Salmonella enterica serovar Typhi (S. typhi) 
causes typhoid fever in humans and accounts for approximately 16 million 
reported cases a year and 600,000 deaths globally. Salmonella enteritidis servovar 
Enterica and Typhimurium (S. enterica, S. typhimurium) are common contaminants 
of raw meat, and cause between 200 million and 1.3 billion cases of intestinal 
disease and approximately 3 million deaths a year (Coburn et al., 2007). As such, 
Salmonella enterica pose a serious commercial problem for the food industry. 
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Vaccination efforts against Salmonella started as early as the 19th century. By 1957 it 
was recognised that vaccination with sub-lethal doses of live bacteria conferred 
protection in humans (Hobson, 1957). Adoptive transfer of immune serum 
improved prognosis, however, found to be inadequate for full protection. 
Subsequent studies addressed the requirement of T cells for the generation of 
protective immune responses (Killar and Eisenstein, 1985; Kotlarski et al., 1989), 
and soon after it was established that both humoral and cellular immune responses 
were essential for pathogen elimination (Mastroeni et al., 1993a).  
 
1.6.1 Salmonella pathogenicity factors, immune evasion and pathology 
The innate and adaptive arm of the immune system play crucial roles in 
both controlling and eliminating pathogen invasion and spreading. Equally, 
Salmonella possess a large range of immune evasion and survival methods, 
enabling it to overcome an otherwise very hostile environment. Responses against 
Salmonella infection can be divided into two categories: pathogen associated 
immune responses, that are directed against the pathogen, and virulence-
associated pro-inflammatory responses, that are caused and exploited by the 
pathogen. The most important pathogenicity determinants are the Salmonella 
Pathogenicity Islands (SPI), SPI-1 and SPI-2, encoding a type III secretion system 
(T3SS) (Galan and Curtiss, 1989; Mills et al., 1995), which injects effector bacterial 
proteins into either host cells, through a process called translocation, or into the 




Although initially recognised for their role in host invasion (Jepson et al., 
2001), T3SS products are now known to be involved in a number of bacterial-host 
interactions that result in cell infiltration and the induction of cell death by the 
activation of caspase-1 (Coburn et al., 2007). When purified SipA, which is encoded 
by SPI-1, is added to intestinal epithelial monolayers, it induces the production of 
pathogen elicited epithelial chemoattractant (PEEC)(Lee et al., 2000), resulting in 
the direct recruitment of polymorphonuclear cells at the site of infection. 
Neutrophil infiltration to the gut lumen is linked to the disruption of the intestinal 
wall, crypt abscess formation, epithelial necrosis, oedema and fluid secretion 
(Clarke and Gyles, 1987; Finlay et al., 1989; Giannella et al., 1973; McGovern and 
Slavutin, 1979). SipB, which is also encoded by SPI-1, is translocated into the 
cytosol of host cells, where it binds caspase-1, leading to the release of pro-
inflammatory cytokines IL-1β and IL-18 (Hersh et al., 1999), and inducing cell 
death by apoptosis and necrosis, a process termed pyroptosis. Although, 
pyroptosis, was initially believed to be essential for pathogen spreading from the 
intestinal lumen to systemic sites (Monack et al., 2000), studies using caspase-1 
deficient mice showed that they are more susceptible to infection, suggesting that 
pyroptosis might be beneficial to the host (Lara-Tejero et al., 2006). SopE, encoded 
by SPI-1 is involved in the induction of bacterial uptake by phagocytes (Hardt et 
al., 1998), and inducing early inflammatory responses in the epithelium. Complete 
deletion of the SPI-1 gene results in delayed inflammatory responses against 
Salmonella, however systemic responses remain unaltered (Zeng et al., 2003).  
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The molecular products encoded by SPI-1 genes is known to be transcribed 
during early stages of invasion of the intestinal site, however, it is yet unclear 
whether the SPI-1 – encoded molecular apparatus is critical for invasiveness. SPI-1 
is, however, linked to early inflammation and infiltration of polymorphonuclear 
cells at the site of bacterial invasion. Perhaps early inflammation which can lead to 
destruction of the gut lumen architecture, allows for faster translocation of 
pathogens to systemic sites. 
 
1.6.3 SPI-2 
The molecular apparatus encoded by SPI-2 is essential for intracellular 
parasitism and virulence. Strains lacking SPI-2 genes are attenuated by up to five 
orders of magnitude compared to wild type strains, as identified by oral and 
intraperitoneal administration of these strains to naïve mice (Shea et al., 1996). 
Early studies on SPI-2 deficiencies described poor survival of Salmonella within 
MΦs, suggesting that proteins encoded by this pathogenicity island are interfering 
with the proteolytic pathways involved in intracellular killing mechanisms by 
phagocytic cells (Ochman et al., 1996). Interestingly, SPI-2 products induce the 
production of IL-10, prostaglandins and prostacyclins in MΦs (Uchiya et al., 2004; 
Uchiya and Nikai, 2004). These findings suggest that Salmonella may be actively 
inducing a regulatory microenvironment within the cells they invade. 
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1.6.4 Antigenic hindrance and survival of Salmonella 
When a single bacterium translocates from the intestinal lumen into the 
lamina propria, and subsequently gets internalised by phagocytic cells, it changes 
its gene expression profile in order to survive detection and elimination by the 
host. Salmonella transitions from an exrtracellular phase (STEX) to an intracellular 
phase  (STIN), a process that enables it to grow outside and inside host cells, 
respectively (Alaniz et al., 2006). FliC, a potent T cell stimulating subunit protein 
found predominantly on the flagellum (Strindelius et al., 2004), is also expressed 
on the bacterial surface. STEX bacteria can potently stimulate FliC specific T cells, 
however, intracellular bacteria fail to do so (Cummings et al., 2005). When 
Salmonella transitions from STEX to STIN phase it localises FliC to intracellular 
compartments rather than the bacterial membrane (Alaniz et al., 2006). In addition, 
intracellular Salmonella reduces FliC expression levels in order to avoid detection 
by T cells, while, simultaneously, it actively downregulates co-stimulatory 
expression by APCs (Cummings et al., 2005). PhoP is a gene involved in the 
regulation of the remodelling of the bacterial surface. During the transition from 
extracellular to intracellular compartments, PhoP becomes active and affects LPS 
recognition by the host by adding fatty acids, phosphoethanolamine and 4-amino-
4-deoxy-L-arabinose, as well as acetylating the O-antigen (Gunn, 2001). 
Additionally, PhoP activity has been shown to decrease bacterial membrane 
permeability, allowing for survival in late endosomal and lysosomal compartments 
in the host (Murata et al., 2007). Salmonella can also inhibit the phagosome-
lysosome fusion required for bacterial degradation (Tobar et al., 2004), thereby 
impeding antigen processing and presentation. While Salmonella can inhibit 
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recognition, degrading and presentation of Ag on APCs, it has also been shown to 
inhibit T cell activation via a direct, contact-dependent mechanism (van der Velden 
et al., 2005). Taken together, these findings demonstrate some of the challenges the 
host has to overcome in order to elicit an effective immune response against this 
pathogen. 
 
1.6.5 Experimental model 
The mouse model of Salmonella enterica serovar Typhimurium (Salmonella 
typhimurim) is commonly used in order to dissect the different aspects of immunity 
involved in the clearance of this pathogen. Salmonella typhimurium causes a 
systemic infection in mice akin to that of Salmonella typhi in humans. In particular, 
mice lacking the natural resistance-associated macrophage protein (NRAMP) gene 
that codes for iron transporter proteins, required for iron depletion of the 
phagolysosome within phagocytes, are highly susceptible to infection. NRAMP 
deficient mice such as BALB/c and C57BL/6 succumb to infections with virulent 
Salmonella typhimurium strains (Collins et al., 2002). However, those mice exhibit 
full protection when immunised with attenuated strains, prior to challenge with a 
virulent strain (Mastroeni et al., 1992). Common Salmonella typhimurium strains 
used to study how immunity and protection are conferred, are mutated at sites 
coding for SPI-1 or SPI-2 pathogenicity island genes (Niedergang et al., 2000), as 
well as genes that encode for aromatic amino acid synthesis (AroA) (Clarke and 
Gyles, 1987). While bacterial strains lacking virulence factors have thrown insight 
into the interplay of bacterial proteins and cells of the immune system, AroA 
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strains are better at characterising immune response development and protection, 
since they are antigenically identical to wild type strains.  
 
1.6.6 Bacterial invasion of the intestinal tract 
Salmonella has been described to invade two morphologically distinct sites at 
the distal illeum, the follicular associated epithelium, where Peyer’s patches are 
found, and the epithelium overlying villi (Carter and Collins, 1974). Bacteria 
preferentially invade and destroy M cells near Peyer’s patches (Jones et al., 1994; 
Mowat, 2003), creating gaps in the intestinal architecture and allowing adjacent cell 
infection (Jepson and Clark, 2001) (Figure 1.3). In addition, CD11b- CD8α+ 
lymphoid DCs and CD11b- CD8α- DCs, residing at interfollicular regions may be 
actively capturing and transporting Salmonella to the mesenteric lymph nodes 
(Iwasaki and Kelsall, 2001; Salazar-Gonzalez et al., 2006). Furthermore, CX3CR1+ 
DCs have also been reported to extend dendrites into the lumen and actively 
capture Ag and bacteria at columnar villus epithelium sites (Niess et al., 2005) 
(Figure 1.3), a process involving signalling through TLRs (Chieppa et al., 2006), 
however their role in direct immune response initiation is yet unclear. Bacteria 
reach Peyer’s patches through active transport of internalised Salmonella by DCs or 
M cells, or by pyroptosis of MΦs and DCs (Figure 1.3), which release bacteria to the 
interstitium and allow bacterial spreading through the lymphatics to secondary 
lymphoid organs.  
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1.6.7 DCs and Macrophages in S. typhimurium infections 
DCs and MΦs recognise lipopolysaccharide (LPS) on the cell wall of 
Salmonella through TLR-2. Extracellular flagellins are recognized by TLR-5, while 
internalized flagellins by the Nod-like receptor Ipaf (Franchi et al., 2006; Miao et 
al., 2006). DCs are the most abundant APCs in Peyer’s patches, outnumbering MΦs 
(Hopkins et al., 2000), and as such are most likely to encounter the pathogen early. 
Furthermore, DCs, but not MΦs, infected in vitro with Salmonella express CCR7 
and, when transferred to naïve animals, migrate to lymph nodes, while infected 
MΦs do not (Zhao et al., 2006). Although MΦs have been shown to internalise and 
kill bacteria at a faster rate than DCs (Delamarre et al., 2005), they also serve as a 
site for bacterial replication (Salcedo et al., 2001). Salmonella do not replicate within 
bone marrow derived DCs, and survival of the bacteria within late endosomal 
compartments in those cells is not dependent on the expression of SPI-2 genes by 
the pathogen, as is in the case of MΦs (Jantsch et al., 2003; Salcedo et al., 2001). The 
preferential survival of Salmonella within DCs might be important for the activation 
of the antigen presenting molecular apparatus. It has been reported that antigen 
presentation by MΦs but not DCs is impaired when Salmonella are deficient in 
virulence factors such as SPI-2, suggesting that DCs do not require active 
translocation of pathogen derived products in order to become activated 
(Niedergang et al., 2000). Human studies addressing the involvement of dednritic 
cells and MΦs in salmonellosis, reported that MΦs are more potent inducers of 
cytokine production, suggesting that they may have a greater role in recruitment of 
lymphocytes at the site of infection (Pietila et al., 2005). On the other hand, infected 
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DCs induce stronger T cell responses than MΦs, and as such they initiate immune 
responses against Salmonella more effectively (Kalupahana et al., 2005). While MΦs 
are not required for the generation of primary CTL CD8+ responses against this 
pathogen (Wijburg et al., 2002), both DCs and MΦs are capable of inducing the 
generation of memory CD8+ T cell populations (Pozzi et al., 2005).  
 
1.6.8 Immune responses against S. typhimurium 
Early stages of S. typhimurium infection are characterised by the production 
of pro-inflammatory cytokines such as IL-1β, IL-6, IL-24, TNF-α, IL-23 and IL-
12p70 by APCs, fibroblasts and epithelial cells, resulting in infiltration of 
polymorphonuclear cells (PMNs) at the site of infection. Studies using GR1+ 
depletion methods have demonstrated that neutrophil infiltration can be both 
detrimental due to tissue damage, as well as beneficial to the host, depending on 
the type of pathology studied.  
The presence of T cells is absolutely crucial for immunity against S. 
typhimurium, however, initial disease suppression is mediated by the innate arm 
immunity (Hormaeche et al., 1990). Upon activation, APCs migrate to secondary 
lymphoid organs and up-regulate CD80, CD86 and CD40. During this process 
DCs, degrade internalised bacteria and process Ag on MHC class II and MHC class 
I molecules for presentation to CD4+ and CD8+ T cells respectively, while they also 
secrete cytokines such as TNF-α, IL-12, IL-6, IL-23 and IL-1β. TNF-α released by 
DCs and MΦs during Salmonella infection enhances up-regulation of CD40, thereby 
promoting T cell activation (Pozzi et al., 2005).  
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Absence of TNF-α during primary or secondary infections, results in poor 
formation of granulomatous abscesses, characterised by early and high mortality 
rates in susceptible mice, irrespectively of their immunisation profile (Mastroeni et 
al., 1993b). Absence of TNF-α during later stages of infection also affects 
granuloma formation and allows for bacterial growth in both susceptible and 
resistant mice (Mastroeni et al., 1991; Mastroeni et al., 1995; Mastroeni et al., 1992). 
IL-12 is thought to be involved in controlling bacterial growth during S. 
typhimurium infections by promoting T cells to become polarised towards a T 
helper 1 phenotype and secrete IFN-γ (Mastroeni et al., 1998). Neutralising IL-12 
during S. typhimurium infection results in deficient granuloma formation and 
impaired IFN-γ responses, in turn, affecting antigen presentation, nitric oxide 
synthase activity in MΦs and generalised increased mortality in susceptible mice 
(Mastroeni et al., 1996; Mastroeni et al., 1998). MΦs harbouring bacteria require 
IFN-γ in order to control and eliminate the pathogen, since depletion of this 
cytokine results in re-activation of latent S. typhimurium bacteria found to reside 
within MΦs (Monack et al., 2004). In the absence of T cells, early IFN-γ has been 
shown to be secreted by NK cells, nevertheless it is insufficient for controlling 
disease progression, suggesting that the importance of CD4+ T cells in clearing 
salmonellosis extends beyond their ability to secrete cytokine (Ramarathinam et al., 
1993).  
Naïve CD4+ T cells become activated in Peyer’s patches as early as 3 hours 
after oral infection (McSorley et al., 2002), however those T cells are restricted to 
the gut mucosa and do not recirculate to infected spleens or livers (McSorley et al., 
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2002). Following the initial activation of T cells in the gut mucosa, CD8+ and CD4+ 
T cells are activated by APCs in secondary lymphoid organs and are distributed to 
systemic sites of infection, where they either release cytokine, aiding leukocyte 
recruitment, or are involved in direct killing of infected cells (Kirby et al., 2004; Lo 
et al., 1999). While both CD8+ and CD4+ are crucial for pathogen clearance, γδ T 
cells may contribute but are not essential for improved prognosis, since they have 
been found to be dispensable in Salmonella infections, (Mixter et al., 1994; 
Weintraub et al., 1997). CD8+ T cells are required for either direct bacterial killing 
through the release of granulysin (Stenger et al., 1998), or for the elimination of 
infected cells (Lo et al., 1999). Although CD8+ T cells have been shown to be 
dispensable during primary immune responses, they are required during 
secondary challenges, since their absence results in poor bacterial clearing 
irrespectively of whether mice have been immunised or not (Lo et al., 1999). 
Activation of CD4+ T cells induces IFN-γ and TNF-α production, direct killing of 
infected cells, as well as activation of B cells. CD4+ T cells are required for the 
generation of memory CD8+ T cells as well as the generation of B cell clones that 
act as potent antigen presenting cells and Ab producers (Mittrucker et al., 1999; 
Shedlock and Shen, 2003). B cell role in amelioration of Salmonella infections has 
been widely attributed to their ability to produce Ab (Mastroeni et al., 1993a). Ab-
coated bacteria are recognised by Fc receptors on phagocytes, and targeted directly 
to the phagolysosome for degradation, bypassing microbial evasive mechanisms 
(Tobar et al., 2004). B cells, nevertheless, can also present Ag and provide CD4+ T 
cells with help for the induction of CD4+ and CD8+ T cell memory responses, thus 
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contributing towards immunity at different stages of infection (Crawford et al., 
2006; Mastroeni, 2002; Mastroeni and Sheppard, 2004; Mastroeni et al., 2000a).  
 
1.7 Aims 
DCs are the main APC, capable of driving immune responses 100 times 
more efficiently than other lymphocytes. We hypothesised that this unique 
capacity of DCs to translate message received in the periphery into signal for the 
initiation of immune responses, posed them as a very good candidate to 
investigate the highly controversial and dividing topic in the medical and scientific 
community of the efficacy of ultra-high dilutions of antigen. 
Our understanding of the interactions between Salmonella bacteria and the 
host they invade has dramatically increased over the past 20 years. The different 
aspects of the adaptive arm of immunity required to confer protection against this 
pathogen have been well characterised. However, the contribution of the innate 
arm of immunity, and more specifically that of DCs, towards the generation of 
protective immune responses remains elusive. The experimental work performed 
in this thesis attempts to reveal possible innate factors that may be contributing to 
the generation of effective adaptive immune responses against S.typhimurium. 
Specifically, we investigated DC role in the generation of S. typhimurium-specific 
immunity. Furthermore, we addressed the role of the innate cytokine, IL-23, in the 
generation of adaptive immune responses against Salmonella.   
The specific questions addressed in this thesis are: 
1) Can ultra-high dilutions of Ag influence DC maturation (Chapter 3) 
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2) Can ultra-high dilutions of Ag influence immune response development by 
DCs (Chapter 3) 
3) Can immune responses elicited by DC transferred into naïve mice alter 
immunopathology caused by S. typhimurium infections? (Chapter 4) 
4) Does IL-23 influence immune response development against Salmonella 
infections? (Chapter 5) 
5) Does IL-23 affect the generation of protective immunity against S. 






















































Figure 1.1. DC progenitors and and subsets. DC develop from haemopoietic stem 
cell progenitors (HSCs) which give rise to lymphoid precursors (LP) and myeloid 
precursors (MP).  
LPs develop into plasmacytoid DCs (pDC) and conventional DC precursors 
(Pre-cDCs), which circulate in the blood. Pre-cDCs can develop into conventional 
DCs that home to lymphoid tissues or DCs that home to mucosal sites, such as the 
intestinal lamina propria.  
MPs develop into macrophage dendritic cell precursors (MDPs) which give 
rise to recirculating monocytes. These can develop into MΦs, myeloid-derived 











Figure 1.2. Overview of CD4+ T helper cell subsets. Functions, transcription 
factors, as well as cytokines both produced by and crucial for the determination 








Figure 1.3. Salmonella invasion and spreading. Salmonella can invade its host by a) 
transversing epithelial cells b) by invading M cells or c) by direct bacterial capture 
by DCs that extend dendrites into the intestinal lumen. Lamina propria DCs 
internalise Salmonella bacteria that exit M cells. These DCs can go through 
pyroptosis, thereby releasing bacteria into the lamina propria, which can then 
migrate as free bacteria through lymphatics to secondary lymphoid organs. 
Alternatively, lamina propria DCs carrying bacteria may migrate to secondary 
lymphoid organs, thereby contributing to bacterial dissemination. CXC3CR1 DCs 
have been described to extend dendrites into the intestinal lumen, a process also 









Materials and Methods 
 
2.1 Animals and reagents 
WT C57BL/6 and p19-/- mice were bred and maintained in the Ann 
Walker Animal Facility or The March Animal Facility, University of Edinburgh. 
All mice were maintained in specific pathogen free conditions. Home Office 
personal and project license guidance was followed for all experiments. Six-
twelve week old mice were used as bone marrow donors for DC culture. The 
antigens used for DC stimulation were chosen for physiological relevance and 
for correlation with previously published work. Heat-killed Propionibacterium 
acnes (P. acnes) was supplied by Professor Ian Poxton (University of Edinburgh), 
heat-killed Salmonella typhimurium strains SL1344 and SL3261 were supplied by 
Dr. Maurice Gallagher (University of Edinburgh) and heat-killed, purified and 
sonicated S. typhimurium was supplied by Professor David Gray (University of 
Edinburgh). Live, attenuated SL3261 and virulent SL1344 strains of S. 
typhimurium were grown in house from stocks kindly provided by Professor 
Gray and Dr. Maurice Gallagher, respectively. Concentrations of antigens used 
were based on experiments previously carried out in-house. Concentrations of 
live Salmonella infections were determined in-house as described in chapter 4. 
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2.2 Preparation of High and Ultra-high dilutions of antigen 
In order to ensure minimal levels of contamination, high and ultra-high 
dilutions of heat-killed S. typhimurium SL 1344 strain, P. acnes or Cholera Toxin 
(Sigma Aldrich, Poole, USA) were prepared in-house using low endotoxin water 
(Sigma Aldrich). The different antigens were diluted in 10 ml of water in a 50 ml 
Falcon tube (CELLSTAR, Germany) at a concentration typically used for 
stimulating dendritic cells: stimulatory concentrations of the different antigens 
were determined by their ability to phenotypically activate DCs and/or the 
ability of DCs to induce immune response development in naïve animals  
(5µg/ml P.a, 5µg/ml S.t or 5µg/ml CT). The first dilution was named a 1CH 
dilution. The diluted sample was then shaken vigorously manually or 
automatically using a custom made DYNAMAT machine (DYNAMAT, Labotec, 
Brussels, Belgium) for a hundred repetitions. 100 µl of the 1CH dilution of 
antigen were then transferred to 10 ml of water and the process was repeated. 
The procedure was repeated up to 30 times resulting in a 30CH dilution of the 
original concentration (nCH = 10-[(n*2)-2)] of 1CH, where 1CH = stimulatory 
concentration of antigen). Control (water) dilutions were prepared identically as 
described above, except that the starting 1CH sample was generated by adding 
100 µl of water to 10 ml of water. The purchased water (Sigma) as well as the 
dilutions generated from it was tested for the presence of contaminants using 
Gas Ion  exchange mass spectrometry (Figure 2.3). No contaminants were found 
either in the purchased water or in our ultra-high dilutions (Figure 2.3). 
All high and ultra-high dilutions of antigen were generated in pure water 
which lacks minerals, amino acids and nutrients, and has much lower 
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osmolarity than the RPMI 1640 (GIBCO, Life Technologies, Paisley, UK) media 
DCs are normally incubated in. In order to normalise the osmotic and nutrient 
conditions of the high and ultra-high dilutions of antigen, RPMI 1640 (GIBCO) 
in powder form was used to make DC incubation medium at twice the 
concentration standardly used in the lab to incubate DCs. The media was 
prepared by adding half the amount of water than that recommended by the 
company’s specifications, and twice the recommended concentration of 
supplements; 20% FCS (Harlan, Loughborough, UK), 100 units/ml 
Penicillin/Streptomycin (GIBCO), 4mM L-glutamine and 10ng/ml GM-CSF 
(Peprotech, Rocky Hill, NJ, USA). This 2 * concentrated media was then filter 
sterilised by passing it through a 0.2µm Millex syringe filter (Millipore Corp.., 
Bedford, USA) and mixed at 1/1 with the ultra-high dilutions of antigen.  
 
2.3 Dendritic Cell Culture  
Bone marrow-derived DC culture was performed as previously described 
(Lutz et al., 1999). Tibia and femurs were removed from sacrificed C57BL/6 
mice. Attached muscle tissue was removed using forceps and 70 % ethanol 
soaked tissue. The bones were immediately placed in low endotoxin Dulbecco’s 
Phosphate Buffered saline (PBS) (Sigma Aldrich). PBS medium was discarded 
under sterile conditions and bones were washed in 70 % ethanol for 30 seconds 
before washing them three more times in PBS. Using razor blades sterilised in 70 
% ethanol, the tips of both tibia and femurs were cut off. Bone marrow was 
flushed from the bones by injecting PBS through a 25G needle (Becton 
Dickinson, Mountain View, USA). To ensure that cell clusters were dispersed, 
 56 
liberated bone marrow was then passed through an 18G needle (Becton 
Dickinson). Cells were seeded into standard bacteriological Petri dishes (Philip 
Harris Scientific, Cheshire, UK) at 2 *105 cells/ml in 10 ml of RPMI 1640 (Sigma) 
media supplemented with 10% low endotoxin FCS (Harlan), 100 U/ml 
Penicillin-Streptomycin (Gibco), 2mM L-glutamine (Gibco) and 20ng/ml 
recombinant GM-CSF (Peprotech). Cells were incubated at 37 °C and 5% CO2. 
On day 3, 10 ml of additional medium was added to each plate, while on days 6 
and 8, 9 ml medium was carefully removed from the plate and replaced gently 
with 10ml of fresh medium. On day 11, DCs were harvested by gentle expulsion 
of medium over the dish to gather all semi-adherent DCs, counted using a 
haemocytometer, then re-plated in 24-well plates (Corning Incorporated, 
Corning, NY) in 1 ml of medium at a concentration of 1*106 cells/ml. 
DCs were then incubated for 24 hours in fresh medium, high or ultra-
high dilutions of antigen. Stimulatory concentrations of the different antigens 
(described above) were then added for a further 24 hours. After stimulation, 
DCs were harvested by gentle washing, centrifuged at 200 g for 5 minutes, and 
the supernatants stored at -20°C for subsequent ELISA analysis. Harvested cells 




All ELISA antibodies, reagents and protocols had been previously 
optimised in house. Table 2.1 contains the list of antibodies, coating buffers, 
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recombinant cytokine standards and detection substrates. In brief, 96 well F96 
MaxiSorp Nunc-immunoplates (Nalgene Nunc International, Hereford, UK) 
were incubated at 4°C overnight with coating antibodies. Between each step, 
plates were washed 4-8 times with PBS containing 0.1% Tween. The following 
day, plates were blocked for two hours at room temperature in PBS containing 
10% FCS or 1% BSA (TNF-α only). Samples and recombinant cytokine standards 
were added in duplicate and incubated overnight at 4°C. Standard curves were 
generated by doubling dilutions of recombinant cytokines. Biotinylated 
detection antibodies were added for two hours at 37°C and peroxidase-
streptavidin (Kirkegaard and Perry Laboratories, Maryland, USA) was added 
for 30 minutes at 37°C. ELISAs were developed using TMB Microwell Perox 
(Kirkegaard and Perry Laboratories) with the reaction stopped with 0.18M 
H2SO4, or ABTS (Kirkegaard and Perry Laboratories). Plates developed using 
TMB were read at 450nm wavelength, while plates developed in ABTS were 
read at 405 nm wavelength, using Multiscan Ascent Labsystems equipment 
and software. TMB substrate was used for detection of lower levels of cytokine 
given its superior resolution, while ABTS was allocated for more robust cytokine 
production. Absolute concentrations were derived from optical densities using 
two-site binding (hyperbola) equations on the standard curve using Prism 
software. Only the linear phase of the equation was used in order to determine 
the values of individual experimental samples. 
Ab ELISAs were performed using 96 well F96 MaxiSorp Nunc-
immunoplates (Nalgene Nunc International, Hereford, UK). Wells were coated 
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overnight with purified sonicated S. typhimurium in PBS (Gibco). Serum from 
either non-immunised animals (Chapter 4 experiments) or previously 
immunised animals (Chapter 5 experiments) was used as standard.  
 
2.5 Flow cytometry 
Approximately 2*105 cells/200 µl were added to a V-bottomed 96 well 
FACS plate (Greiner Bio-One GmbH, Frickenhausen, Germany), incubated with 
αFcR block (2.4G2, 1µg/well) for 20 minutes at 4°C. Antibodies against cell 
surface markers described in Table 2.2 were then added for a further 30 minutes 
at 4°C. Samples were acquired using FACSCalibur (Becton Dickinson) and 
CellQuest software and analysed using FlowJo software (Treestar inc, Oregon, 
USA).  
Live cells were gated using forward versus side scatter (Figure 2.1.A). 
Unstained controls were first used to calibrate for auto-fluorescence. All samples 
were then acquired on the FACSCalibur including isotype controls for each 
sample. Gating on fluorescence was determined by gating out 98% of the 
isotype control for each sample. DC purity was assessed by CD11c staining, 
CD4+ T cell purity was determined by CD4 staining and B cell purity was 
assessed by CD19 staining (Figure 2.2). DC, T cell and B cell purity was 




2.6 T cell and B cell purifications 
4*107 splenocytes from each individual mouse were collected and pooled 
within their own groups. Cells were centrifuged at 300g for 5 minutes and 
resuspended in PBS (Sigma Aldrich) supplemented with 2% FCS (Harlan) at a 
concentration of 1*108 cells/900µl. 100µl of anti CD4 beads (Miltenyi Biotec 
GmbH, Bergisch Gladbach, Germany) were added and the cells were kept at 4°C 
for 30 minutes. The cells were centrifuged at 300g for 5 minutes washed with 
PBS (Sigma Aldrich) supplemented with 2% FCS (Harlan) and resuspended in 
500µls PBS (Sigma Aldrich) supplemented with 2% FCS. CD4+ positive selection 
was performed by washing LD columns (Miltenyi Biotech) with PBS (Sigma 
Aldrich) supplemented with 2% FCS (Harlan) once before adding the 500µl of 
CD4-bead coated splenocytes. The LD (Miltenyi) columns were washed 3 times 
with 3ml PBS (Sigma Aldrich) supplemented with 2% FCS (Hralan). Another 
5mls of PBS (Sigma Aldrich) supplemented with 2% FCS (Harlan) was added, 
the column was removed from the magnet and the captured cells were washed 
into a fresh Falcon tube by applying pressure with a plunger.  
B cell sorting was performed by positive selection applying the same 
method as that for T cells, with the distinction that CD19+ coated beads were 
used instead of CD4+. Purity was determined as described above (Figure 2.2). 
 
2.7 Dendritic Cell transfer Assays 
DCs were harvested after being exposed to antigen, and resuspended in 
5*106 cells/ml in low endotoxin PBS. Mice were injected with 50 µl of the cell 
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suspension either subcutaneously or into the footpad of each hind leg using a 
25G needle and a 1 ml syringe. Mice were kept for a week in the animal facilities 
of the School of Biological Sciences at the University of Edinburgh before being 
sacrificed for further analysis. For some experiments, following the same 
injection protocol, mice were kept for 3 days or 5 weeks in the animal facilities of 
the School of Biological Sciences at the University of Edinburgh before being 
orally infected with the virulent SL1344 strain of S. typhimurium (see below). 
 
2.8 Bacterial cultures and Infections 
S. typhimurium strain SL3261 was grown overnight from stock in 20 ml of 
liquid agar broth anaerobically at 37 °C. 1 ml of the cultured bacteria was 
transferred into 9 ml of PBS. Yield was determined by serially diluting the 1/10 
concentrate of the original culture ten fold and plating onto agar-coated Petri 
dishes. Bacterial yields varied between 1*107 CFU/ml and 1*108 CFU/ml. Mice 
were immunised i.p. with 100 µl of the 1/10 concentrate. 
S. typhimurium strain SL1344 was grown overnight from stock kindly 
provided by Dr. Maurice Gallagher (University of Edinburgh) in 5 ml of liquid 
agar broth anaerobically at 37 °C. Gram staining was performed the following 
day to ensure absence of contamination. Cells were washed in PBS and yield 
was determined by serially diluting ten fold and plating onto agar-coated Petri 
dishes. Bacterial yields varied between 1*1010 CFU/ml to 5*1010 CFU/ml of 
liquid agar. Bacteria were resuspended at 2*108 CFU/100µl in PBS and 
administered orally by gavage. 
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2.9 Assessment of morbidity and serum harvest 
For the immunisation procedures with attenuated SL3261 strain mice 
were weighed at the day of infection and every 2 days after the infections were 
preformed for the first 14 days in order to assess primary immunopathology 
caused by avirulent SL3261 infection. Mice were bled every 7 days in order to 
perform antibody serum analysis. Blood was left to clot for 24 hours at 4 °C 
before centrifuging at 600g for 10 minutes and serum collected for antibody 
analysis was stored at -20 °C. 
For challenge infection with SL1344 virulent S. typhimurium strain, mice 
were weighed at the day of infection and every day post infection at 24 hour 
intervals. Mice were bled at the end point of each experiment (Day 3 or 4 
depending on morbidity). Blood was left to clot for 24 hours at 4 °C before 
centrifuging at 600g for 10 minutes. Serum was collected and stored at -20 °C till 
antibody and cytokine analysis by ELISA were performed. Ab titres (using 
standards and negative controls) (Figure 4.12) were determined by calculating 
how many times greater was the absorbance value from serum from 
experimental groups than that from non-immunised negative standards. The 
values were determined from the linear phase of a two-site binding hyperbola 
from the experimental groups. 
 
2.10 Infection recall responses  
Mice were sacrificed one week or 10 weeks post immunisations with the 
avirulent SL3261 strains, or 4 days after challenge with the virulent SL1344 
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strain. Spleens and mesenteric lymph nodes were removed and processed under 
sterile conditions into single cell suspensions using sterile 5 ml syringe plungers 
and cell strainers (Falcon). Spleens were collected in order to assess systemic 
responses while mesenteric lymph nodes were collected in order to assess 
localised responses at the primary invasion and infection site. Splenocytes were 
centrifuged for 5 minutes at 300g and resuspended in 3 ml RBC lysis buffer 
(Sigma) for 2 minutes to remove any red blood cells. Cells were washed twice in 
DMEM (prepared in-house), were then resuspended at 1*107 cells/ml in DMEM 
supplemented with 5% FCS (Harlan), 5mM penicillin streptomycin (GIBCO), 
2mM L-glutamine and 2-mercaptoethanol (2ME). The cells were plated at 
200µl/well in a 96 flat-bottomed tissue culture plate (Corning Inc.) for 3 days at 
37 °C and 5% CO2. Lymph node cells (5*106 cells/ml, 200µl/well) were plated in 
a 96 round-bottomed tissue culture plate (Corning Inc.) for 3 days at 37 °C and 
5% CO2. Mesenteric lymph nodes yield smaller number of cells compare to 
spleens. As such the number of cells used to address recall MLN responses is 
smaller than that used for spleens. Since the number of working cells is smaller, 
round bottom plates were used in order to ensure cell-cell contact. Flat bottom 
plates were used for splenocyte responses, due to the fact that spleens yield 
more cells and as such more cells can be added in each well. A larger number of 
cells allows for cell-cell contact even in a flat bottom plate. 
 
2.11 Recall responses following DC transfer  
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Mice were sacrificed either one week or five weeks after being injected 
with differently activated DCs. Spleens and inguinal lymph nodes were 
removed and processed under sterile conditions into single cell suspensions 
using sterile 5 ml syringe plungers and cell strainers (Falcon). Splenocytes were 
centrifuged for 5 minutes at 300g and resuspended in 3 ml RBC lysis buffer 
(Sigma) for 2 minutes to remove any red blood cells. Cells were washed 2 times 
in DMEM (Sigma), were then resuspended at 1*107 cells/ml in X-vivo serum free 
media (Cambrex Bio Science, MD) supplemented with 2mM L-glutamine and 2-
mercaptoethanol (2ME). X-vivo media was chosen for these recall response 
assays because it lacks serum. Since DCs were originally grown in medium 
supplemented with foetal calf serum, it was imperative that we avoided any 
response against serum proteins, which might alter the picture of the immune 
responses against the antigens investigated. Spleen cells from infected mice 
were resuspended at 1*107 cells/ml in X-vivo supplemented with 2 ME and L-
glutamine and 10 units/ml gentamicin (Gibco) and were plated at 200µl/well in 
a 96 flat-bottomed tissue culture plate (Corning Inc.). Lymph node cells (5*106 
cells/ml, 200µl/well) were plated in a 96 round-bottomed tissue culture plate 
(Corning Inc.) for 3 days at 37 °C and 5% CO2. 
 
2.12 Statistical analysis 
All data are represented as means. Error bars, wherever visible, represent 
standard error of the mean. The Student’s unpaired t-test was used to determine 
whether means between groups differed significantly. Statistical significance 
was assigned to data returning a ‘P value’ of less than 0.05. Two-Way ANOVA 
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analysis was performed to determine significance in time-dependent 
experiments. Statistical significance for data analysed by Two-Way ANOVA was 
assigned for a ‘P value’ of less than 0.01. Data for which no statistical 
significance has been measured were obtained from samples with an n=1. More 
specifically, DC cytokine secretion (Chapter 1: Figures 3.1, 3.2, 3.3, 3.4, 3.5, 3.6) 
was determined by stimulating DCs in single wells, while cytokine analysis was 
performed in triplicate wells on the ELISA plate. As such, error bars denote 
technical variation on the ELISA plate and not biological variation. Cytokine 
secretion by purified T cells (Chapter 5: Figures 5.3, 5.5, 5.6, 5.9, 5.10) was 
determined by pooling splenocytes from mice of each experimental group. 
Supernatants were analysed in triplicate wells on an ELISA plate. Error bars 
denote technical variation. Biological variation could not be statistically 
measured since cytokine levels secreted by splenocytes from individual mice are 
lacking. 
Experiments of a more controversial nature, such as those performed 
investigating the effect of ultra-high dilution of antigen on the ability of DCs to 
direct immune response development, were performed up to 7 times under 
identical experimental conditions. For the purpose of obtaining a more robust 
statistical picture of the conferred result we performed meta analysis on 7 repeat 
experiments. The results are summarised in Chapter 3.2.5.  
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Clone Isotype Host Dilution 
MHC II (IA/IE) FITC M5114 
(in house)  
IgG2b Rat 1:200 





CD40 PE 3/23 
(Pharmingen) 
IgG2a k Rat 1:100 
CD80 PE 16/10A1 
(Pharmingen) 
IgG2 k Armenian 
Hamster 
1:100 
CD86 PE GL1 
(Pharmingen) 
IgG2a k Rat 1:100 
 
CD4 APC RM4-5 
(Pharmingen) 
IgG2a k Rat 1:400 
Isotype APC RTK4530 
(Pharmingen) 
IgG2b, k Rat 1:200 
Isotype FITC RTK2071 
(Pharmingen) 
IgG1, k Rat 1:200 
























Figure 2.1. DC cell gating and purity assessment. Cultured cells were assessed 


























Figure 2.2 Representative staining of purified CD4+ and CD19+ cells following 
processing of spleens or lymph nodes into single cell suspensions and addition 
of magnetic beads as described in 2.6. Cells were analysed for CD4+ or CD19+ 




















              30CH H2O Sigma 125                                               30CH Pa Sigma 115 
Figure 2.3. Gas-Ion mass spectrometry analysis of water. Two different batches 
of water purchased from Sigma Aldrich were tested for the presence of 
contaminants. The respective water dilutions  (30CH H2O) as well as P.a (30CH 
P.a) dilutions were also tested for the presence of contaminants. A single peak 
was found in all samples, reflecting H2O. The absence of any other peaks 





The effect of ultra-high dilution of antigen on DC 
function and immune response development 
 
Abstract 
Homeopathy is considered as a complementary medical discipline, 
which is gaining rapid popularity in the western world. In Europe and the 
United States, an average of 25% of the population has at some point sought 
homeopathic treatment or advice. Nevertheless, there is no real empirical 
evidence supporting that it has a measurable biological effect. A number of 
homeopathic medications use substances diluted many times beyond 
Avogadro’s number, making it impossible to explain how any biological 
effect of such dilutions could be brought about in the first place. Basic 
scientific research addressing this subject is minimal. To date, no studies exist 
that have investigated whether such low or ultra-low dilutions of antigen 
might influence immune response development. Dendritic cells are the 
surveyors of the immune system. They constantly sample their surrounding 
microenvironment through pinocytosis and phagocytosis and alert the 
immune system at the first sign of danger. With the aid of cytokine protein 
and co-stimulatory molecule expression DCs direct naïve CD4+ T cells 
towards a range of phenotypes, including Treg, Th1, Th2, and Th17 phenotype. 
As, such we hypothesised that DCs are an excellent candidate cell to test 
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whether extreme dilutions of antigen exert a biological effect. We addressed 
whether ultra-high dilutions of antigen could confer a measurable effect on 
DC activation, and whether DCs treated with such extreme Ag dilutions 
displayed altered ability to influence immune response development. We 
found that ultra-high dilutions of antigen have no measurable effect on DC 
activation state. However, DCs that have been treated with such dilutions 
may display altered function, inducing exaggerated immune responses to 
certain antigens. 
 
3.1.1 A short history of homeopathy 
The principles of homeopathy were introduced in early 19th century by 
Samuel Hahnemann. They were based on the idea that substances causing 
symptoms similar to these observed in distinct pathological conditions had a 
therapeutic potency towards the corresponding pathology. The experiments 
leading to this conclusion, involved self-administration of various substances, 
ranging from elements such as sulphur to tree extracts such as quinine – a 
common anti-malaria drug at the time. He recorded the symptoms caused by 
those substances and compared them to symptoms caused by pathological 
conditions. He proposed that serially diluting his samples and administering 
them to patients with pathological conditions exhibiting symptoms similar to 
those conferred by the various substances he used, had a therapeutic effect (S. 
Hahnemann, Materia Medica Pura: 1827). 
During the 19th century, medicine used very crude therapeutic methods, 
such as blood letting and purging (1890) usually resulted in deterioration rather 
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than improvement of the patients’ condition (Bloodletting Over the Centuries, 
Gilbert R. Seigworth, 1980). Substances such as mercury and arsenic, which are 
today known to be toxic and harmful were included in the American 
pharmacopoeia and commonly prescribed for conditions such as psoriasis 
(Farber, 1992). Hahnemann’s proposed methods of treatment appeared to be a 
huge improvement over the existing ones. Homeopathy gained vast popularity 
in Europe as well as in America. A large number of hospitals practising the new 
form of medicine were established while an increasing number of medical 
practitioners trained in homeopathy. The popularity of the practice of 
homeopathy started to decline at the end of the 19th century, around the time 
when scientific method and rigor found application in medical practice. 
Scientific research led to the rapid improvement in therapeutics, which left 
homeopathy in the margin. Revival came in the 1970s when herbal and 
alternative medicine gained popularity. The proportion of the public seeking 
alternative medical advice outside the NHS has been dramatically increasing in 
the last 10 years, posing a need for more rigorous scientific research in this field 
(Thomas and Coleman, 2004; Thomas et al., 2003).  
  
3.1.2 Principles of homeopathic remedies 
Substances, ranging from crude extracts such as that of the tree Rus 
Toxicodendrum to simple compounds such as Sulphur are base materials for the 
preparation of remedies. At high concentrations these substances can have toxic 
or allergic effects causing a variety of symptoms, which homeopathic 
practitioners claim resemble symptoms naturally occurring in pathologic 
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conditions. These substances are serially diluted 10 or 100 fold at a time in 
water, alcohol or even milk in a process called potensisation (Witt et al., 2006). 
Between each successful dilution the samples are shaken vigorously, a process 
called dynamisation (Sunila et al., 2009). Different schools of thought exist 
describing potensisation and dynamisation methods, resulting in a variety of 
protocols used worldwide. The number of shaking repetitions and the nature of 
the diluent can therefore vary according to the protocol used. What remains 
constant between protocols is the final concentration of the solute. The resulting 
dilution can vary from a 1000 fold dilution of the original concentration up to 
102000 dilution of the original concentration. 
 
3.1.3 Homeopathic dilutions; an absurd concept 
The amount of a substance that contains as many atoms, molecules, ions, 
or other elementary units as the number of atoms in 12 grams of carbon is called 
the Avogadro’s number. This number is 6.0225*1023, which is the amount of 
elementary units in a mole of any substance. Any dilution generated by 12 one 
hundred-fold dilutions is equal to 1*10-24 of the starting solution. A one molar 
starting solution would therefore be completely diluted out, meaning that not a 
single molecule of the solute should remain in solution. A dilution of 30 CH (30 
times 100 fold dilutions) is equal to 10-60 concentration of the original solution. 
To attempt to put this concept into context, a 40 CH dilution could in theory 
dilute the whole universe down to a single proton since the universe is 
constituted from approximately 1080 protons (1.575 × 1079 by Arthur Eddington's 
best estimate in his "The Philosophy of Physical Science” lecture in 1939). Some 
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homeopathic dilutions are much greater than 40CH. Given the fact that most 
homeopathic preparations theoretically contain no substance other than the 
diluent, the biggest challenge of any data interpretation is explaining why any 
measurable effect should exist in the first place. The most common and logical 
scientific argument is that since there is no active ingredient in the solution, 
there should be no effect. Nevertheless, this does not prevent the widespread 
use and application of homeopathic techniques throughout the world. Thus, 
whether or not homeopathic treatments exert a scientifically measurable 
biological effect is still a matter of controversy and socioeconomic significance, 
and as such investigating the matter in a controlled scrutinised fashion is 
necessary. 
 
3.1.4 Clinical Research and The placebo effect 
There is no scientifically approved explanation as to why homeopathic 
preparations might exert a real effect. Over time, many clinical trials have been 
performed in order to assess the efficacy of homeopathic remedies (Kleijnen et 
al., 1991; Linde et al., 1997; Shang et al., 2005). However, the amount of clinical 
research that has been performed in this field is limited, and quite often been 
criticised for not meeting the clinical research standards of “mainstream” 
medicine. One major argument medical practitioners use to explain the 
homeopathic effect is by attributing it to a placebo effect. The average 
consultation time in normal hospitals of the NHS takes on average 17 minutes, 
while consulting a homeopathic practitioner takes at least in the first couple of 
instances between one and two hours (Bikker et al., 2005; Richards et al., 2004; 
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Thompson and Weiss, 2006). It is well established that the patient-practitioner 
trust relationship is a major contributor towards the placebo effect (Price et al., 
2006; Thompson and Weiss, 2006). As a result, many medics feel that prolonged 
consultation time offered by homeopathic practitioners can be one of the reasons 
why patients believe they are being treated with more care, therefore enhancing 
the placebo effect (Thompson and Weiss, 2006). The differences between 
therapeutic approach between homeopathic and conventional medicine make 
comparative clinical trial design hard, and as such the need for more 
reductionist approaches in basic research are necessary. 
 
3.1.5 Basic research  
Basic scientific research in homeopathy was highlighted to the world in 
1988 when Jacques Beneviste published in Nature the effects of homeopathic 
dilutions of lung histamine and Apis melifica, a diluted bee venom, on the 
degranulation of basophils (Publication removed from records). His findings 
indicated that different dilutions of histamine or Apis melifica greater than 
Avogadro’s number induced either degranulation of basophils or inhibition of 
degranulation of basophils. His work was immediately heavily criticized, while 
his experiments were repeated unsuccessfully by a number of independent 
laboratories (Maddox et al., 1988). Within a year his work was universally 
discredited and Nature withdrew the initial publication and apologised to their 
readers. His initial experiments, however, drew the attention of curious 
scientists who re-addressed his question. Progress in immunology, the 
identification of cell surface markers together with the introduction of flow 
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cytometric techniques, enabled researchers to address Jacques Benevistes’ initial 
questions in a much more controlled and quantitative fashion. Multicentre 
experiments were performed and in 1999 inhibition of degranulation of 
basophils in response to homeopathic preparations of histamine was confirmed 
in a publication in Inflammation Research (Belon et al., 1999), followed by one 
more publication in the same journal in 2001 (Brown and Ennis, 2001). Although 
the basophil degranulation experiments were in the epicentre of the 
homeopathic debate (Benveniste et al., 1994; Pool, 1988; Wiegant, 1994), some 
limited amount of basic research published in non-homeopathic journals, 
addressing the same question in different models does exist. A Ruta graveolens 
extract (plant extract) was used at a 10-12 concentration to investigate its effect on 
lymphocyte and cancer cell survival and death signalling. The study reported 
that the Ruta extract selectively induces cell death in brain cancer cells but 
proliferation in normal peripheral blood lymphocytes (Pathak et al., 2003). An 
independent laboratory showed that a 10-400 concentration of Sabal serrulata 
(plant extract) had a significant effect on prostate cancer cell growth 
(MacLaughlin et al., 2006). A simple model utilizing inhibition of luminescence 
in the bacterium Vibrio fischeri, reported that an ultra-high dilution of 3,5-
dichlorophenol had a statistically significant but minute effect on luminescence 
(Lee et al., 1993). No study, however has aimed to identify the effect of 
homeopathic preparations on immune response development. Given that 
dendritic cells are capable of amplifying immune responses by activating 
adaptive cells, we hypothesized that DCs are an appropriate cell type to 





1) To investigate the effect of sub-optimal and very low concentrations of 
antigen on DC activation 
2) To investigate the effect of ultra-low concentrations of antigen on DC 
activation 
3) To investigate the effect of ultra-low concentrations of antigen on 
immune response development 
 
3.2.1 Effect of low antigen concentrations on DC activation 
Before investigating the effect of ultra-high dilutions of Ag on DC 
maturation and immune response development it was necessary to establish 
whether DCs are capable of recognising sub-optimal concentrations of Ag. 
Furthermore we wished to determine whether DCs that had been stimulated 
with sub-optimal concentrations of Ag, were able to respond to further 
activation with a previously determined stimulatory concentration of the same 
Ag.  
It has been previously reported that DCs become refractory to 
stimulation when they repeatedly encounter activatory doses of antigen 
(Langenkamp et al., 2000).  Although, this may have profound implications in 
the way immune responses are initiated or controlled during disease 
progression, little work has been done on the ability of low-antigen dose-treated 
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DCs to respond to stimulatory concentrations of the same antigen. We 
investigated how different pathogens and pathogenic compounds influenced 
DC activation. Furthermore, we addressed whether the activation state of DCs 
could be influenced by previous exposure to sub-optimal and very low 
concentrations of the same Ag. In order to achieve this, bone marrow derived 
DC were incubated for 24 hours in sub-optimal or very low concentrations of 
HK P. acnes (P.a), HK S. typhimurium (S.t) or Cholera Toxin (CT) antigen from 
Vibrio cholera bacteria. DCs were then stimulated in previously determined 
stimulatory doses of these antigens for a further 24 hours.  
 
3.2.2 Effect of sub-optimal and very low concentrations of antigen on DC 
activation 
DC incubated for 24 hours in the presence of a stimulatory dose of HK P. 
acnes (5µg/ml) secreted a significant amount of TNF-α, IL-6 and IL-12 p40 
(Figure 3.1). After adding a further 5µg/ml of HK P. acnes, DCs secreted more 
IL-6 and IL-12 p40 but failed to secrete any more TNF-α (Figure 3.1). While 
stimulating DCs with 0.025µg/ml HK P. acnes had no effect on cytokine 
production, stimulating these DCs with a further 5µg/ml HK P. acnes induced 
secretion of similar levels of IL-6, TNF-α and IL-12 p40 to DC that were pre-
incubated in media alone followed by a 5µg/ml P. acnes stimulation. 
Interestingly, DC pre-incubated with 0.025µg/ml HK P. acnes and stimulated 
with 5µg/ml HK P. acnes produced more IL-12 p70 than DC that were pre-
incubated in media alone followed by a 5µg/ml P. acnes stimulation (Figure 3.1). 
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Pre-incubating DC in 0.0025fg/ml HK P. acnes had no effect on the amount of 
cytokine they secreted after being stimulated with 5µg/ml. 
Cholera Toxin has been reported to upregulate IL-6 production by DC, 
and depending on the biological model it is used in it can act as a Th2 or T 
regulatory response inducer (Gagliardi et al., 2000; Lavelle et al., 2003). We 
investigated whether pre-treating DCs with low concentrationd of CT could 
alter their activation state after exposure to a stimulatory dose of CT. 
Stimulating DCs with 5µg/ml Cholera Toxin induced secretion of IL-6 alone 
(Figure 3.2). Interestingly, DCs that had been pre-treated with 5µg/ml CT for 24 
hours and then stimulated with a further 5µg/ml CT secreted more IL-6 and a 
measurable amount of IL-12 p40 than DCs stimulated with a single dose of 
5µg/ml CT. Strikingly, DCs incubated for 24 hours with as little as 0.025µg/ml 
CT secreted IL-6 and IL-12 p40, while adding 5µg/ml CT to these DCs for a 
further 24 hours, induced secretion of TNF-α and IL-12 p70 as well as IL-6 
production, suggesting that activating DCs with different concentrations of CT 
may affect the type of response these polarise (Figure 3.2). Stimulating DCs that 
had been previously incubated for 24 hours with 0.0025fg/ml CT with 5µg/ml 
CT had no effect on cytokine secretion, and no effect on their ability to respond 
to a stimulatory dose of CT (Figure3.2), compared to media pre-incubated, 
control DCs. 
DCs incubated for 24 hours with 5µg/ml HK S.t secreted significant 
levels of IL-6, TNF-α, IL-12 p40 and IL-12 p70 (Figure 3.3). However, when these 
DCs were stimulated with a further 5µg/ml HK S.t they secreted less IL-6, TNF-
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α and IL-12 p40 than DCs stimulated only once with 5µg/ml S.t (Figure 3.3), 
suggesting, similarly to HK P. acnes stimulation, that classically activated DCs 
are refractory to further stimulation. Incubating HK DCs with 0.025µg/ml had 
no effect on their ability to secrete cytokine, nevertheless, stimulating these DCs 
with 5µg/ml HK S.t induced similar cytokine level secretion as that observed 
when DCs where pre-incubated with 5µg/ml S.t follwed by a 5µg/ml HK S.t 
stimulation, suggesting that HK S.t can render DCs refractory to stimulation at 
much lower concentrations than those that induce classical activation. DCs that 
had been pre-incubated in 0.0025fg/ml S.t and then stimulated with 5µg/ml 
secreted similar cytokine levels to DCs pre-incubated in media alone (Figure 
3.3). 
 
3.2.3 Effect of ultra-high dilutions of antigen on DC activation 
We wished to address whether various antigens diluted beyond the 
Avogadro’s number had any measurable biological effect on DC activation. To 
this end we investigated whether ultra-high dilutions of antigen could induce a 
change in DC activation profile or condition DC to respond differently upon 
exposure to stimulatory concentrations of pathogens or pathogen derived 
compounds. DC were incubated in ultra-high dilutions of antigen or water 
alone for 48 hours or incubated in ultra-high dilutions of antigen or water for 24 
hours before exposing them to a stimulatory dose of antigen for a further 24 
hours. In order to control for any variability introduced due to contamination 
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during the dynamisation and dilution process, water was also diluted and 
dynamised identically to the ultra-high dilution antigen preparations  
In no occasion did DCs that had been incubated in ultra-high dilutions 
(30CH=10-58 of the starting 5µg/ml concentration) of P.a (Figure 3.4) showed a 
significant difference in IL-12 p40 and IL-12 p70, IL-6 or TNF-α production in 
comparison to DC incubated with water controls. Similarly, pre-treating DC in 
ultra-high dilutions of P. acnes did not condition them to secrete different 
amounts of TNF-α, IL-6 IL-12 p70 or IL-12 p40 after addition of a stimulatory 
dose of P. acnes (Figure 3.4). Not surprisingly DCs that had been treated with 
ultra-high dilutions of P.a had the same levels of MHC II molecule, CD40 and 
CD86 expression on their surface as DCs that had been treated with 30CH water 
dilutions (Figure 3.7.a). Similarly, DCs that had been pre-treated in 30CH P.a or 
30CH H2O showed no statistical difference in expression levels of MHC II 
molecules, CD40 or CD86 after being stimulated with 5µg/ml P.a (Figure 3.7.b). 
Overall, the cytokine and surface molecule expression data suggested that ultra-
high dilutions of P.a had no effect either on DC activation or conditioning DCs 
to respond differently to stimulatory concetrations of P.a. 
DCs that had been treated in 30CH S. typhimurium (30CH St) or 30CH 
H2O for 48 hours produced similar levels of IL-12 p40, IL-12 p70, IL-6 and TNF-
α (Figure 3.5). DCs that had been pre-treated in, control, ultra-high dilutions of 
water for 24 hours and then stimulated with 5µg/ml S. typhimurium were 
classically activated, characterised by IL-12 p40 and p70 production, as well as 
IL-6 and TNF-α (Figure 3.5). DCs that had been pre-treated in the ultra-high 
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preparations of HK S.t before being exposed to a stimulatory concentration of 
HK S.t displayed similar level of cytokine secretion to their controls (Figure 3.5). 
DCs that had been treated with ultra-high dilutions of S.t had the same levels of 
MHC II molecule, CD40 and CD86 expression on their surface as DCs that had 
been treated with 30CH water dilutions (Figure 3.7.a). DCs that had been 
treated with ultra-high dilutions of S.t had the same levels of MHC II molecule, 
CD40 and CD86 expression on their surface as DCs that had been treated with 
30CH water dilutions (Figure 3.7.a). Similarly, DCs that had been pre-treated in 
30CH S.t or 30CH H2O showed no statistical difference in expression levels of 
MHC II molecules, CD40 or CD86 after being stimulated with 5µg/ml P.a 
(Figure 3.7.b), suggesting that ultra-high dilutions of HK S.t have no effect on 
DC activation or the ability of DC to respond differently to stimulatory 
concentrations of S.t. 
CT induced secretion of IL-6 by DC and a detectable amount of IL-12 p40 
(Figure 3.6). Pre-treating DCs with ultra-high dilutions of CT had no effect on 
the capacity of DCs to respond to a stimulatory dose of the same antigen (Figure 
3.6). In accord with the experiments performed with P.a and S.t ultra-high 
dilutions of CT failed to induce any apparent change in expression levels of 
MHC II molecule, CD40 or CD86 (Figure 3.7.a). Furthermore, ultra-high 
dilutions of CT did not condition DCs to alter their surface molecule expression 
when compared to ultra-high dilutions of water pre-treated DC, after adding  a 
stimulatory concentration of CT (Figure 3.7.b). 
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3.2.4 Assessing whether ultra-high dilutions of antigen can instruct DC to 
influence immune response development 
In vitro DC incubation with ultra-high dilutions of different antigens had 
no apparent effect on their activation or in their ability to respond differently to 
stimulation with optimal concentrations of antigen. These results indicated that 
there was no biological effect of ultra-high dilutions. However, it is not 
uncommon for antigens to induce no apparent change on DC activation. Th2 
polarising antigens which do not activate DCs in a classical way, very often fail 
to induce cytokine secretion or surface molecule expression changes on DCs 
(Kelsall et al., 2002) . Nevertheless, such antigens are still capable of polarising 
Th2 responses via DCs. As such, in order to conclude whether ultra-high 
dilutions of antigen do not exert a biological effect on DCs, we assessed whether 
such dilutions of Ag confer a change in immune response development in an in 
vivo setting. To that end we pre-treated DCs with ultra-high dilutions of antigen 
for 24 hours, and then added a previously determined stimulatory dose of the 
same antigen for a further 24 hours. We then transferred those DCs into naïve 
mice and a week later assessed splenocyte recall responses.  
P. acnes, a well studied pathogen, is known to drive T helper 1 responses. 
Heat-killed P. acnes has been shown to conventionally activate DCs, and can 
induce a T helper 1 response when injected into mice directly or delivered via 
DCs (Sher et al., 2003). We first assessed whether DCs treated in ultra-high 
dilutions of antigen were able to prime a measurable immune response in mice. 
DC were treated for 48 hours with 30CH H2O or 30CH P.a and were then 
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transferred into naïve mice. Splenocytes from recipient mice were restimulated a 
week later in either media or with 1µg/ml HK P.a. IFN-γ and IL-10 production 
by splenocytes was significantly increased in both groups of mice upon the 
addition of 1µg/ml P.a (Figure 3.8), suggesting that P.a induces cytokine 
production by splenocytes, which is possibly of innate origin. There was no 
difference, however, in IFN-γ or IL-10 production by splenocytes between 
recipient mice that had received DCs treated with ultra-high dilution of P. acnes 
or water controls, suggesting that ultra-high dilutions of antigen do not prime P. 
acnes specific responses (Figure 3.8). This experiment was performed 7 times 
and in none of the experimental repeats did 30CH P.a treated DCs succeed in 
inducing a different splenocyte response than water controls. 
Although 30CH P.a treated DCs failed to induce a different immune 
response in recipient mice than their water control treated DCs, it was important 
to examine whether 30CH P.a was able to condition DCs, altering the way they 
responded to antigen acquisition and subsequently immune response priming. 
We addressed this question by following the same DC transfer protocol but 
altering the in vitro DC treatment stages by exposing DCs to a stimulatory dose 
of P.a after 30CH P.a pre-treatment. DCs were incubated overnight in a 30CH 
water or 30CH P.a dilution, and were then exposed to 5µg/ml P. acnes for a 
further 24 hours. DCs were then transferred to naïve mice and spleen recall 
responses were assessed a week later. Surprisingly, IFN-γ production from 
spleens of recipient mice that received the 30CH P.a pre-treated - P. acnes pulsed 
DCs was significantly greater than that from mice receiving 30CH H2O pre-
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treated-P. acnes pulsed DCs (P<0.05) (Figure 3.9), suggesting that ultra-high 
dilutions of antigen condition DC ability to acquire antigen and induce immune 
responses.  Recall IL-10 production was not affected (Figure 3.9), suggesting that 
the mechanism by which conditioned DCs act is not dependent on regulation, 
but rather a direct induction of inflammatory responses. Due to the 
extraordinary nature of the experiment and the results obtained, we repeated 
the same experiment under identical conditions 7 times. Statistical significance 
was achieved in only 3 out of the 7 experiments, while the same trend was 
observed in 6 out of 7 experiments. For that reason we decided to perform a 
meta analytical study discussed further on. 
However interesting the results obtained by transferring 30CH P.a pre-
treated - P. acnes pulsed DCs into naïve recipient mice, it was important to 
establish whether generating ultra-high dilutions of other antigenic stimuli, such 
as heat-killed S. typhimurium, could also exert a measurable effect on immune 
response development. Since the S. typhimurium  model had not been previously 
used in our lab it was also important to investigate whether DCs pulsed in HK 
S.typhimurium and transferred into naïve mice could induce immune responses. 
DCs were exposed for 24 hours to three different doses of HK S.t (5µg/ml, 
10µg/ml and 20µg/ml). They were then transferred subcutaneously to naïve 
mice and 7 days later spleens were removed and restimulated with either media 
or 1µg/ml S.t. S. typhimurium specific splenocyte IFN-γ was detected when DCs 
were exposed to the highest, 20µg/ml dose of S.t (Figure 3.10). Splenocyte IL-10 
production decreased with increasing doses of DC exposure to HK S.t. Highest 
level of IL-10 production was detected when DCs had been exposed to the 
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lowest S.t concentration of 5µg/ml, while exposing DCs to 20µg/ml HK S.t 
failed to induce any more IL-10 than background (Figure 3.10). On the basis of 
this data the concentration of 20µg/ml HK S.t was selected as the optimal dose 
for the induction of Th1 responses via DCs. 
Having established the concentration of HK S. typhimurium that induces 
optimal Th1 responses, we addressed the ability of 30CH S.t-treated DCs to 
affect immune response development. This was performed by incubating DCs 
for 24 hours in either 30CH H2O or 30CH S.t before exposing them for a further 
24 hours to 20µg/ml heat-killed S.t. The DCs were then transferred 
subcutaneously into naïve mice and 7 days later spleens were removed and 
splenocytes restimulated with either media or 1µg/ml HK S.t. DCs that had 
been exposed to 30CH H2O or 30CH S.t before being exposed to a stimulatory 
concentration of S.t induced statistically similar splenocyte IFN-γ production in 
recipient mice (Figure 3.11). Surprisingly, S.t specific splenocyte IL-10 
production by splenocytes of recipient mice that received DCs that had been 
pre-treated with 30CH S.t was significantly higher (P<0.05) than that secreted by 
splenocytes from recipient mice that had received DCs pre-treated with 30CH 
H2O (Figure 3.11).  
Given the extraordinary nature of the results obtained with ultra-high 
dilutions of P. acnes and S. typhimurium, we wished to re-address the question 
with a different antigen, this time in a blind fashion. There were two reasons 
behind this approach. First, we wanted to investigate the same question with an 
antigen for which the ultra-high dilution effect had not been previously 
investigated and as such we had no bias towards the “expected” result. And 
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second, we performed the experiment in a blind fashion to eliminate any bias 
introduced during handling. For that reason we addressed the question with the 
Th2/Treg driving antigen, Cholera Toxin. 
BMDCs that had been treated with either water controls or an ultra-high 
dilution of CT did not differ in their ability to induce IL-5, IL-10, IFN-γ or IL-4 
production by spleen cells of recipient mice upon CT restimulation (Figure 
3.12).  
The potential of ultra-high dilutions of Ag to condition DCs exposed to 
ultra-high dilutions of antigen was investigated by incubating 30CH CT or 
30CH H2O (control) pre-treated DCs with 5µg/ml CT for 24 hours, and then 
transferring these DC to naïve, recipient mice. Splenocytes from recipient mice 
were restimulated with 2 different doses of CT for 3 days, and the recall 
immune response conferred by the two groups of DCs was assessed by ELISA. 
Control recipient mice mounted a Th2 response characterised by IL-5 and IL-10 
production by splenocytes, while CT specific IL-4 only emerged at the higher 
restimulation dose of 0.5µg/ml CT (Figure 3.13). Surprisingly, IL-5 and IL-4 
production by splenocytes of recipient mice receiving 30CH CT pre-treated – CT 
pulsed DC was significantly higher than that observed by control mice (P<0.05). 
Interestingly 30CH CT-pre-treated – CT pulsed DCs induced an IFN-γ specific 
response in splenocytes from recipient mice that had been restimulated with the 
lower 50ng/ml CT concentration. At this restimulation concentration the 30CH 
CT-pre-treated – CT pulsed DC failed to induce a significantly larger amount of 
IL-4 or IL-10 than the 30CH H2O (control) pre-treated DC group (Figure 3.13). 
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This suggests that IL-4/IL-10 and IFN-γ were possibly counter-regulating each 
other. In contrast, when splenocytes were restimulated with the higher 
concentration (500ng/ml) of CT the picture was reversed. Ultra-high dilution of 
CT pre-treated DC induced significantly more IL-4 and IL-10 than ultra-high 
dilution of water (control) pre-treated DC (Figure 3.13). At this restimulation 
concentration, no more IFN-γ was secreted by mice receiving ultra-high dilution 
of CT pre-treated DC than mice receiving ultra-high dilution of water pre-
treated DC, further supporting the notion that the IL-4/IL-10 axis may be acting 
in a counter-regulatory mechanism towards IFN-γ (Figure 3.13).  
 
3.2.5 Meta analysis reveals minute but statistically significant effect of 
ultra-high dilutions of antigen on immune response initiation by DCs 
 The nature of our investigation into the biological effect of ultra-high 
dilutions of antigen is highly unusual simply because we are working with 
dilutions that exceed Avogadro’s number. For that reason we repeated the 
experiment addressing the effects of ultra-high dilutions of P. acnes 7 times 
under identical conditions. Mean IFN-γ production from mice receiving 30CH 
P.a pre-treated – P.a stimulated DC was higher than the mean amount of IFN-γ 
secreted by controls in 6 experimental repeats. Statistical significance was 
achieved in only 3 of those experiments. In order to obtain a statistically relevant 
result from our experimental repeats we decided to perform meta analysis, 
(Figure 3.14). The results of the meta analysis suggest that, in our system, IFN-γ 
secretion by splenocytes from mice receiving 30CH P.a pre-treated – P.a 
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stimulated DCs was statistically higher than that induced in splenocytes from 
recipient mice of water control pre-treated – P.a stimulated DCs (Figure 3.12). 
The mean IFN-γ production from splenocytes of recipient mice that received 
30CH P.a pre-treated – P.a stimulated DC was 9ng/ml higher than that of 30 CH 
water pre-treated - P.a stimulated DC. Both upper and lower bound values 
(variation) were above the null effect mark with 95% confidence.  
 
3.3 Discussion 
DCs respond differently to antigen stimulation when they have been 
previously “conditioned” by low concentrations of the same antigen. Ultra-high 
dilutions of antigen have no effect on DC activation. Nevertheless, ultra-high 
dilutions of antigen exert a significant, yet minute, effect on immune response 
priming by DCs. Conditioning of DCs by ultra-high dilutions of antigen is a 
novel way to study the biological relevance of homeopathic practice. However 
uncommon, our work has provided some interesting as well as surprising 
insight into this elusive field. 
 
3.3.1 DCs encountering low concentrations of antigen are differentially 
activated by stimulatory concentrations of the same antigen 
We found that exposing DCs to a stimulatory concentration (5µg/ml) of 
HK S.t twice over a period of 48 hours, results in an inability to secrete more 
cytokine than that produced by DCs encountering HK S.t just once (Figure 3.3). 
On the other hand DCs encountering 5µg/ml of P.a or CT twice, secreted more 
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IL-6 and and IL-12 p40 than DCs stimulated only once with the respective 
antigen (Figure 3.1, 3.2). The contrast between the way repetitive S.t and P.a 
stimulation influence the ability of DCs to secrete cytokine suggests that there 
are intrinsic differences between these two Th1 driving pathogens and the way 
they influence DC activation. Whether, during pathogen invasion and 
spreading, a single DC can repetitively encounter pathogens or antigenic 
molecules is unclear, nevertheless not entirely improbable. In vitro assessment of 
the activation state of DCs after repetitive exposure to pathogens could throw 
some light into how this cell type might be influenced by different pathogens at 
distinct stages during disease pathology. It would be worth investigating 
whether DCs that are being stimulated with the same antigen repetitively go 
through apoptosis or necrosis, and whether they do so at a different rate than 
DCs that have been activated with antigen only once. Simple PI (propidium 
iodide) versus anexin-5 staining could reveal whether the type and rate of cell 
death differs between DCs that have been stimulated repetitively with antigen 
prior to activation and DCs that have been only activated with a stimulatory 
concentration of antigen once. Further characterisation of DCs by anti-CD80, 
CD86 and CD40 staining should give us a better picture of their activation state. 
Additionally, it would be interesting to investigate how these DCs initiate 
immune responses. Transferring DCs that have encountered stimulatory 
concentrations of antigen twice, into naïve mice, could give us some useful 
information about how disease progression could affect the way DCs polarise 
responses against various pathogens. Using antigens for which animal disease 
models are readily available could enable direct comparison between the 
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immune profile established during disease progression and that established 
after transferring differently activated DCs.  
Stimmulating DCs with 0.025µg/ml S.t failed to induce any cytokine 
secretion, however when these DCs were then activated with 5µg/ml S.t, they 
secreted similar levels of cytokine to DCs that had been stimulated with 5µg/ml 
S.t twice (Figure 3.3). Whether Salmonella antigen can pose DCs refractory to 
stimulation at much lower concentration than that required to classically 
activate DCs is unclear, however it would be worth investigating. Transferring  
DCs that have received a high+high or low+high concentration of S.t to naïve 
animals and assessing the immune response developed would give an 
indication as to whether a low concentration of HK S.t can indeed have a 
refractory to further stimmulation effect on DCs.  
Surprisingly, stimulating DCs with 0.025µg/ml CT followed by a further 
stimulation with 5µg/ml CT induced secretion of IL-12p70, IL-6 and TNF-α 
(Figure 3.2). It would be worth investigating whether DCs that have been 
exposed to these concentrations of antigen upregulate CD40, CD80 and CD86 
and whether they initiate Th1 responses in recipient mice. Nevertheless, this 
result poses a question about the way CT influences DCs and consequently the 
way CT influences immune response development. While in our hands CT 
behaved as a Th2 inducing antigen (Figure 3.13), the emergence of TNF-α and 
IL-12 p70 after a low+high CT stimulation of DCs would suggest that these DCs 
might be better at polarising CT specific Th1 responses. It would be worth 
investigating whether in an in vivo setting, the antigen concentration, as well as 
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the route of exposure to CT can have an impact on the type of immune response 
developed.  
DCs that had been pre-treated in a 30CH dilution of P.a did not respond 
differently to a stimulatory dose of P. acnes than DCs that had been pre-treated 
in 30CH H2O. The production of proinflammatory cytokines by DCs, such as IL-
6 and TNF-α and cytokines often associated with polarisation of Th1 responses 
such as IL-12 p40 and IL-12 p70 was not significantly altered by pre-treating 
DCs in ultra-high dilutions of P.a (Figure 3.4). Similarly we found no difference 
in surface molecule expression between DCs that had been treated or pre-
treated in ultra-high dilution of P.a and DCs that had been treated or pre-treated 
in ultra-high dilution of water (Figure 3.7.a, 3.7.b). No measurable effect was 
detected in the ability of ultra-high dilution preparations of either Cholera Toxin 
or S. typhimurium to alter surface molecule expression and cytokine secretion by 
DCs (Figure 3.5, 3.6, 3.7.a, 3.7.b). Not surprisingly, these findings suggested that 
ultra-high dilutions of antigen conferred no biological effect on DCs.  
 
3.3.2 Immune response development 
We demonstrated that ultra-high dilution preparations of heat-killed 
bacteria or antigen can condition DCs to prime different immune responses than 
those primed by untreated DCs. The recall immune response to heat-killed P.a 
detected in the spleens of recipient mice that had received DCs exposed to P.a 
was characterised by IFN-γ and IL-10 production (Figure 3.9). Strikingly, IFN-γ 
production by splenocytes of mice that had received 30CH P.a – pre-treated DCs 
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was greater than that produced by splenocytes of control mice. The induction of 
the exaggerated Th1 response by the 30CH P.a pre-treated DCs compared to 
control DCs was not due to an inhibition of an IL-10 dependent regulatory 
mechanism, since IL-10 production in the spleen of recipient mice was identical 
in both control and experimental groups of mice (Figure 3.9). Given the fact that 
we observed, no apparent effect of ultra-high dilution of antigen on DC 
activation state (Figure 3.4, 3.5, 3.6, 3.7), it is hard to discern the reason why 
such dilutions of antigen may influence immune response development by DCs. 
Nevertheless, the in vivo DC transfer experiments would suggest that ultra-high 
dilutions of P.a should have a biological effect on DC activation state. In order to 
identify possible factors that might be contributing towards the observed 
difference between the ability of 30CH P.a – pre-treated DCs and 30CH H2O - 
pre-treated DCs to drive P.a specific IFN-γ responses in naïve, recipient mice, we 
would need to perform gene array analysis of both DC groups. Although, gene 
arrays would not explain how such extreme dilutions of antigen that exceed 
Avogadro’s number exert their effect, they might explain whether such extreme 
antigen dilutions have indeed a direct biological effect on DC activation state.  
In order to investigate whether ultra-high dilutions of a different Th1 
polarising antigen could condition the way DCs drive immune responses, we 
repeated the DC transfer experiments using heat-killed Salmonella typhimurium 
as the antigen in question. We investigated whether transferring DCs that had 
been pre-treated with ultra-high diluted HK S.t could have an effect on immune 
response development. Once again the results were intriguing. Recall responses 
were characterised by significantly more IL-10 production from the spleens of 
 93 
recipient mice that had received 30CH S.t pre-treated – S.t pulsed DCs than 
control, 30CH H2O pre-treated - S.t pulsed DCs (Figure 3.11). There was no 
difference detected in splenocyte IFN-γ levels between the two groups of mice. 
Interestingly, there was a contrast in the way 30CH P.a and 30CH S.t influenced 
immune response development via DCs stimulated with the respective antigens. 
While 30CH P.a induced an exaggerated IFN-γ response be splenocytes of 
recipient mice, 30CH S.t induced an exaggerated IL-10 response, suggesting 
extreme dilutions of different Th1 polarising antigens have distinct ways by 
which they influence DCs to drive immune responses. Alternatively, the 
observed difference in the way ultra-high dilutions of different antigens 
condition DCs to drive immune responses might be influenced by the 
concentration of antigen used to stimulate DCs and not by the ultra-high 
dilution of antigen. As we observed in Figure 3.10 increasing the concentration 
of S.t DCs were stimulated with, shifted the response from an IL-10 specific one 
to an IFN-γ specific one. Whether identical ultra-high dilutions of antigen might 
be exerting their effect in a number of ways, depending on the stimulatory dose 
of antigen used to activate DCs with, is open to investigation.  In order to 
explain whether ultra-high dilutions of P.a or S.t condition DCs in distinct ways 
or similar ways depending on antigen concentration, we would need to perform 
the DC transfer experiments using DCs that have been stimulated with a range 
of concentrations of S.t and P.a.  
Our observations using the Th1 polarising antigens P.a and S.t were, 
indeed, very intriguing, however controversial. We decided to perform the same 
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DC transfer experiments in a blind fashion, using a different, Th2 polarising 
antigen. By performing the experiment in a blind fashion using an antigen for 
which we did not have an “expected” result, we hoped to eliminate any kind of 
bias introduced during the preparation of the dilutions, or handling bias. 
Strikingly, Th2 response induction by CT-pulsed DCs was also altered when the 
transferred DCs had been pre-treated with a 30CH CT dilution prior to 
incubating them with a stimulatory dose of antigen (Figure 3.13). CT specific 
recall responses in the spleens of recipient mice that had received the 30CH CT 
pre-treated – CT pulsed DCs were characterised by increased IL-4 and IL-5 
compared to the water control pre-treated – CT pulsed DCs. IL-5 production by 
splenocytes of recipient mice was detected irrespectively of the restimulation 
dose of CT used. CT specific IL-4, however, was only detected upon the higher 
restimulation dose and was significantly elevated by splenocytes of recipient 
mice that had received 30CH CT pre-treated – CT pulsed DCs compared to 
controls. In contrast, IFN-γ specific recall response was significantly higher in 
splenocytes of recipient mice that had received 30CH CT pre-treated – CT 
pulsed DCs compared to 30CH water pre-treated – CT pulsed DCs, when the 
lower (50ng/ml CT) CT restimulation concentration was used (Figure 3.13). It is 
possible that the observed switch from an IFN-γ to an IL-4 response is due to the 
fact that Th1 and Th2 are known to counter regulate each other. Nevertheless, it 
is interesting that depending on the restimulation concentration of CT we 
observe a significant effect on the type of response developed. In light of the 
results obtained in Figure 3.2 where DCs responded differently to CT 
depending on dose and frequency of stimulation, it would certainly be worth 
 95 
investigating whether the DC stimulation dose as well as the splenocyte 
restimulation dose can have an effect on the type of the immune response 
developed. Furthermore, it would be interesting to examine whether extreme 
dilutions of CT can affect the way such responses are polarised. 
Ultra-high dilutions of different antigens altered immune response 
development in vivo in distinct ways. We addressed how ultra-high dilutions of 
three different antigens affect the ability of DCs to initiate immune responses 
against their respective antigens. It would be interesting to investigate whether 
the effect an extreme dilution of an antigen has on the ability of DCs to drive 
immune responses is specific to the antigen itself or whether it can exhibit 
“cross-reactivity”. Commonly prescribed homeopathic preparations against 
diseases are usually of a different nature than the agents that are actually 
causing pathology. To assess whether cross reactivity between homeopathic 
preparations and pathogens occurs we would need to repeat the DC transfer 
experiments using a number of different combinations of homeopathic 
preparations and antigenic stimuli. 
Our investigations into the very controversial field of homeopathy 
warranted extreme scrutiny. As seen in Figure 2.3, we assessed the purity of the 
water utilised to generate the extreme dilutions of antigen by gas-ion exchange 
mass spectrometry. The reason behind this was to eliminate any possibility of 
contamination that might affect DC activation. Furthermore, in order to 
eliminate handling bias, we performed a transfer experiment in a blind fashion. 
Last, we performed a meta-analytical study of 7 independent, identical DC 
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transfer experiments. Meta analysis revealed a significant effect of 30CH P.a on 
the ability of DCs to drive IFN-γ responses (Figure 3.14).  
Although we did not succeed in identifying any possible reasons as to 
why preparations of antigen that has been diluted beyond Avogadro’s number 
should exert a measurable biological effect, our meta analytical results suggest 

















Pre-treatment                                
-                                                      - 
(5µg/ml P.a)                                              +                                                     + 
(0.025µg/ml P.a)                                                  +                                                    + 
(0.0025fg/ml P.a)                                                           +                                                     + 
 
Figure 3.1 Effect of low-dose HK P.a on the ability of DCs to secrete cytokine. 
DC were either incubated in media alone for 24 hours and then activated with 
5µg/ml of HK Pa for a further 24 hours, or incubated with 5µg/ml HK P.a for 24 
hours followed by another 5µg/ml P.a for a further 24 hours, or incubated with 
0.025 µg/ml of HK P.a for 24 hours and then activated with 5µg/ml P.a for 24 
hours, or incubated with 0.0025 fg/ml HK P.a for 24 hours followed by a further 
24 hour incubation with 5µg/ml P.a. Each bar is represented by mean and 
standard error mean (SEM) from 3 replicates on the ELISA plates. Data are 
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Figure 3.2 Effect of low-dose CT on the ability of DCs to secrete cytokine. DC 
were either incubated in media alone for 24 hours and then activated with 
5µg/ml of CT for a further 24 hours, or incubated with 5µg/ml CT for 24 hours 
followed by another 5µg/ml CT for a further 24 hours, or incubated with 0.025 
µg/ml of CT for 24 hours and then activated with 5µg/ml CT for 24 hours, or 
incubated with 0.0025 fg/ml CT for 24 hours followed by a further 24 hour 
incubation with 5µg/ml CT. Cytokine was measured by ELISA. Each bar is 
represented by mean and standard error mean (SEM) from 3 replicates on the 
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Figure 3.3 Effect of low-dose HK SL1344 on ability of DC to secrete cytokine. 
DC were either incubated in media alone for 24 hours and then activated with 
5µg/ml of HK SL1344 for a further 24 hours, or incubated with 5µg/ml HK 
SL1344 for 24 hours followed by another 5µg/ml SL1344 for a further 24 hours 
(cells not washed in between stimulations), or incubated with 0.025 µg/ml of 
HK SL1344 for 24 hours and then activated with 5µg/ml SL1344 for 24 hours, or 
incubated with 0.0025 fg/ml HK SL1344 for 24 hours followed by a further 24 
hour incubation with 5µg/ml SL1344. Cytokine was measured by ELISA 
Experiment is representative of 3 individual experiments. Each bar is 
represented by mean and standard error mean (SEM) from 3 replicates on the 



































                             








                                                                    30CHH2O         30CH Pa               30CHH2O        30CH Pa 
 
Figure 3.4. Pre-treating DC with ultra-high dilutions of P. acnes does not 
affect cytokine production upon exposure to a stimulatory dose of P.acnes. DC 
were incubated for 24 hours in 30CH H2O or 30CH P. acnes. Pre-treated DCs 
were then exposed to a stimulatory dose of 5µg/ml heat-killed P. acnes for a 
further 18 hours. Cytokine was measured by ELISA. Bars are represented by 
mean and stadard error mean of 3 replicate wells on the ELISA plate. Data 



























































                                                                                       30CHH2O        30CH St                     30CHH2O         30CH St 
                                                              
Figure 3.5. Pre-treating DC with ultra-high dilutions of HK S. typhimurium 
does not affect their ability to respond to a stimulatory dose of HK S. 
typhimurium. DC were incubated for 24 hours in 30CH H2O or 30CH S. 
typhimurium (St). Pre-treated DCs were then exposed to a stimulatory dose of 
5µg/ml heat-killed S. typhimurium for a further 18 hours. Cytokine was 
measured by ELISA. Bars are represented by mean and stadard error mean of 3 

































































                                                             
 
 
                                                                                    30CH H2O      300CH CT                 30CH H2O        30CH CT 
 
Figure 3.6. Pre-treating DC with ultra-high dilutions of Cholera toxin does not 
affect their ability to respond to a stimulatory dose of CT. DC were incubated 
for 24 hours in 30CH H2O or 30CH CT. Pre-treated DC were then exposed to a 
stimulatory dose of 5µg/ml CT for a further 18 hours. Cytokine was measured 
by ELISA. Bars are represented by mean and standard error mean of 3 replicate 
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Figure 3.7.a. Incubating DC with ultra-high dilutions of different antigens 
does not alter expression levels of surface markers of activation. DC were 
incubated either in 30CH H2O, 30CH Pa, 30CH CT or 30CH St for 48 hours. Cells 
were analysed for expression of MHC II, CD80 and CD40 expression. Graphs 
are represented by 30CH H2O (black line) over 30CH antigen (blue line). Data 
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Figure 3.7.b. Pre-treating DC with ultra-high dilutions of different antigens 
does not alter expression levels of surface markers of activation after exposing 
those DC to stimulatory concentrations of the respective antigens. DC were 
incubated either in 30CH H2O, 30CH Pa, 30CH CT or 30CH St for overnight. A 
stimulatory concentration of 5µg/ml of the respective antigen was then added 
for a further 24 hours. Cells were analysed for expression of MHC II, CD80 and 
CD40 expression. Graphs are represented by 30CH H2O (black line) over 30CH 















 DC treatment                                               30CHH2O          30CHP a                            30CHH2O           30CHP a 
 
Figure 3.8. 30CH P. acnes treated DC do not induce a stronger IFN-γ  response 
in splenocytes of recipient mice than 30CH H2O treated ones. DC were pre-
treated with 30CH H2O or 30CH P. acnes for 42 hours. They were then 
transferred subcutaneously into naïve mice and 7 days later spleens were 
removed, processed into single cell suspensions and restimulated with either 
media or 1µg/ml P. acnes. IFN-γ and IL-10 was measured by ELISA. Bars 
represent mean and standard error mean of 4 mice per group. Data are 
representative of seven individual experiments. Statistics were performed using  















































DC pre-treatment               30CHH2O   30CHH2O    30CHP a                30CHH2O   30CHH2O    30CHP a  
DC pulsing (5µg/ml P.acnes)   -                 +                 +                              -                 +                 + 
 
Figure 3.9. Splenocyte cytokine production by mice receiving 30CH P.a pre-
treated DC. DC were treated with 30CH H2O or 30CH P.a for 24 hours. They 
were then incubated in media or 5µg/ml Hk P.a for a further 24 hours. DCs 
were then transferred subcutaneously into naïve mice and 7 days later spleens 
were removed, processed into single cell suspensions and restimulated with 
either media or 1µg/ml HK P.a. IFN-γ and IL-10 was measured by ELISA. Bars 
represent mean and standard error mean of 4 mice per group. Data are 
representative of seven individual experiments. Statistics were performed using  



















































DC pulsing dose                     -        5µg/ml  10µg/ml 20µg/ml                    -        5µg/ml  10µg/ml 20µg/ml 
 
Figure 3.10. Splenocyte cytokine production by mice receiving DCs exposed 
to increasing doses of HK S.t. DCs were incubater in media for 24 hours. 
5µg/ml, 10µg/ml, or 20µg/ml HK S.t was then added for a further  24 hours. 
DCs were transferred subcutaneously into naïve mice and 7 days later spleens 
were removed, processed into single cell suspensions and restimulated with 
either media (open bars) or 1 µg/ml HK S.t (closed bars). Splenocyte IFN-γ and 
IL-10 was measured by ELISA. Error bars represent standard mean and 
standard error mean of 4 mice per group. Experiment is representative of two 



















































DC pre-treatment                             30CHH2O    30CHH2O   30CHSt            30CHH2O    30CHH2O   30CHSt                                         
DC pulsing (20µg/ml S. typhimurium)   -                  +                +                         -                  +                + 
 
Figure 3.11. Splenocyte cytokine production by mice receiving 30CH S.t pre-
treated DC. DC were treated with 30CH H2O or 30CH S.t for 24 hours. They 
were then incubated in media or 20µg/ml HK S.t for 24 hours. DCs were 
transferred subcutaneously into naïve mice and 7 days later spleens were 
removed, processed into single cell suspensions and restimulated with either 
media (open bars) or 1µg/ml HK S.t (closed bars). Splenocyte supernatant IFN-γ 
and IL-10 was measured by ELISA. Error bars represent standard error mean of 
4 mice per group. Experiment is representative of three individual experiments 
























































DC treatment                                                30CHH2O                30CHCT                         30CHH2O                30CHCT  
 
Figure 3.12. 30CH CT treatment of DC does not induce any different recall 
responses than 30CH H2O treatment. DC were pre-treated with 30CH H2O or 
30CH CT for 24 hours. They were then transferred subcutaneously into naïve 
mice and 7 days later spleens were removed, processed into single cell 
suspensions and restimulated with either media, 50ng/ml CT or 0.5µg/ml. IL-4, 
IL-5, IL-10 and IFN-γ were measured by ELISA. Bars represent mean and 
standard error mean from 3 mice per group. Experiment is representative of two 
individual experiments. Experiment performed in a “blind” fashion. Statistics 

































































DC pre-treatment                 30CHH2O     30CHH2O     30CHCT                   30CHH2O     30CHH2O      30CHCT                      











DC pre-treatment                 30CHH2O    30CHH2O     30CHCT                     30CHH2O    30CHH2O      30CHCT                 
DC Pulsing (5µg/ml CT)             -                   +                   +                                 -                   +                   +                                                      
 
Figure 3.13. Induction of a Th2 response by ultra-high dilution of CT treated 
DC. DC were pre-treated with 30CHH2O or 30CH CT for 24 hours. They were 
then incubated in media or 5µg/ml CT for a further 18 hours. DC were then 
transferred subcutaneously into naïve mice and 7 days later spleens were 
removed, processed into single cell suspensions and restimulated in either  
media, 50ng/ml CT or 0.5 µg/ml CT. IL-4, IL-5, IL-10 and IFN-γ were measured 
by ELISA. Bars represent mean and standard error mean from 3 mice per group. 
Experiment is representative of two individual experiments. Experiment 























































































Figure 3.14. Meta analysis of 7 independent experiments addressing the effect 
of ultra-high dilution of antigen on immune response development reveals 
minute but statistically significant biological effect of such extreme dilutions 
on the ability of DCs to drive immune responses.  Y axis represents the effect 
size in ng/ml of IFN-γ secreted by splenocytes of recipient mice that had 
received 30CH P.a pre-treated- P.a stimulated DC over 30CH water pre-treated- 
P.a stimulated DC. Y axis = 0 denotes a null effect on immune response 
development by ultra-high dilution of Ag pre-treated DC. Y axis < 0 denotes an 
inhibitory effect on IFN-γ priming by 30CH P.a pre-treated DCs and Y axis > 0 
denotes a positive effect on IFN-γ priming by 30CH P.a pre-treated DCs. X axis: 
Groups 1-7 represent 7 independent experiments performed under identical 
conditions. Group 8 represents the statistical sum of all 7 experiments, after 
performing meta analysis. Squares represent the mean effect size of IFN-γ 
secretion by splenocytes from recipient mice that had received 30CH P.a pre-
treated DCs over mice that had received 30CH H2O pre-treated DCs. Error bars 
represent the variation within each experiment. Degree of freedom=9.0, Q 
statistics=8.720, Summary Mean=9.095, Lower Bound of 95% CI=3.606, Upper 



























Can vaccination with dendritic cells alter the course of 
Salmonella typhimurium infections? 
 
Abstract 
DCs are required for the initiation of adaptive immune responses. 
Recent work addressing the role of DCs in immune response development 
against Salmonella infections has shown, interestingly, that DCs are also 
responsible for bacterial dissemination. We decided to use the murine S. 
typhimurium disease model in order to investigate this intricate relationship 
between DCs and Salmonella bacteria. We wished to address whether the 
adaptive immune responses elicited by DCs in naïve mice could affect S. 
typhimurium-induced immunopathology. We approached this question by 
vaccinating naïve animals with DCs that had been previously exposed to 
stimulatory concentrations of heat-killed S. typhimurium. We then addressed 
whether primary or memory responses induced by this vaccination regime 
could alter immunopathology caused by live virulent SL1344 S. typhimurium 
infections. Memory responses in vaccinated-infected mice were characterised 
by significantly elevated serum and splenocyte IFN-γ  responses as well as 
type 1, and strikingly, type 2 Ab levels. Additionally, we found that memory 
responses in vaccinated animals were characterised by reduced serum TNF-α  
and slower weight loss patterns.  
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4.1 Introduction  
 Salmonella enterica servovar Typhimurium is a Gram-negative 
facultative intra-cellular anaerobic bacterium. It is one of around 2500 serovars 
identified, grouped into 6 sub-species (Ochman and Groisman, 1994). In 
humans Salmonella infections can be divided into two groups according to the 
clinical symptoms observed; typhoid and enterocolitis. Typhoid is a systemic 
infection in humans cause by servoars Typhi, Paratyphi and Sendai, while most 
other serovars cause enterocolitis/diarrhea and bacteremia (Fierer and Guiney, 
2001). Salmonella enterica serovar Typhimurium (or Salmonella typhimurium) 
causes enterocolitis in humans. However, it has proven to be a very good model 
for the study of typhoid fever, since, similarly with the human S.typhi, it causes 
systemic infection in mice, characterised by extensive dissemination of the 
pathogen to secondary lymphoid organs as well as sterile sites such as the heart. 
 
4.1.1 Pathogen invasion 
Salmonella infects humans and animals via the oral route, usually due to 
contaminated food and water. The initial uptake and transfer of Salmonella 
typhimurium from the gut lumen to Peyer’s patches involves an interplay 
between the host and the pathogen. Invading bacteria survive the acidic 
environment of the stomach and colonise the ileum and cecum, by 
outcompeting commensal bacteria (Baumler et al., 1997; Jones et al., 1994). M 
cells and DCs have been identified as crucial factors for the invasion and 
translocation of the pathogen from the lumen to Peyer’s patches (Jones et al., 
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1994; Rescigno et al., 2001a; Rescigno et al., 2001b). Within Peyer’s patches 
CCR6+ dendritic cells instruct resident T cells to become activated (Rescigno, 
2006; Salazar-Gonzalez et al., 2006), while bacteria are disseminated through 
CD18+ macrophages to the spleen and liver (Vazquez-Torres et al., 1999). There, 
the bacteria are internalised and reside within polymorphonuclear cells (PMNs) 
(GR1+ cells), DCs (CD11c+, MHC class II+ cells), and B cells (Liang-Takasaki et 
al., 1983; Souwer et al., 2009; Warren et al., 2002; Yrlid et al., 2001a).  
 
4.1.2 Host immunity and clearance 
Understanding the underlying mechanisms that enable the host to clear 
any infection, is key for the development of effective ways to either generate 
vaccination strategies or treatment regimes. The animal model (mouse) of 
Salmonella enterica serovar Typhimurium provides us with a useful tool to better 
understand typhoid fever in humans. The NRAMP gene, which encodes for a 
bivalent metal pump that is recruited to the Salmonella-containing phagosome is 
crucial for the early clearance of the pathogen (Vidal et al., 1993), and as such 
NRAMP deficient mice are highly susceptible to Salmonella infections. No such 
gene has been identified in humans (Dunstan et al., 2001), however the clinical 
symptoms of Salmonella typhimurium in mice lacking NRAMP and Salmonella 
typhi in humans are very similar, characterised by rapid bacterial dissemination 
and dehydration.  
Early host defences against Salmonella require reactive oxygen 
intermediates. These are generated intracellularly via a process initiated by 
NADPH oxidase (Mastroeni et al., 2000b). This form of oxidative killing is 
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regulated by TNF-α (Vazquez-Torres et al., 2001). Similarly TNF-α plays an 
important role in the formation of granulomatous lesions, which are involved in 
containing the pathogen, as it has been demonstrated in mice treated with anti-
TNF-α antibodies (Mastroeni et al., 1995). Macrophages, recruited to the infected 
sites are responsible for the formation of such granulomas, while their provision 
of pro-inflammatory cytokines such as IL-12 and IL-18 enables NK T-cell killing 
of infected cells. Late responses against Salmonella involve both cellular as well 
as humoral immunity (Mastroeni et al., 1993a). It has been shown that CD4+, 
CD8+ T cells, B cells, as well as the presence of Ab are required for protective 
immunity (Chapter 1.6) (Barr et al., 2009; Mastroeni and Menager, 2003).  
 
4.1.3 Vaccination strategies against S. typhimurium 
  Attempts to prevent salmonellosis by implementation of hygiene 
methods have proven ineffective, while antibiotic treatment, although effective, 
is problematic due to the emergence of multi-drug resistant Salmonella strains 
(Mastroeni et al., 2001). 
 Vaccination is a powerful tool for the prevention of infectious diseases. 
Three different vaccination approaches are today available against Salmonella 
infections; a) Whole-cell killed vaccines, b) Subunit vaccines and c) live 
attenuated vaccines (Mastroeni et al., 2001). 
 Whole-cell killed vaccines are generated by either heat-killing or acetone 
treating Salmonella bacteria and administering the preparations parenterally 
(Mastroeni et al., 2001). Whole-cell killed vaccines induce good antibody 
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responses in humans, however they have proven to provide poor cell mediated 
immunity (Mastroeni et al., 2001). Nevertheless, this vaccination regime confers 
>70% protection in humans, however, it is less effective in NRAMP deficient 
mice (Engels et al., 1998; Harrison et al., 1997; Levine et al., 1989). Despite their 
relatively high protective efficacy in humans, whole-cell killed vaccines are 
reactogenic, inducing adverse effects, and as such are not used commercially 
(Collins, 1974; Engels et al., 1998). 
 Salmonella subunit vaccines are generated by purifying immunogenic 
proteins from bacterial cultures (Mastroeni et al., 2001). Although they confer 
worse protection against Salmonella than whole-cell vaccines, they induce less or 
no adverse effects (Engels et al., 1998). There is one commercially available 
subunit vaccine against Salmonella recommended by the World Health 
Organisation (WHO), the Vi (virulence) capsular polysaccharide vaccine 
(ViCPS). It is made from purified Vi capsular polysaccharide from the Ty2 
Salmonella typhi strain and confers between 55 and 70% protection (Engels et al., 
1998). When it is bound to protein carriers its protective efficacy can be, 
however, increased (Mastroeni et al., 2001). Other subunit vaccines have been 
tested experimentally, such as ones based on detoxified LPS, cell extracts, porins 
and O-polysaccharides, however, these vaccines have been proven to be less 
efficacious (Mastroeni et al., 2001).  
 The availability of the complete genome sequences for S.typhi and S. 
typhimurium, in conjunction with advances in genetic modification, allowed for 
extensive research in the efficacy of live-attenuated Salmonella strains as 
vaccines. One commercially available live-attenuated vaccine, which is 
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recommended by the WHO, Ty21a, is an rpoS (RNA polymerase, sigma S - 
sigma 38 - factor) mutant derivative of the wild type Ty2 S. typhi strain. Ty21a, 
has been found to confer comparable protection levels to the ViCPS vaccine 
(Yang et al., 2001b). Many different attenuated strains are currently used in 
animal infection models as well as in clinical trials. The Ty800 strain, which was 
generated by deleting the PhoP/PhoQ genes (Chapter 1.6.4) of the Ty2 S. typhi 
strain has been shown to confer both humoral and cellular immunity in humans 
(Hohmann et al., 1996). The AroA attenuated strain (Chapter 1.6), which is 
widely used in animal models, is an auxotroph mutant of the SL1344 wild type 
strain and confers full protective immunity in NRAMP deficient mice (Harrison 
et al., 1997).   
DCs, which are known to be involved in the generation of adaptive 
immune responses, are one of the first cell type that encounters Salmonella 
bacteria. However, little is known about the contribution of this cell type in the 
generation of protective immune responses against S. typhimurium infections. As 
such, we wished to investigate whether DCs are indeed able to induce 




1) To establish immunopathological parameters induced by S. typhimurium 
infections in NRAMP- mice. 
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2) To investigate whether primary and memory immune responses generated by 
HK Salmonella-pulsed DCs in recipient mice alter immunopathology caused by 
S. typhimurium infections. 
 
4.2 Results  
We wished to assess whether immune responses elicited by DCs 
transferred into naïve mice were sufficient to alter immunopathology following 
infection with virulent SL1344 strain S. typhimurium. However, before we could 
proceed to these investigations we needed to established the pathological 
parameters of different infective doses of S. typhimurium infection in C57BL/6 
(NRAMP-) mice. 
 
4.2.1 Salmonella typhimurium infection – pathology in C57BL/6 mice 
Previous work on S. typhimurium infections has shown that different 
strains of mice have different natural resistance to S. typhimurium.  Disease 
progression and mortality is dependent on route of infection, infective dose as 
well as the strain of S. typhimurium used. In order to keep continuity between 
our previous DC transfer and infection experiments we decided to use C57BL/6 
(NRAMP-) mice for all infection experiments. 
Immunopathology caused by S. typhimurium strain SL1344 was assessed 
by orally infecting mice with increasing doses of S. typhimurium and measuring 
weight changes during infection as well as serum levels of cytokine, 
splenomegaly and bacterial loads in the spleens and livers of infected mice. The 
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method of infection was chosen in order to keep in line with the naturally 
occurring route of infection (i.e. oral). 
Mice were infected with 100µl of either 1*106, 1*107 or 1*108 CFU 
SL1344/100µl PBS. Mouse weights were recorded at the day of infection and at 
day 4 after infection (Figure 4.1.A). Since individual mice were not marked, the 
pattern of weight loss for each mouse within a group could not be plotted. 
Standard variation within each group was therefore deduced by combining the 
standard variations at day 0 and day 3 of infections according to J.A Nissim’s 
mathematical formula (J.A.Nissim). 
There was no significant difference in weight loss between any of the 
groups of mice receiving the different doses of S. typhimurium (Figure 4.1.A). All 
infected mice exhibited spleen enlargement (Figure 4.1.B). There was no 
correlation, however, found between infective dose and splenomegaly.  
Bacterial loads in the spleen and livers of infected mice correlated with 
increasing infective doses (Figure 4.2). We cannot infer to the statistical 
significance of this observation since the livers and spleens from individual mice 
within groups were pooled. However, livers from mice receiving 1*106 CFU 
SL1344 had approximately 2 logs less mean bacterial loads per gram of tissue 
than those receiving 1*108 CFU. The difference in the spleens was less 
pronounced with only one log difference in the bacterial burden between mice 
receiving the lowest, 1*106 CFU, and highest 1*108 CFU S. typhimurium (Figure 
4.2). The intermediate infecting dose of 1*107 CFU resulted in intermediate 
bacterial burdens in both the spleen and the liver.  
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Serum IFN-γ and TNF-α was measured at day 4 post infection. Serum 
IFN-γ levels peaked at the 107 CFU/100µl PBS concentration (Figure 4.3). Both, 
the 106 and 108 CFU/100µl PBS bacterial concentrations induced significantly 
less serum IFN-γ than the 107 CFU/10µl PBS concentration (P<0.05) (Figure 4.3). 
Interestingly, serum TNF-α levels showed a different picture. The highest 
infective dose of SL1344 (108 CFU/100µl PBS) induced significantly more TNF-α 
than the rest of the infective doses (P<0.05) (Figure 4.3). 
                                                         
4.2.2 Can primary immune responses induced by DCs exposed to heat-
killed S. typhimurium alter the course of S. typhimurium infections? 
First we established that heat-killed S. typhimurium induces DC activation 
(Chapter 3), which in turn can induce an immunological response in naïve mice. 
We wanted to examine whether the immune response developed as a result of 
transferring heat-killed S. typhimurium-pulsed DCs could alter pathology 
conferred during infection with live virulent SL1344 S. typhimurium. DCs were 
grown from bone marrow and stimulated with 10µg/ml HK S.t according to 
material and methods 2.3. DCs were injected in mice according to materials and 
methods section 2.7 in the footpads. 3 days later mice were infected orally with 
2*107 CFU/100µl PBS. The infective dose was chosen in view of the serum IFN-γ 
and TNF-α observed in Figure 4.3. The fact that the highest infective dose 
induced an exaggerated TNF-α response as well as preventing the onset of an 
IFN-γ one, suggested that at this bacterial concentration the mice were perhaps 
exhibiting excess immunopathology, which might shadow any future 
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immunological observations we wished to make. Accordingly, we chose the 107 
CFU/100µl PBS infective dose. 
No significant difference was observed between weight loss patterns of 
naïve mice, mice receiving unstimulated DCs or mice receiving heat-killed S. 
typhimurium-pulsed DCs (Figure 4.4), after infecting them with 2*107 CFU/100µl 
PBS. Similarly, liver bacterial burdens as well as splenomegaly were not affected 
by primary immune responses generated by S. typhimurium-pulsed DCs (Figure 
4.5.A, 4.5.B), suggesting that primary immune response development by HK S.t 
pulsed DCs was insufficient to alter pathology. IFN-γ and TNF-α levels in the 
serum were statistically similar in all groups of infected mice (Figure 4.6). To 
further assess whether there was any difference in the immunological profile 
between the non-vaccinated and the different groups of DC-vaccinated mice, 
spleens were removed and splenocytes of individual mice were incubated in the 
presence of gentamycin, penicillin and streptomycin alone or in the presence of 
gentamycin, penicillin, streptomycin and heat-killed S. typhimurium. The reason 
exogenous S. typhimurium was added to the spleen cell cultures was to eliminate 
any difference in splenic bacterial burdens the infected mice may have between 
them. By adding 10µg/ml heat-killed S. typhimurium the amount of bacteria in 
the splenocytes was increased by approximately 2 logs, effectively decreasing 
the dose variability in the splenocyte cultures by 2 decimal places. There was no 
significant difference in the levels of IFN-γ, IL-17 or IL-10 produced by 
splenocytes between naïve mice, mice that received unstimulated DCs or mice 
that had received HK St-pulsed DCs (Figure 4.7).  
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4.2.3 Can immunological memory induction by DCs alter the course of S. 
typhimurium infections? 
We wished to investigate whether memory responses conferred in 
recipient mice by DCs that had been pulsed with S. typhimurium altered the 
course of S. typhimurium infections. To this end we transferred HK S.t pulsed-
DCs five weeks before infecting mice orally with 1.72*107 CFU SL1344.  
No statistical difference in weight loss patterns during the first 5 days of 
infection was observed between mice receiving unstimulated DCs and mice 
receiving HK S.t-pulsed DCs (Figure 4.8). Nevertheless, mice that had received 
HK S.t-pulsed DCs lost significantly less weight than naïve mice, after being 
infected (P<0.01), suggesting that DC vaccination delayed the onset of 
pathology. No difference in liver bacterial burdens was observed between the 
different groups of mice (Figure 4.9.A). Strikingly, mice that had received S.t-
pulsed DCs exhibited significantly less splenomegaly than naïve mice or mice 
receiving unstimulated DCs (P<0.05) (Figure 4.9.B), suggesting that the memory 
immune response elicited by HK S.t-pulsed DCs altered immunopathology 
caused by S. typhimurium infection. Moreover, serum IFN-γ levels were 
significantly higher in mice that had received HK S.t-pulsed DCs than that 
observed in naïve mice or mice that had received unstimulated DCs  (P<0.05) 
(Figure 4.10). Serum TNF-α levels were significantly lower in mice that had 
received HK S.t-pulsed DCs than naïve-infected mice, further suggesting that 
memory immune responses elicited by St-pulsed DCs altered immunopathology 
during infection (Figure 4.10).  Similarly to serum IFN-γ, splenocytes from mice 
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that had received S.t-pulsed DCs secreted significantly more IFN-γ than naïve-
infected mice or mice that had received unstimulated DCs (P<0.05) (Figure 
4.11). There was no statistically significant difference in the levels of IL-10 
secreted by splenocytes from the different groups of infected mice, suggesting 
that the IFN-γ responses observed previously were not due to regulatory 
responses elicited by S. typhimurium (Figure 4.11). IL-17 secretion by splenocytes 
from mice that had received S.t-pulsed DCs was significantly higher than that 
secreted by splenocytes of mice that had received unstimulated DCs (P<0.05) 
(Figure 4.11).   
Surprisingly, mice that had received S.typhimurium – pulsed DCs 
exhibited higher total antibody titers, at day 5 of infection, than mice that had 
received no DCs or unstimulated DCs (Figure 4.12), suggesting that DCs might 
be involved in whole antigen presentation to B cells. More specifically, IgG2b 
and IgG2c titers (both Th1 associated Abs), were higher in mice that had 
received S.typhimurium – pulsed DCs (Figure 4.12). This finding is consistent 
with the increased IFN-γ secreted by splenocytes from S.t pulsed-DC recipient 
mice. Surprisingly, mice that had received S. typhimurium  - pulsed DCs 
exhibited a significantly higher titer of IgG1 Ab, which is associated with Th2 
responses (Figure 4.12). This finding suggests that S. typhimurium pulsed DCs 
may be inducing a mixed Th1/Th2 response. No significant difference in IgM 




We established pathological parameters induced by various infective 
doses of S. typhimurium SL1344 strain in C57BL/6 mice. Our data clearly 
demonstrated that animals succumb to sever disease, characterised primarily by 
rapid weight loss, splenomegaly and increased levels of TNF-α in the serum 
(Figure 4.1, 4.3).  
 
4.3.1 S. typhimurium infections cause severe immunopathology in 
C57BL/6 mice 
Mice infected with virulent S. typhumurium deteriorate rapidly, many 
exhibiting terminal, as established by Home Office Regulations, weight loss 
patterns by day 3 of infection. In our experimental setting, mice frequently 
dropped below 20% of their initial weight, and in some cases down to 30% of 
their original weight, by losing 10% or more within a 24h period of time. It was 
evident that infected mice exhibited clear signs of severe dehydration, ruffled 
and wet fur, hunching, immobility and in more severe cases periorbital 
inflammation. The increased TNF-α found in the serum of infected mice (Figure 
4.3), may be playing responsible for the weight loss patterns since it is known to 
cause vasodilatation and increased endothelial permeability to water (Worrall et 
al., 1997). Livers from infected mice were often characterised by white patching, 
which is characteristic of hepatic septicaemia, granuloma formation and lesions, 
we would, however, need to perform histological analysis to confirm these 
observations.  
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The purpose of our investigations into the effect different concentrations 
of live S. typhimurium SL1344 have on immunopathology C57BL/6 mice was to 
establish which infective dose would be optimal for further work performed 
using DCs as vaccines. We decided that 107 CFU/100µl PBS was an appropriate 
infective dose since at this concentration mice exhibited the highest serum IFN-γ 
responses in conjunction to moderate serum TNF-α levels (Figure 4.3). 
 
4.3.2 Primary immune responses elicited by DCs are insufficient to alter 
immunopathology caused by S. typhimurium infections 
Transferring S. typhimurium pulsed DCs into naïve recipient mice 3 days 
before infecting them did not alter disease pathology, suggesting that the 
primary immune response conferred by bone marrow derived DCs is 
insufficient to protect from salmonellosis (Figure 4.4, 4.5, 4.6). Weight loss 
patterns from mice that had received DCs pulsed with heat-killed S. 
typhimurium were statistically similar to those observed in infected mice that 
had not received DCs or mice that had received unstimulated DCs (Figure 4.4). 
Similarly, neither liver bacterial burdens nor spleen enlargement was affected 
by this vaccination protocol (Figure 4.5.A, 4.5.B). Furthermore, neither serum 
cytokine levels nor cytokine levels determined by splenocyte recall responses 
seemed to be affected by transferring HK S.t pulsed-DCs to naïve mice 3 days 
prior to infecting (Figure 4.6, 4.7), strongly suggesting that the immune 
responses elicited by DCs were inadequate to alter immunopathology.  
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4.3.3 Memory responses elicited by DCs reduce immunopatholgy caused 
by S. typhimurium infections. 
Interestingly, mice that had received DCs stimulated with HK S. 
typhimurium SL1344 5 weeks prior to being infected, exhibited slower weight 
loss patterns, reduced splenomegaly and serum TNF-α as well as elevated levels 
of IFN-γ and IL-17 than naïve-infected mice (Figure 4.8, 4.9, 4.10, 4.11).  
TNF-α has been previously shown to be involved in S. typimurium 
induced granuloma formation (Mastroeni et al., 1992), which is essential for 
preventing bacterial spreading. In contrast, TNF-α is also responsible for 
vasodilatation and increased water permeability of endothelial cells (Worrall et 
al., 1997). HK S.t-DC vaccinated mice exhibited slower patters of weight loss as 
well as significantly less serum TNF-α compared to naïve-infected animals, an 
observation that supports the notion that perhaps excess TNF-α is detrimental 
to the well-being of the animals (Figure 4.8, 4.10). We could try and verify this 
hypothesis by providing animals, that have previously been immunised with 
live-attenuated Salmonella strains, with recombinant TNF-α and observe 
whether, such fully protected animals, do indeed experience TNF-α dependent 
dehydration. TNF-α is known to be important for the containment of Salmonella 
within granulomas (Mastroeni et al., 1992). As such it might be worth 
investigating whether there are either differences in the number of granulomas 
or differences in the cell infiltrate of each granuloma between HK S.t-pulsed 
DC-vaccinated mice and naïve mice, following infection. This would allow us to 
determine whether the different levels of serum TNF-α we detected between 
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different groups of mice in our experimental model correlate with bacterial 
containment. In order to exclude the possibility that factors other than TNF-α 
might be contributing towards granuloma formation in our experimental model, 
we would need to include TNF-α depleted groups of mice.  
We found that mice that had been vaccinated with S.t-pulsed DCs did no 
exhibit splenomegaly, compared to mice that had not been vaccinated or had 
been vaccinated with unstimulated DCs (Figure 4.9.B). It has been previously 
reported that the presence of TNF-α correlates with splenomegaly (Mastroeni et 
al., 1992), however, the mechanisms that govern this observation are unknown. 
TNF-α is known to be a chemoattractant for leukocytes (Mannel and 
Echtenacher, 2000), while it also induces dysfunctional endothelial permeability 
(Worrall et al., 1997), both factors that could contribute towards spleen 
enlargement. Flow cytometric analysis of the numbers of cells as well as the type 
of cells infiltrating the spleens of infected animals might give us an answer as to 
the factors contributing towards spleen enlragement. 
DCs that had been pulsed with H.K S.t induced Salmonella-specific IFN-γ 
and IL-17 in splenocytes of recipient, infected, mice (Figure 4.11). Intracellular 
staining of splenocytes, might give us a better picture about which cell 
populations are responsible for the increased IFN-γ and IL-17 we observed in 
the S.t-pulsed DC vaccinated mice compared to naïve and unstimulated DC 
transferred mice. Analysing for the presence of intracellular IFN-γ in CD4+ and 
CD8+ T cell populations would give us useful information about the ability of 
DCs to drive both CD4+ and CD8+ T cell responses in this experimental setting. 
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Previous work has shown that IFN-γ contribute towards the ability of MΦs to 
contain Salmonella. As such, it would be worth investigating whether the 
differences in IFN-γ observed between the various groups of mice also correlate 
with altered ability to contain the bacteria within MΦs.  
Surprisingly, IgG2b and IgG2c was significantly elevated in the serum of 
St-DC vaccinated mice, as compared to naïve mice, or mice that had received 
unstimulated DCs, strongly suggesting that DC vaccinations conferred humoral 
immunity in recipient mice (Figure 4,12). We cannot rule out the possibility that 
free, S. typhimurium, Ag, which might have been present in the supernatant of 
the in vitro S.t DC stimulation assay, was transferred to recipient mice, thereby 
inducing Ab responses. Previous work performed in our laboratory has shown 
that supernatant from in vitro P. acnes-DC stimulation assays is insufficient to 
induce P. acnes-specific cytokine recall responses in recipient mice. We would, 
however, need to test this in the Salmonella system, as well as testing whether 
such supernatant can induce humoral responses.  
It has previously been reported that DCs are able to confer humoral 
responses (Wykes et al., 1998). We showed that, interestingly, S.t pulsed-DCs 
induce type 1 and, strikingly, type 2 Ab responses (Figure 4.12). Whether the 
induction of type 2 Abs in our DC transfer model is a due to the culture 
conditions of the BMDCs, which were grown in foetal calf serum, is open to 
investigation. Unstimulated DCs, however, failed to induce type 2 Abs, which 
would support the notion that the BMDC culture conditions are not responsible 
for the induction of type 2 responses (Figure 4.12). We would need to test 
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whether in our system HK Salmonella induces IL-4, IL-5 and IL-13 cytokine 
secretion. This would give us an indication whether HK Salmonella elicits a 
mixed Th1/Th2 response. Mixed responses are not uncommon in pathological 
conditions. The Salmonella flagellar protein FliC, has been previously shown to 
elicit Th2 or Th1 responses depending on whether it is found in soluble form or 
attached to bacteria, respectively (Cunningham et al., 2004). It would be 
interesting to investigate whether a mixed Th1/Th2 response is beneficial to the 
host or the pathogen in our experimental model. Identifying which party in this 
pathogen-host interaction is the beneficiary of such mixed responses might 
allow us to re-evaluate the way we design Salmonella-specific vaccines. 
It has previously been reported that, in contrast to humans, live 
attenuated vaccines confer better protection in NRAMP deficient mice than 
whole-cell killed vaccines (Engels et al., 1998; Harrison et al., 1997). 
Nevertheless, the reasons for this are unknown. As we discussed in Chapter 1.6, 
when Salmonella bacteria transition from an extracellular to an intracellular 
phase, they modify cell surface protein expression, and at the same time induce 
the secretion of proteins required for their survival within intracellular 
compartments (Chapter 1.6.4). Whole cell vaccines are made from in vitro 
Salmonella cultures, which correspond to the extracellular phase of the bacterial 
life cycle. Whether proteins, which are secreted during the intracellular phase 
are immunogenic or not is uncertain, however, an interesting question worth 
investigating. Designing whole cell killed vaccines from Salmonella bacteria 
purified from infected animals rather then from in vitro cultures might give us a 
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better indication as to whether intracellular and extracellular Salmonella bacteria 
present different Ags to DCs and subsequently to T cells.  
Acetone treated whole-cell killed vaccines have been shown to be better 
at conferring cellular and humoral immune responses in NRAMP deficient mice 
than whole-cell heat-killed vaccines (Diena et al., 1973). This may not be 
surprising, since heat-killing bacteria will most certainly result in excessive 
protein denaturing and degradation, which can affect both MHC presentation of 
peptides as well as B cell antibody responses. Given that the difference in the 
immunogenic capability of acetone-treated versus heat-killed vaccines has 
already been established (Diena et al., 1973), it would be very interesting to 
identify which proteins are denatured and degraded in the heat-killed 
preparations compared to the acetone treated preparations. This might provide 
us with useful information about which Salmonella derived Ags are 
immunogenic, in effect providing us with useful information on how to 
approach subunit vaccine design. 
The DC vaccination experiments provided us with useful information 
about the role of this cell type in immunity against S. typhimurium. The 
advantage of this reductionist approach of the DC vaccination system in 
contrast to whole animal vaccination was that it provided us with detailed 
information about the specific role of DCs in immune response development 
against S. typhimurium.  Further work, involving investigations of different 
subunit vaccines or even live attenuated vaccines, utilising this DC transfer 
system, might provide us with useful information about the intricate 
relationship of this APC with Salmonella. With the recent introduction of the 
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transgenic CD11c/diphtheria toxin receptor mouse, which allows for short term 
ablation of DCs in vivo, it is certain that more information will soon become 
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Figure 4.1. Weight loss and splenomegaly. Increasing doses of S. typhimurium 
infection do not affect splenomegaly in C57BL/6 mice. Mice were either 
administered orally 100µl PBS or infected orally with 1*106, 1*107 or 1*108 CFU 
SL1344/100µl PBS (5 mice per group). Graph A represents mean and standard 
error mean percentage weight change at day 4 of infection for 5 mice per group. 
Graph B represents splenomegaly expressed as spleen to total mouse-body 
weight ratio at day 4 of infection. Bars represent mean and standard error mean 
(SEM) of 5 mice per group. Data are representative of two independent 
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Figure 4.2. Increasing the infective dose of live S. typhimurium correlates with 
increasing bacterial loads in the spleens and livers of infected C57BL/6 mice. 
Mice were either administered orally 100µl PBS or infected orally with 1*106, 
1*107 or 1*108 CFU SL1344/100µl PBS (5 mice per group). Animals were 
sacrificed and CFUs were determined at day 4 of infection. Bars represent 
pooled livers and pooled spleens from 5 animals per group. Liver and Spleen 
CFU titres were determined by plating serial dilutions of either liver or spleen 
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Figure 4.3.  Increasing the infective dose of live S. typhimurium correlates with 
increased TNF-α  levels but not IFN-γ  levels in the serum of C57BL/6 mice at 
day 4 of infection. Mice were either administered orally 100µl PBS or infected 
orally with 1*106, 1*107 or 1*108 CFU SL1344/100µl PBS (5 mice per group). 
Serum was collected at day 4 of infection and IFN-γ and TNF-α were measured 
by ELISA. Bars represent mean and standard error mean (SEM) of 5 mice per 
group and 2 wells per group on the ELISA plate per mouse. Data are 
representative of two independent experiments. Statistics were performed using 





















































Figure 4.4. Primary immune response induced by HK St-pulsed DCs does not 
affect rate of weight loss in mice infected with virulent SL1344 S. 
typhimurium. Mice were either naïve, transferred sub cutaneously (s.c) with 
unstimulated DCs, or DCs pulsed with 10µg/ml heat killed S. typhimurium. 3 
days later all mice were infected orally with 2*107 CFU of S. typhimuruim. 
Weights recorded daily. Graph represents average percentage loss and SEM for 
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Figure 4.5. Primary immune response induced by HK St-pulsed DCs does not 
affect liver bacterial loads or splenomegaly of mice infected with virulent 
SL1344 S. typhimurium. Mice were either naïve, transferred s.c with 
unstimulated DCs or DCs pulsed with 10µg/ml heat killed S. typhimurium. 3 
days later they were infected orally with 2*107 CFU of S. typhimuruim (SL1344) 
for a further 4 days. A) Bacterial titers were determined by serially diluting 
individual liver homogenates. B) Splenomegaly (white bars uninfected mice, 
closed bars infected mice) expressed as spleen to total mouse-body weight ratio 
at day 4 of infection. Bars represent mean and standard error mean of 5 mice per 
group. Data are representative of 2 independent experiments. Statistics were 
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Figure 4.6. Primary immune response induced by HK St-pulsed DCs does not 
affect IFN-γ  or TNF-α  levels in the serum of mice infected with virulent 
SL1344 S. typhimurium. Mice were either naïve, transferred s.c with 
unstimulated DCs or DCs pulsed with 10µg/ml heat killed S. typhimurium 
SL1344. 3 days later they were infected orally with 2*107 CFU of S. typhimuruim 
(SL1344) for a further 4 days. Serum was taken at day 4 of infection and cytokine 
was measure by ELISA. Bars represent mean and standard error mean of 5 mice 
per group and 2 replicate wells on the ELISA plate per mouse. Data are 
representative of 2 independent experiments. Statistics were performed using a 


















































DC Treatment                         NoDC            DC         10µg/ml                   NoDC           DC         10µg/ml 
                                                                                       S.tDC                                                          S.tDC  










DC Treatment                         NoDC            DC         10µg/ml  
                                                                                        S.tDC  
Infection  (2*107 CFU)                +                 +                 +                             
 
 
Figure 4.7. Primary immune response induced by HK St-pulsed DCs does not 
affect recall splenocyte responses in mice infected with virulent SL1344 S. 
typhimurium. Mice were either naïve, transferred s.c with unstimulated DCs or 
DCs pulsed with 10µg/ml heat killed S. typhimurium. 3 days later they were 
infected orally with 2*107 CFU of S. typhimuruim (SL1344) for a further 4 days. 
Spleens were processed into single cell suspensions at day 4 of infection and 
cytokine was measure by ELISA. Bars represent mean and standard error mean 
(SEM) of 5 mice per group and duplicate wells on ELISA plates per mouse. Data 
are representative of two independent experiments. Statistics were performed 





















































Figure 4.8. Memory responses induced by HK St-pulsed DCs prevent weight 
loss induced by SL1344 S. typhimurium infection. Mice were either naïve, 
transferred s.c with unstimulated DCs or DCs pulsed with 10µg/ml heat killed 
S. typhimurium SL1344. 5 weeks later they were infected orally with 1.72*107 CFU 
of S. typhimuruim (SL1344) for a further 5 days. Weights recorded daily. Graph 
represents average percentage weight loss plus standard error mean of 5 mice 
per group. Data representative of 3 independent experiments. Statistics 
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Figure 4.9 Memory responses induced by HK St-pulsed DCs alter 
immunopathology in mice infected with virulent SL1344 S. typhimurium. 
Mice were either naïve, transferred s.c with unstimulated DCs or DCs pulsed 
with 10µg/ml heat killed S. typhimurium SL1344. 5 weeks later they were 
infected orally with 1.72*107 CFU of S. typhimuruim (SL1344) for a further 5 days. 
A) Bacterial titers were determined by serially diluting individual liver 
homogenates. B) Splenomegaly (white bars uninfected mice, closed bars infected 
mice) expressed as spleen to total mouse-body weight ratio at day 5 of infection. 
Bars represent mean and standard error mean of 5 mice per group. Data are 
representative of 3 independent experiments. Statistics were performed using a 
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Figure 4.10 Memory responses induced by HK St-pulsed DCs are 
characterised by elevated IFN-γ  but no change in TNF-α  in the serum of mice 
infected with virulent S. typhimurium. Mice were either naïve, transferred s.c 
with unstimulated DCs or DCs pulsed with 10µg/ml heat killed S. typhimurium 
SL1344. 5 weeks later they were infected orally with 1.72*107 CFU of S. 
typhimuruim (SL1344) for a further 5 days. Serum was collected at day 5 of 
infection and cytokine was measure by ELISA. Bars represent mean and 
standard error mean of 5 mice per group and 3 replicate wells on the ELISA 
plate per mouse. Data are representative of 3 independent experiments. 
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Figure 4.11. Memory responses induced by HK St-pulsed DCs affect recall 
splenocyte responses in mice infected with virulent SL1344 S. typhimurium. 
Mice were either naïve, transferred s.c with unstimulated DCs or DCs pulsed 
with 10µg/ml heat killed S. typhimurium SL1344. 5 weeks later they were 
infected orally with 1.72*107 CFU of S. typhimuruim (SL1344) for a further 5 days. 
Spleens were processed into single cell suspensions at day 5 of infection and 
cytokine was measure by ELISA. Bars represent mean and standard error mean 
(SEM) of 5 mice per group and duplicate wells on ELISA plates per mouse. Data 
are representative of 3 independent experiments. Statistics were performed 
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Figure 4.12. HK St-pulsed DCs induce type 1 antibody responses. Mice were 
either naïve, transferred s.c with unstimulated DCs or DCs pulsed with 
10µg/ml heat killed S. typhimurium SL1344. 5 weeks later they were infected 
orally with 1.72*107 CFU of S. typhimuruim (SL1344) for a further 5 days. Serum 
was collected at day 5 of infection and antibody titers were determined by 
ELISA. Bars represent mean fold increase and standard error mean of antibody 
titer over non immune serum. Data are representative of 3 independent 






































The role of IL-23 in immunity against Salmonella typhimurium 
 
Abstract  
IL-23 is a heterodimeric cytokine composed of two subunits, p19 and 
p40.  While both IL-12 and IL-23 share the common subunit p40 they contain 
distinct p35 and p19 subunits respectively, and are thought to play distinct 
roles in activating T cells. IL-12 has been described to be a key factor in 
combating bacterial and viral infections by inducing T helper 1 cells to secrete 
IFN-γ . IL-23 has recently been described to be a major cytokine inducing IL-17 
secretion from activated T cells. It is thought to be important for the 
pathogenesis of organ-specific autoimmune diseases, such as experimental 
autoimmune encephalomyelitis and rheumatoid arthritis, as well as for the 
clearance of bacterial and fungal pathogens. We addressed how IL-23 affects 
primary, memory and secondary challenge responses against Salmonella 
typhimurium. We found that IL-23 is not only critical for the development of 
memory T helper 17 cells, but that it is also required for the activation or 
survival of memory IFN-γ  producing Th1 cells at infected loci.  
 
5.1 Introduction 
Dendritic cells (DCs) are professional antigen presenting cells that, 
together with macrophages and B cells, are thought to orchestrate immune 
responses. It is widely accepted that the cytokine milieu DCs are found in, the 
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type of antigen that they internalise and their homing capacity are all critical 
factors that influence their activation state, which in turn determines the 
polarisation state of T cells.  
Recent developments in immunology have reshaped our oversimplified 
view of Th1 and Th2 CD4+ T cell responses. New additions are introduced at a 
fast pace and today we can identify responses including Treg, Th0, Th1, Th2, Th3 
and Th17. While T cell responses are required for disease resolution, it is the 
APCs that are responsible for initiating the distinct immune profiles of the 
adaptive arm of immunity. Together with the expression of co-stimulatory 
molecules, APC-derived cytokines such as IL12p70, IL-10, IL-6, TNF-α, type 1 
interferons and IL-1β are important factors that can be involved in determining 
the fate of T cell immune responses. Novel DC derived cytokines such as IL-23 
and IL-27 are now also being identified as important regulators of immune 
responses.  
IL-23 is composed of two polypeptide subunits; p19, unique to IL-23, and 
p40, which is common to IL-12 (Oppmann et al., 2000). Since its discovery in 
2000 (Oppmann et al., 2000), IL-23 has been the subject of intense investigation. 
The initial study by Oppmann et. al that identified this molecule showed that IL-
23 shares a common subunit with IL-12p70, which binds to the common IL-
12Rβ1 chain and induces proliferation of CD4+ CD45Rblow T cells, activates 
STAT-4 and subsequently induces IFN-γ, and activates CD45RO memory T cells 
(Oppmann et al., 2000). IL-23 was later described to signal though both IL-12Rβ1 
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chain and the IL-23 receptor activating both STAT-4 and STAT-3, respectively 
(Parham et al., 2002).  
 
5.1.1 Pathogen induced IL-23 secretion by APC 
Differently stimulated DCs tune T cells towards different effector 
phenotypes that are important for both combating a wide range of pathogens as 
well as immune regulation. IL-23 secretion by DCs can also be triggered by 
distinct pathogens and stimulatory agents which are not normally involved in 
the induction of Th1 polarising cytokines such as IL-12. Gram negative and 
Gram positive commensal bacteria, as well as their cell wall components in 
isolation, have been found to stimulate DCs to induce different levels of IL-12 
and IL-23 (Smits et al., 2004), suggesting that differential TLR-2 and TLR-4 
ligation provide distinct activation thresholds that lead to the induction of IL-23. 
Activation of DCs though TLR-3 and TLR-7 simultaneously can also lead to a 
preferential IL-23 production by DCs when they are infected with Theiler's 
murine encephalomyelitis virus (TMEV) (Al-Salleeh and Petro, 2007).  Flagellin 
from members of the Bordetella species such as B. pertussis (which is known to 
induce inflammation through TLR-5 ligation (Lopez-Boado et al., 2005)), drives 
IL-23 but not IL-12 production by DCs (Fedele et al., 2005). The hyphae from 
Candida albicans, which is known to be able to stimulate DCs through the 
mannose receptor as well as TLRs, is a potent IL-23 inducer and an inhibitor of 
IL-12 (Acosta-Rodriguez et al., 2007b). Similarly, prostagladin E2 has also been 
shown to be a potent IL-23 inducer (Sheibanie et al., 2004). Together, these 
findings indicate that IL-23 production is dependent on the nature of the 
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stimulatory agent the DC encounters and the combination of PAMP recognition 
by PRRs.  The range of the different IL-23-driving agents as well as the 
specificity with which these stimulate the production of IL-23 by APCs, strongly 
suggests that there is a distinct role for IL-23 in immune regulation, pathology 
and possibly immune protection. 
 
5.1.2 IL-23 involvement in autoimmune disease 
The introduction of the Th1-Th2 model provided by Mosmann and 
Coffman in the 80s (Mosmann et al., 1986) attempted to explain how different 
CD4+T cell subsets play a critical role in immunity to infection, and pathogenesis 
of autoimmune disease and asthma. IFN-γ producing CD4 +T cells have been 
known to be the most important T cell subset for aiding clearance of viral, 
bacterial and protozoa infections (Flynn et al., 1993; Suzuki et al., 1988; Yu et al., 
1996), as well as the causative agent of immunopathology during organ specific 
autoimmune diseases such as experimental autoimmune encephalomyelitis 
(EAE)  - a mouse model for human multiple sclerosis (MS) - and rheumatoid 
arthritis (RA).  
Inconsistencies, however, with the idea that Th1 cells are crucial for 
autoimmune disease pathology started arising when it was first suggested that 
IFN-γ may not in fact be responsible for clinical severity of EAE, as 
demonstrated in IFN-γ deficient mice (Ferber et al., 1996). Indeed, some studies 
suggested that IFN-γ may actually confer resistance to EAE (Krakowski and 
Owens, 1996), and be protective against collagen induced RA (Vermeire et al., 
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1997). Similarly, mice lacking the IL-12Rβ2, the p35 specific receptor, also 
showed exacerbated pathology associated with EAE (Zhang et al., 2003).   
Following these studies indicating that the IL-12 - IFN-γ paradigm could 
no longer explain the onset of pathology in certain organ specific autoimmune 
diseases, it was shown that IL-23, not IL-12, was responsible for autoimmune 
disease in EAE (Cua et al., 2003). Moreover, while it had initially been described 
to be able to drive IFN-γ production by CD4+ T cells, IL-23 was also found to 
promote a distinct population of IL-17 producing CD4+ cells that were required 
for the induction of EAE (Aggarwal et al., 2003; Langrish et al., 2005). These 
studies demonstrated the importance of IL-23 in autoimmune disease as well as 
identifying it as a key molecule involved in the induction of IL-17 responses. 
Recent work on the autoimmune disease model of EAE has shown that IL-17 
secreting CD4+ T cells can not home to non-inflamed tissue, but are readily 
recruited once lesions have been established (O'Connor et al., 2008), a finding 
suggesting that perhaps IL-17 secreting CD4+ T cells are not involved in the 
initiation but rather the propagation of autoimmune disease pathology. 
 
5.1.3 IL-23 involvement in immunity against pathogen invasion 
The role of IL-23 in bacterial or viral, or even helminth, infections is still 
somewhat elusive. Studies using bacterial infection models such as that of the 
Gram negative bacterium Klebsiella pneumoniae have identified that IL-23 is 
important for mounting protective immunity against this pathogen (Happel et 
al., 2005). Mice lacking IL-23 were severely impaired in their ability to induce IL-
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17, and showed increased susceptibility to Klebsiella infections. Nevertheless, 
when IL-23 deficient mice were infected with the Gram positive bacterium M. 
tuberculosis, they exhibited normal IFN-γ responses, and unaltered protective 
immunity against this pathogen (Khader et al., 2005). IL-17 deficient mice have 
also been shown to be protected against Mycobacterium bovis Bacille Calmette-
Guerin infections (Umemura et al., 2007). These two studies suggest that IL-23 
and IL-17 are not required for protective immunity against this pathogen.  
Using the same infectious model, however, a different group has shown 
that IL-23 production by DCs is required for optimal protection against M. 
tuberculosis (Wozniak et al., 2006). During the same study, it was additionally 
discovered that in the absence of IFN-γ, IL-17 alone was able to confer partial 
protection against the pathogen (Wozniak et al., 2006). In accord with previous 
work performed on this infection model, it was found that IL-23, independently 
of IL-12, was able to initiate IFN-γ responses, which conferred complete 
protection against M. tuberculosis (Wozniak et al., 2006). It has also been shown 
that IL-23 dependent memory Th17 responses are required for the rapid 
infiltration of IFN-γ secreting T cells at alveolar spaces during secondary M. 
tuberculosis infections, thus attributing an important role for IL-23 in Th1 CD4+ 
cell migration against tissue specific pathogens (Khader et al., 2007).  
Supporting the notion that IL-23 can promote IFN-γ along with IL-17, a 
study by Kullberg and colleagues has demonstrated that inflammatory bowel 
disease (IBD) severity is heavily dependent on IL-23 (Kullberg et al., 2006), and 
that IL-23 alone is sufficient to induce the production of both IL-17 and IFN-γ by 
 150 
CD4+ T cells. Colitis pathology in this Helicobacter hepaticus model was abrogated 
when both IL-23 and IL-12 were knocked out. However, IL-23 was found to be 
the main contributor towards disease severity. Subsequent work on IBD 
identified that IL-23 had no impact on systemic T cell inflammatory responses, 
but was essential for the induction of disease pathology in the intestine (Hue et 
al., 2006), suggesting that the effect of IL-23 and IL-17 may be localised to 
specific tissues.  
A different aspect of the possible involvement of IL-23 in immunity was 
demonstrated in a S. typhimurium model, where it was demonstrated that IL-23 
dependent IL-17 secretion induced T cells to produce IL-22. IL-22 was found to 
be responsible for microbial killing via the induction of defensin secretion by 
epithelial cells and keratinocytes (Schulz et al., 2008). 
Outwith the realms of bacteria, studies concentrating on high pathology, 
Th1-skewed murine models of Schistosomiasis have identified IL-23 and IL-17 
as important factors contributing towards immunopathology in certain mouse 
strains (Rutitzky and Stadecker, 2006; Shainheit et al., 2008). Neutralisation of 
either IL-23 or IL-17, but not IL-12p70 or IFN-γ, improved prognosis, suggesting 
a distinct role for IL-23/IL-17 responses in infection.  
Although the role of IL-23 in bacterial or helminth infections remains 
currently unclear, there are strong indications that it is a crucial cytokine for 
conferring disease pathology, and possibly immune protection. Similarly to the 
IL-12 and IFN-γ paradigm, the impact of IL-23 and IL-17 appears to be highly 
dependent on the disease model and mouse strain used. However, the studies 
concentrating on M. tuberculosis and IBD seem to point in the direction that IL-23 
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may have a tissue specific, localised mode of action perhaps involved in the 
recruitment of other cells of the immune system. While IL-23 absence results in a 
systemic loss of IL-17 production by T cells, its effects are more pronounced at 
specific sites of infection. 
 
5.1.4 IL-23-driven IL-17 is essential for lymphocyte recruitment 
IL-17 has been implicated in the clearance of extracellular bacteria and 
fungi. Models using K. pneumoniae, Bacteroides fragilis, Borrelia burgdorferi and M. 
tuberculosis, have shown that IL-17 induces neutrophil recruitment, abscess 
formation, and chemokine secretion required for the rapid infiltration of 
lymphocytes to mucosal tissues (Chung et al., 2003; Infante-Duarte et al., 2000; 
Khader et al., 2007; Ye et al., 2001). Infection models using M. tuberculosis and S. 
typhimurium have shown that IL-23 dependent IL-17 secretion is involved in the 
infiltration of IFN-γ secreting CD4+ T cells to the site of infection (Khader et al., 
2007; Schulz et al., 2008). IL-17 producing CD4+ T cells are thought to home to 
infected loci earlier than IFN-γ secreting cells. At the site of infection they induce 
the upregulation of chemokines and defensins such as β-defensin 2, and 
calgranulins (Siegemund et al., 2009), which are also known to be involved in 
lymphocyte recruitment. This results in the migration of effector cells to the sites 
of infection.  
The link between IL-23 and IL-17 provided a very fertile matrix for the 
deeper understanding of the intricacies of immune responses and their effect on 
both “self” and invading organisms. However, a number of studies have 
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identified some unique roles of this cytokine that might help explain a number 
of the previous observations. IL-23 over-expression in mice was early on 
identified to cause neutrophilia and elevated levels of the pro-inflammatory 
cytokine TNF-α, and IL-1 (Wiekowski et al., 2001).  It was later reported that IL-
23 dependent IL-17 secretion is important for the recruitment of neutrophils to 
the site of inflammation and clearance of bacterial infections (Smith et al., 2007; 
Stark et al., 2005; Ye et al., 2001). Moreover the homeostatic control of neutrophil 
infiltration at the site of inflammation was found to be crucial for granulopoesis 
and lesion formation, suggesting that IL-23 might be indirectly involved in these 
processes. The high pathology model of Schistomiasis has demonstrated that 
granulomas from IL-23 deficient mice show a decreased Gr-1+ cell recruitment, 
indicating that IL-23 may be important for normal granuloma formation 
(Rutitzky et al., 2008). These studies together suggest that IL-23 may be playing 
a key role in the recruitment of neutrophils and possibly other granulocytes to 
the site of infection of inflammation, and consequently promoting lesion and 
granuloma formation.   
S. typhimurium is an intracellular bacterium that uses the fecal-oral route 
for infection. It invades hosts by attaching and transversing the epithelial lumen, 
invading APCs and translocating to spleens and livers where it replicates within 
macrophages (Yrlid et al., 2001b). Pathology is associated with high bacterial 
burdens in the spleens and livers, but it is not uncommon for this pathogen to 
also invade to a lesser degree sterile sites such as the heart. Effective immunity 
against Salmonella is characterized by Th1 responses involving both T and B cells 
and containment of the pathogen within granulomatous regions. Nevertheless, 
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the exact factors that limit bacterial replication and spreading are not yet 
identified. The pluripotent role of IL-23 in immunity posed the S. typhimurium 
model as a very attractive system to learn more about both the pathogen and 




1) To investigate the role of IL-23 in the induction and maintenance of 
CD4+ T cell and B cell primary and memory responses, respectively, during S. 
typhimurium infections. To investigate the role of IL-23 in immunopathology 
caused by S. typhimurium infections. 
2) To investigate the role of IL-23 in maintaining effective CD4+ T cell and 
B cell responses against secondary challenge with S. typhimurium infections. To 
investigate the role of IL-23 in immunopathology caused by secondary exposure 
to S typhimurium. 
 
In order to investigate whether IL-23 is important for the induction and 
maintenance of primary immune responses, as well as following secondary 
infection, we addressed immunological and pathological parameters a week 
post primary infection (induction), 10 weeks post primary infection 
(maintenance/memory) and 4 days after secondary infection (challenge) of 
animals that had been given a primary infection 10 weeks previously.  
 154 
To examine whether IL-23 contributed towards local and/or systemic 
immunity we analysed responses from both mesenteric lymph nodes 
(MLN)(local) and spleens (systemic). 
 
5.2 IL-23 contribution towards the primary response against S. 
typhimurium 
Salmonella enterica serovar Typhimurium is a Gram negative pathogen 
that is known to induce T helper 1 responses in both humans and mice 
associated with high level production of IL-12, TNF-α, IL-6 and IFN-γ. 
Protective immunity requires both the contribution of CD4+ T cells in the form 
of cytokine as well as B cells in the form of antibodies and as Ag presenting cells 
(Barr et al., 2009; Mastroeni and Menager, 2003). IgG2b and IgG2c are well-
characterised Th1 associated antibodies produced during S. typhimurium 
infections, involved in protective immunity against this pathogen (Barr et al., 
2009; Mastroeni and Menager, 2003). 
In order to assess the contribution of IL-23 in the induction of immune 
responses against S. typhimurium we immunised i.p either C57BL/6 wild type 
(WT) or p19-/- mice with either PBS alone (control mice) or 1*106 colony forming 
units (CFUs) of the attenuated SL3261 strain in PBS. Spleens and lymph nodes 
were processed, and single cell suspensions were restimulated in vitro with 
either media alone, or heat-killed (HK) avirulent SL3261. To determine whether 
IL-23 affected the ability of T cells to produce cytokine we purified CD4+ T cells 
from splenocytes of infected animals. Purified T cells were then stimulated with 
 155 
increasing doses of HK, sonicated S. typhimurium in the presence of irradiated 
APCs (from irradiated splenocytes from a naïve syngeneic mouse). Cytokine 
production from whole splenocyte restimulation cultures, lymph node 
restimulation cultures as well as purified CD4+ T cell stimulation cultures was 
measured by ELISA.    
 
5.2.1 Localised responses 
MLN cells from WT and p19-/- mice that were immunised with 1*106 CFU 
SL3261 7 days previously, restimulated with HK SL1344 (Figure 5.1), produced 
statistically identical levels of IL-17, suggesting that during the primary stages 
of a S. typhimurium infection IL-23 does not contribute towards the localised IL-
17 response. Interestingly, MLN cells from immunised p19-/- mice secreted 
significantly more IFN-γ than those from WT mice when restimulated with HK 
SL1344 (Figure 5.1). There was no significant difference between the amount of 
IL-10 secreted by WT and p19-/- lymph node cells when restimulated with 
SL1344 (Figure 5.1).   
MLN cells from WT or p19 -/- mice that had been immunised with 1*106 
CFU of SL3261 failed to produce marked amounts of IFN-γ, IL-10 or IL-17 when 
cultured in media alone (Figure 5.1).  As expected lymph node cells from naïve 
WT and p19-/- mice that received PBS injections did not produce any IFN-γ or IL-
17 (Figure 5.1) after being stimulated with HK SL1344. However, MLN cells 
from naïve, PBS injected WT and p19-/- mice secreted a significant amount of IL-
10 in response to stimulation with HK SL1344 (P<0.05) (Figure 5.1). This 
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suggests that HK salmonella can trigger IL-10 production in naïve mice, perhaps 
from innate sources, in vitro.  
 
5.2.2 Systemic responses 
Similar to what was seen with the local response (Figure 5.1), no 
statistical difference was observed between SL3261-immunised WT and SL3261-
immunised p19-/- splenocytes in their ability to secrete IL-17, when restimulated 
with HK SL1344 (Figure 5.2), suggesting that IL-23 is not required for the 
induction of IL-17 responses either systemically (Figure 5.2) or locally (Figure 
5.1). However, in contrast to what was seen in the MLN, splenocytes from 
immunised p19-/- mice secreted similar amounts of IFN-γ to those from WT 
mice, when restimulated with HK SL1344 (Figure 5.2), suggesting that the role 
of IL-23 in regulation of IFNg may be more important in sites proximal rather 
than distal to infection.  
Interestingly, splenocytes from immunised p19-/- mice secreted 
significantly less IL-10 than splenocytes from immunised WT mice when 
restimulated with SL1344 (Figure 5.2). Nevertheless, the reduced production of 
IL-10 by p19-/- splenocytes had no impact on either IFN-γ or IL-17 secretion by 
these cells (Figure 5.2). Similar to what was seen with MLN cells, bulk 
splenocyte cultures from control, uninfected WT or p19-/- mice that received PBS 
injections responded to HK salmonella by producing significant amounts of IL-
10.  In contrast to the MLN cells, they also produced detectable IFN-γ when 
exposed to HK bacteria for the first time. As expected, splenocytes from these 
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naïve animals did not secrete significant amounts of IFN-γ, IL-10 or IL-17 when 
cultured in media alone (Figure 5.2). Splenocytes from WT or p19-/- mice that 
were immunised with 1*106 CFU SL3261 also failed to secrete marked quantities 
of either IL-10 or IL-17 (Figure 5.2) when cutured in media alone, but did 
produce detectable IFN-γ in this setting.  
 
5.2.3 IL-23 role in T cell polarisation during primary responses against S. 
typhimurium 
In order to focus on the contribution of IL-23 in driving T cell responses 
specifically during primary S. typhimurium infections, we purified CD4+T cells 
from pooled groups of splenocytes by positive selection using magnetic beads, 
and stimulated them in the presence of irradiated APCs and increasing doses of 
HK S. typhimurium.  
Once purified from the bulk splenocytes, and in accord with lymph node 
cell responses, stimulation of purified splenic CD4+ T cells showed that there is a 
role for IL-23 in the regulation of IFN-γ in the S. typhimurium infection setting.  
CD4+T cells from WT mice that had been infected with SL3261 secreted 
increased levels of IFN-γ with increasing concentrations of HK S. typhimurium 
(Figure 5.3). CD4+T cells from IL-23 deficient mice secreted significantly higher 
levels of IFN-γ than those from WT mice, irrespective of the concentration of Ag 
used for stimulation (Figure 5.3).  Coincident with this, and reflecting the result 
from bulk cultures (Figure 5.2), IL-10 levels were also impaired in CD4+T cells 
isolated from p19-/- mice. 
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Not surprisingly, T cells from control, uninfected WT and p19-/- mice that 
were injected with PBS failed to produce any IFN-γ regardless of the dose of 
antigen used to stimulate them with (Figure 5.3).  
Underscoring the fact that IL-23 is not essential for the induction of a 
primary CD4+ T cell IL-17 response during the early stages of a S. typhimurium 
infection, purified T cells from infected IL-23 deficient mice secreted IL-17 
similarly to those isolated from WT infection.  IL-17 secretion by CD4+T cells 
from WT infected mice peaked at the lowest (1µg/ml) concentration of antigen 
used to stimulate them with, and decreased with increasing doses of antigen 
(Figure 5.3). In comparison, T cells from IL-23 deficient, PBS injected naïve  
mice, failed to secrete any detectable IL-17 (Figure 5.3).  Somewhat surprisingly, 
and in contrast to what was seen with IL-23 deficient cells or bulk spenocyte 
cultures (Figure 5.2), CD4+ T cells purified from naïve WT mice produced 
detectable IL-17 in a dose-dependent manner following stimulation with HK. 
T cells from both WT and p19-/- mice that had been injected with SL3261 
produced more IL-10 than their PBS-injected controls (Figure 5.3). Since the 
groups are pooled it is hard to convincingly infer to the statistical relevance this 
observation may have. 
Interestingly, a measurable amount of IL-10 was detected in purified 
naïve CD4+ T cell cultures that were stimulated with HK salmonella. Together 
with the results from the whole naïve splenocyte stimulations (Figure 5.2), this 
indicates that HK salmonella can stimulate IL-10 production directly in naïve 
mice from a combination of innate cells and CD4+ T cells, but IFN-γ only from a 
non-CD4+ source.  
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No obvious differences were observed between WT and p19-/- mice that 
had been injected with either PBS or SL3261 in their ability to produce IL-2 
(Figure 5.3), perhaps due to the fact that IL-2 is not abundant during primary T 
cell responses. 
 
5.2.4 IL-23 role in early B cell responses against S. typhimurium 
Early B cell responses were characterised by significantly higher 
production of type 1 antibodies by immunised p19-/- mice than WT immunised 
mice. Serum IgG2b and IgG2c as well as total immunoglobulin (Ig) were 
significantly higher in SL3261 immunised p19-/- mice than SL3261 immunised 
WT mice (Figure 5.11, suggesting that the early increased IFN-γ secreted by p19-
/- mice may enhance type 1 antibody secretion by B cells. Furthermore, IgG2c 
responses in SL3261 immunised p19-/- mice were characterised by different 
kinetics than those observed in immunised SL3261 WT mice as determined by 
interaction statistics using Two-way ANOVA analysis. Serum IgG1, IgG3 and 
IgM levels were statistically similar between SL3261 immunised WT and SL3261 
immunised p19-/- mice (Figure 5.11). 
 
5.2.5 IL-23 role in maintenance of IL-17 responses during S. typhimurium 
infections 
In order to assess the contribution of IL-23 in maintenance of memory 
responses against S. typhimurium, we immunised C57BL/6 or p19-/- mice with 
either PBS alone (control mice) or with 1*106 CFUs of the attenuated SL3261 
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strain in PBS. Ten weeks later spleens were processed, and single cell 
suspensions were cultured in either media alone, or with 10µg/ml HK avirulent 
SL3261 strain. We wanted to determine whether absence of IL-23 affected the 
ability of different memory cell populations to produce cytokine. We 
approached this by purifying by positive selection using magnetic beads T and 
B cells from pooled groups of splenocytes from infected or PBS injected control 
animals. CD4+T cell populations were stimulated with increasing doses of HK, 
S. typhimurium in the presence of naïve irradiated APCs, while purified B cells 
were stimulated with HK SL3261. Cytokine production from whole splenocyte 
cultures, as well as T and B cell stimulation assays, was measured by ELISA.    
In stark contrast to the lack of requirement for IL-23 in generation of the 
primary IL-17 response (Figures 5.1-5.3), IL-23 was a fundamental requirement 
for maintaining long-term IL-17 responses during S. typhimurium infections. 
Splenocytes from WT mice that had been infected 10 weeks previously with 
SL3261, restimulated with HK SL1344, secreted significantly higher levels of IL-
17 compared to splenocytes from PBS-immunised WT controls (Figure 5.4). 
Interestingly, and in contrast to primary responses - during which splenocytes 
from immunised IL-23 deficient mice secreted significant levels of IL-17 (Figure 
5.2) - splenocytes from p19-/- immunised mice failed to produce any measurable 
IL-17 (Figure 5.4). This suggests that, in the S. typhimurium infection setting, IL-
23 is indispensable for either the homeostasis of IL-17 producing cells, or for the 
activation of memory cells to secrete IL-17 directly, or indirectly by instructing 
other cells to do so.  
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Similar to primary responses (Figure 5.2), in the memory phase, 
splenocytes from SL3261-immunised WT mice secreted similar levels of IFN-γ to 
SL3261-immunised p19-/- mice, suggesting that IL-23 is not required for the 
maintenance of long term IFN-γ responses (Figure 5.4).  
Surprisingly, splenocytes from SL3261-immunised WT mice secreted 
significantly more IL-2 than splenocytes from SL3261-immunised p19-/- mice, 
irrespectively of whether these two groups were stimulated in media or with 
10µg/ml HK SL1344, suggesting that IL-23 may be playing a role in T and B cell 
proliferation (Figure 5.4). Similarly to primary responses against S. typhimurium, 
splenocytes from WT mice produced significantly more IL-10 than splenocytes 
from p19-/- mice when restimulated with HK SL1344 (Figure 5.4). This IL-10 
production was not dependent on whether the mice were immunised or not, 
suggesting that the response was not antigen specific. As expected, splenocytes 
from either WT or p19-/- mice that had received PBS injections failed to produce 
any measurable IL-17 or IL-2 after being stimulated with HK SL1344 (Figure 
5.4). Splenocytes from both immunised WT and p19-/- mice secreted significant 
levels of IFN-γ compared to uninfected controls when stimulated with HK 
SL1344 (Figure 5.4). No significant amount of IFN-γ was detected in 
supernatants from splenocytes of uninfected WT and p19-/- mice stimulated with 
HK SL1344, or from splenocytes of infected WT and p19-/- mice, stimulated in 
media alone (Figure 5.4). 
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5.2.6 IL-23 role in T cell activation and maintenance during late stages of S. 
typhimurium infections 
Reflecting the results from the bulk splenocyte cultures, purified CD4+T 
cells from SL326- immunised WT mice secreted a significant amount of IL-17 
compared to uninfected controls, while T cells from SL3261-immunised p19-/- 
mice failed to secrete any measurable IL-17 (Figure 5.5), suggesting that IL-23 is 
essential for either the activation of CD4+ IL-17 producing T cells, or for the 
provision of survival signals to CD4+ T cells that have been differentiated into 
IL-17 producing cells during the early phase of S. typhimurium infection.  
In contrast to the responses observed at the primary phase of the 
infection, during which T cells from SL3261-iimmunised p19-/- mice produced 
significantly more IFN-γ than SL3261-infected WT T cells, memory responses 
showed a different picture. Purified CD4+T cells from SL3261-immunised WT 
mice produced similar levels of IFN-γ to T cells from SL3261-immunised p19-/- 
mice (Figure 5.5). Although, as seen in figure 5.5, there is a stimulatory dose 
dependency on IFN-γ secretion for both p19-/- and WT mice, we are unable to 
refer to the significance of this result since T cells were purified from pooled 
splenocytes. Additionally, the small differences in IFN-γ secretion between T 
cells from immunised p19-/- and immunised WT mice are not reflected at the 
splenocyte response level (Figure 5.4), making it hard to ascribe a biological 
significance to this observation. Nevertheless, any potential difference in the 
ability of WT and p19-/- T cells to secrete IFN-γ was not due to an IL-10 
regulatory environment, as was seen in the primary phase of the infection, since 
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splenocytes from SL3261-infected WT mice secreted more IL-10 than 
splenocytes from SL3261-infected p19-/- mice (Figure 5.4). Similar to the primary 
responses, T cells from either PBS injected WT or PBS injected p19-/- mice failed 
to produce any measurable IFN-γ when restimulated with HK sonicated S. 
typhimurium (Figure 5.5).   
T cells purified from immunised WT mice secreted a greater amount of 
IL-2 than T cells from immunised p19-/- mice, suggesting that IL-23 might be 
involved in the ability of memory T cells to expand and proliferate (Figure 5.5) 
 
5.2.7 IL-23 role in B cell responses during late stages of S. typhimurium 
infections 
While early IgG2c, IgG2b and total Ig responses were significantly higher 
in immunised p19-/- mice than WT immunised mice, only serum IgG2c was 
elevated in immunised p19-/- mice compared to immunised WT mice at later 
stages of infection (day 51-day 67) (Figure 5.11). In terms of any possible non-
conventional (i.e. other than Ab production) role for B cells in this setting, we 
found no significant difference in B cell production of IL-6 or IL-10 during 
memory responses, suggesting that the lack of IL-23 in Salmonella typhimurium 
infection does not affect this aspect of B cell activation (Figure 5.6).  
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5.2.8 IL-23 role in immune responses during secondary challenge with S. 
typhimurium 
In order to better understand the role of IL-23 in systemic and localised 
responses against secondary challenge and protection against S. typhimurium, 
we infected previously immunised or naïve WT or p19-/- mice with 1*108 CFU 
SL1344 orally via gavage. Four days after challenge, MLNs and spleens were 
collected and processed into single cell suspensions and stimulated in the 
presence of HK SL1344 or in media alone. We also wished to specifically 
investigate whether IL-23 influenced the activation of T and B cells and their 
ability to secrete cytokine during secondary challenges. To this end we purified 
CD4+ T and CD19+ B cells by positive selection from splenocytes prior to culture. 
We stimulated T cells with HK, sonicated WT S. typhimurium in the presence of 
irradiated APCs and B cells in the presence of HK WT S. typhimurium alone.  
 
5.2.9 Localised responses 
Lymph node cells from WT and p19-/- mice that had been immunised 
with 1*106 CFU SL3261 followed by oral challenge with 1*108 CFU SL1344 10 
weeks later, produced significantly more IFN-γ compared to non-immunised, 
challenged controls when restimulated with 10µg/ml HK SL1344 (Figure 5.7). 
Lymph node cells from SL3261-immunised - SL1344-challenged p19-/- mice 
secreted statistically similar levels of IFN-γ to lymph node cells from SL3261-
immunised - SL1344-challenged WT mice (Figure 5.7). Lymph node cells from 
SL3261-immunised - SL1344-challenged p19-/- mice failed to secrete a 
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measurable amount of IL-17 or IL-2 when restimulated with 10µg/ml HK 
SL1344 (Figure 5.7), suggesting that IL-23 is crucial either in the maintenance or 
activation of effector cytokine responses required during secondary challenge 
responses.  
Lymph node cells from SL3261-immunised - SL1344-challenged p19-/- 
mice secreted significantly less IL-10 than lymph node cells from SL3261-
immunised - SL1344-challenged WT mice (Figure 5.7), suggesting that the 
reduced levels of IFN-γ, IL-17 and IL-2 secreted by p19-/- lymph node cells were 
not to due to an IL-10 dependent regulation. In accord with primary responses 
against avirulent SL3261 S. typhimurium (Figure 5.1), lymph node cells from p19-
/- mice that had been immunised with PBS followed by oral SL1344 challenge 
secreted significantly less IL-10 than lymph node cells than PBS-immunised 
SL1344-infected WT mice when restimulated with HK SL3261 (Figure 5.7). 
Although WT and p19-/- lymph node cells exhibited a different capacity to 
secrete IL-10, no statistical difference was observed between immunised and 
non-immunised animals for either group (Figure 5.7), suggesting that the IL-10 
contributors of this cytokine could be innate cells.  
MLN cells from WT or p19 -/- mice that had been immunised with 1*106 
CFU SL3261 and challenged with 1*108 SL1344 CFU failed to produce any 
measurable amount of IFN-γ or IL-17 when restimulated in media alone (Figure 
5.7). Neither did lymph node cells from WT or p19-/- mice that had been 
immunised with PBS followed by oral SL1344 challenge secrete detectable IL-17, 
IL-10 or IL-2 (Figure 5.7) when stimulated in media alone. 
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5.2.10 Systemic responses 
Similar to what was seen with localised MLN responses, splenocytes 
from WT mice that had been immunised with 1*106 CFU SL3261 followed by 
oral challenge with 1*108 CFU SL1344 10 weeks later produced significant levels 
of IFN-γ, IL-17 and IL-2 compared to non-immunised, challenged controls when 
stimulated with HK SL1344 (Figure 5.8). Surprisingly, and in contrast to lymph 
node responses (Figure 5.7), splenocytes from SL3261-immunised - SL1344 
challenged p19-/- mice failed to secrete significantly more IFN-γ than PBS 
immunised - SL1344-challenged control mice (Figure 5.8). This suggests that IL-
23-dependent secondary challenge IFN-γ responses are differentially induced in 
different tissues. In addition, splenocytes from SL3261-immunised - SL1344-
challenged p19-/- mice failed to secrete a measurable amount of IL-17 or IL-2 
when restimulated with HK SL1344 (Figure 5.8), suggesting that in this S. 
typhimurium infection model, IL-23 promotion of IL-17 maintenance and 
proliferation is systemic. In contrast to MLN responses, splenocytes from 
SL3261-immunised - SL1344-challenged WT mice secreted significantly more IL-
10 than splenocytes from PBS-immunised  - SL1344-challenged WT mice when 
stimulated with HK SL1344 (Figure 5.8).  
 
5.2.11 IL-23 role in maintaining T cell responses during secondary 
challenge with S. typhimurium 
In line with what was seen with bulk splenocyte cultures, purified CD4+ 
T cells from WT mice that had been immunised with 1*106 CFU SL3261 followed 
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by an oral SL1344 challenge with 1*108 CFU secreted significantly more IFN-γ 
than T cells from SL3261-immunised - SL1344-challenged p19-/- mice when 
stimulated with HK S. typhimurium (Figure 5.9). This suggests that, during 
challenge infection with S. typhimurium, IL-23 is required for either the 
maintenance or recruitment of IFN-γ secreting T cells.  
Both WT and p19-/- T cells from mice that had been immunised in PBS 
followed by oral challenge with SL1344 failed to produce a significant amount of 
IFN-γ.  
CD4+ T cells from WT mice that had been immunised with 1*106 CFU 
SL3261 followed by oral challenge with 1*108 CFU of SL1344, produced 
significant levels of IL-17 (Figure 5.9) compared to PBS-immunised SL1344-
challenged controls. Similarly to MLN and bulk splenocyte responses, T cells 
from p19-/- mice that had been immunised with 1*106 CFU SL3261 followed by 
oral challenge with 1*108 CFU of SL1344, failed to produce any measurable IL-17 
(Figure 5.9). In resemblance to the response observed by T cells from p19-/- mice 
that had been stimulated one week post immunisation with SL3261 (Figure 5.3), 
T cells from PBS-immunised - SL1344 challenged mice secreted significantly 
higher levels of IL-17 than T cells from p19-/- mice that had been immunised 
with SL3261 and infected with SL1344 (Figure 5.9, open boxes), further 
suggesting that IL-23 is not required for the induction of IL-17 during primary 
immune responses against either the virulent (SL1344) or avirulent (SL3261) 
strains of S. typhimurium. 
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Similarly to splenocyte responses, no significant difference was observed 
in the amount of IL-10 produced by WT or p19-/- T cells from mice that had been 
immunised with 1*106 CFU SL3261 followed by an oral challenge with 1*108 CFU 
SL1344 (Figure 5.9). Furthermore, both WT and p19-/- T cells from mice that had 
been immunised with PBS followed by an oral SL1344 challenge secreted a 
statistically identical amount of IL-10. This observation is at odds with the 
splenocyte responses, during which splenocytes from non-immunised and 
challenged p19-/- mice secreted more IL-10 than their WT controls (Figure 5.8), 
suggesting that the source of IL-10 in this S. typhimurium infection model is 
other than T cells alone. 
As observed during memory responses, secondary challenge responses 
were characterised by a complete failure of T cells from p19-/- mice that had 
been immunised with PBS followed by an oral SL1344 challenge to secrete IL-2, 
in contrast to WT T cells which secreted significant amount of IL-2 (Figure 5.9). 
 
5.2.12 IL-23 role in B cell responses during later stages of S. typhimurium 
infections 
No significant difference was observed in serum levels of type 1 antibody 
between SL3261-immunised p19-/- and SL3261-imunised WT mice at day 3 post 
challenge with SL1344 (Figure 5.11). Similarly, we observed no significant 
difference in the ability of purified B cells from SL3261-immunised – SL1344 
infected WT and SL3261 immunised – SL1344 infected p19-/- mice to secrete 
either IL-6 or IL-10 (Figure 5.10). The observed results could be explained by the 
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fact that 3 days might be a too short period for any differences in B cell 
activation to become apparent.  
 
5.3 Conclusions 
IL-23 has been previously reported to be involved in the maintenance but 
not the induction of T cell IL-17 responses (Bettelli et al., 2008; Khader et al., 
2007). Our results would agree with this hypothesis. Further, the data presented 
in this chapter would also suggest that, during secondary challenge responses 
against S. typhimurium, IL-23 is required not only for the maintenance of IL-17 
CD4+ T cell responses but also for either the provision of survival signals or 
recruitment of IFN-γ secreting CD4+ T cells to the sites of infection. The role of 
IL-23 in maintaining both IL-17 and IFN-γ responses pose it as a possible 
homeostatic and cheomotactic cytokine during inflammation in general, and not 
restricted to IL-17 alone. 
 
5.3.1 IL-23 is not required for the induction of IL-17 in a S. typhimurium 
primary infection 
Primary IL-17 responses against S. typhimurium are not affected by the 
lack of IL-23, as observed in this model using p19-/- mice.  Splenocytes, MLN 
cells and purified T cells from avirulent S. typhimurium- immunised p19-/- and 
WT mice secreted statistically similar levels of IL-17 (Figure 5.1, 5.2, 5.3). 
Previous reports trying to address cytokine requirements for the generation of 
IL-17 responses have established, in accord with our work, that IL-23 is not 
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essential for inducing T cell derived IL-17 production (Bettelli et al., 2008; 
Khader et al., 2007). Interestingly, we found that in both lymph node cells and 
splenic T cells, IFN-γ secretion during primary stages of infection was 
significantly elevated in p19-/- mice compared to WT mice (Figure 5.1, 5.3). 
Similarly, type 1 IFN-γ dependent antibody production was also significantly 
higher in serum from p19-/- compared to WT mice (Figure 5.11). There was no 
evidence of a statistical difference, however, in IFN-γ production by splenocytes 
from p19-/- and WT mice (Figure 5.2). This is at odds with the difference seen in 
splenic CD4+ T cell responses (Figure 5.3), suggesting that other cell sources of 
IFN-γ (such as NK or CD8+) in whole splenocyte restimulations might be 
contributing towards the total amount of IFN-γ observed. In order to conclude 
as to the reason for the differential IFN-γ secretion between p19-/- and WT mice 
in spleens and lymph nodes we would need to perform intracellular cytokine 
staining for different splenocyte populations. Nevertheless, the differential 
secretion of IFN-γ by p19-/- and WT mice observed between splenocyte and 
lymph node cell responses suggests distinct roles for IL-23 in tissue specific 
immunity. Salmonella invasion mechanisms are characterised by the invasion of 
Peyer’s patches, bacterial transport to MLNs and spleens and replication in MΦs 
in the spleens and livers. It would be interesting therefore to assess cytokine 
production comparing WT and p19KO mice in these other tissue sites.  Perhaps 
IL-23 effect on IFN-γ production is dependent on the infection and replication 
site of Salmonella. 
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Some evidence has pointed out that IL-23 plays an inhibitory role on IFN-
γ production by CD8+ cells, NK cells and, to a certain extent, CD4+ T cells in an in 
vitro and in vivo Listeria monocytogenes infection setting (Sieve at all, 2007). It 
would be interesting to know whether competition for the T cell IL-12β1 
receptor, which is shared for signalling between IL-12 and IL-23, can have an 
effect on the capacity of T cells to secrete IFN-γ. While there is some evidence 
suggesting that IL-17 and IFN-γ secreting cells can counter-regulate each other 
(Cruz et al., 2006), this does not seem to be the case in this S. typhimurium setting 
since splenocytes, lymph node cells and T cells from IL-23 deficient mice 
secreted statistically similar levels of IL-17 to the respective cells from WT mice. 
This would suggest that it is improbable that the reduced IFN-γ secretion from 
WT cells is due to an IL-17 counter-regulatory effect.  
We found that WT mice lost statistically more weight during the initial 
stage of immunisation than p19-/- mice (Figure 5.13A). Looking into other 
parameters of pathology such as bacteraemia and pro-inflammatory cytokine 
secretion in different tissues may reveal a more clear picture about the different 
immunopathological profile between p19-/- and WT mice and between different 
tissues. Differences between p19-/- and WT mice in the activation state of 
phagocyte intracellular compartments containing bacteria or even differences in 
the ability to contain this pathogen within granulomas cannot be excluded. 
Measuring bacterial burdens in spleens, livers and MLNs as well as bacteraemia 
in the blood or lymphatic circulation could answer whether there is a 
requirement for IL-23 in controlling early bacterial replication. It has been 
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previously reported that IL-23 can act directly on DCs to induce nitric oxide 
secretion (Bastos et al., 2005). It would therefore be interesting to find out 
whether IL-23 signaling to DCs or MΦs can impact Salmonella processing and 
survival within those cells. Measuring nitric oxide secretion by phagocytes as 
well as endosomal activity could reveal the possible involvement of IL-23 in 
phagocyte activation.  
The fact that splenocytes from IL-23 deficient mice secreted less IL-10 
than splenocytes from WT mice (Figure 5.2) raises some interesting questions 
about this disease model. Addressing disease pathology parameters in IL-23 
deficient versus wild type mice could reveal whether the observed differential 
secretion of IL-10 and IFN-γ between WT and p19-/- mice is due to different 
immunological requirements for the control of localised tissue pathology. The 
fact that S. typhimurium preferentially occupies spleens and livers may be linked 
to the reduced splenocyte IL-10 in IL-23 deficient mice compared to WT mice. 
IL-23 is known to be important for the induction of G-CSF and subsequently for 
granuloma formation (Langrish et al., 2004; Stark et al., 2005). A possible 
inability of p19-/- mice to contain the pathogen within granulomas could result 
in an early, exaggerated compensatory T cell derived IFN-γ response in IL-23 
deficient mice. Histology of infected sites such as livers and spleens would help 
understand whether IL-23 is involved in bacterial containment within 
granulomas. Measuring granuloma frequencies and cell infiltrates in hepatic 
and splenic granulomatous regions in infected p19-/- and WT mice might 
provide a link between IL-23, IFN-γ and IL-10 in tissue-specific disease 
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pathology and immunity. Furthermore, it would be informative to compare the 
number of IFN-γ producing T cells from WT and p19-/- mice infiltrating different 
tissues. This could establish whether there is a bias for IFN-γ producing T cells 
to infiltrate spleens, livers or sterile tissue such as the heart, allowing for some 
inferences to be made as to whether inability to contain bacteria and immune 
pathology are linked. 
 
5.3.2 IL-23 is indispensable for the maintenance of IL-17 producing CD4+ T 
cells during late stages of Salmonella typhimurium infection 
IL-17 secretion by T cells and splenocytes was completely impaired at the 
10th week post infection in p19-/- mice compared to wild type mice (Figure 5.4). 
As previously described, primary IL-17 responses in p19-/- mice were normal 
compared to WT (Figure 5.1, 5.2, 5.3), suggesting that IL-23 is critical for the 
survival but not the induction of IL-17 CD4+ T cell responses. This is not entirely 
surprising since IL-23 has been previously reported to be acting on memory T 
cells and, more specifically, it has been described to promote maintenance of IL-
17 producing cells (Stritesky et al., 2008). Nevertheless, staining for activation 
and memory markers such as CD45Rb, CD44 and CD62L versus intracellular 
staining for IL-17 and IFN-γ on CD4+ and CD8+T cells from different tissues 
would give us an indication whether IL-17 secretion by T cells is abrogated in 
the absence of IL-23 or whether there is some correlation between activation and 
memory and the requirements for IL-23. 
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Memory responses in IL-23 deficient mice were characterised by 
impaired secretion of IL-2 and IL-17 compared to WT mice along with, in 
contrast to primary responses, normal secretion of IFN-γ. Intracellular staining 
of T cells at the 10th week post immunisation should reveal whether IL-23 
impairment influences single IL-17 producers or its action is extended to single 
IFN-γ and double IL-17/IFN-γ producers. Furthermore, injecting exogenous IL-
23 a short time (day-week) before collecting the T cells and performing the 
aforementioned intracellular staining should reveal whether IL-23 is involved in 
the activation or maintenance of distinct memory T cell populations.  
Antibody secretion by WT and p19-/- during the late stages of S. 
typhimurium infections was characterised, in contrast to primary responses, by 
statistically identical titres of IgG2b (Figure 5.11). However, IgG2c serum titres 
were statistically different between WT and p19-/- mice, even at the later stages 
of the infection (Figure 5.11). It is not entirely clear whether IFN-γ alone, or 
another aspect of Th1 differentiated cells independent of IFN-γ, is responsible 
for driving antibody responses. Using IFN-γ depleting antibodies at different 
time points during infection might answer whether there is a stringent 
requirement of IFN-γ for the generation of type 1 Ab responses in our system. 
Additionally we could try depleting T cells in order to investigate whether the 
induction of Ab responses in this system is cytokine or T cell dependent.  
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5.3.3 IL-23 is required for the induction of tissue specific IFN-γ  responses 
during secondary challenge responses against Salmonella typhimurium 
infections  
Surprisingly, we found that during secondary challenge with virulent 
SL1344 IL-23 deficient mice had impaired IFN-γ responses in the spleens but not 
lymph nodes, compared to WT mice (Figure 5.7, 5.8). This observation was true 
for whole splenocyte responses as well as purified splenic CD4+ T cell responses 
(Figure 5.8, 5.9). In light of the primary responses, where we observed elevated 
T cell derived IFN-γ from p19-/- mice (Figure 5.1), it is clear that in the S. 
typhimurium infection model, IL-23 has an intricate and differential role in the 
induction of primary, memory and challenge IFN-γ responses. As discussed 
earlier (Chapter 5.3.1), pathological parameters such as rate and site of bacterial 
replication and infection may be imposing differential immunological 
challenges to different sites, and as such contributing towards the observed 
differences in tissue specific immune responses. IL-23 dependent IL-17 secreting 
cells are thought to infiltrate the sites of infection earlier than IFN-γ secreting 
cellsin the M. tuberculosis setting (Khader et al., 2007). There, they are thought to 
induce chemokine receptor up-regulation, which results in the recruitment of 
IFN-γ secreting T cells (Khader et al., 2007). It is yet unclear whether, in our 
model, IL-17/IL-23 dependent T cell IFN-γ secretion is a tissue specific, 
migration related event or whether IL-23 is required for the homeostasis of all 
antigen specific IFN-γ secreting T cells. In order to verify whether IL-23 is 
required for activation or homeostasis of IFN-γ responses, we would need to 
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add exogenous IL-17 and IL-23 before or during secondary challenge responses, 
and observe whether IFN-γ responses are rescued or not in either case.  
Strikingly, IFN-γ and CD4+T cell responses in the spleens of p19-/- mice 
were impaired during secondary infection challenge, compared to memory 
responses, during which they appeared to be normal. This suggests that IL-23 
may be playing a role in providing survival signals to activated IFN-γ producing 
T cells. Whether this is done through a direct signalling of IL-23 to T cells or via 
IL-17 is unclear. It would be worth investigating whether exogenous addition of 
either IL-17 or IL-23 could rescue IFN-γ responses during challenge responses.  
Furthermore, comparing the effect of exogenous addition of IL-17 or adoptive 
transfer of IL-17-secreting T cells into IL-23 deficient mice on IFN-γ secretion 
during challenge should answer whether reduced IFN-γ production by T cells is 
due to IL-17 itself, or due to ‘help’ provided by IL-17 secreting T cells. Whether 
the reduced IFN-γ secretion by p19-/- mice during challenge responses could be 
attributed to a lack of IL-23 - IL-12β1 receptor signalling via STAT-4, which is 
required for the induction of IFN-γ responses is an interesting possibility. It 
would be worth investigating whether over expression of STAT-4 or addition of 
exogenous IL-12 p70 could rescue IFN-γ responses in this system. 
Work on M. tuberculosis and S. typhimurium has revealed that IL-17 
secreting T cells are important for the induction of tissue specific immune 
responses by recruiting neutrophils and macrophages to the site of infection 
(Khader et al., 2007) (Schulz et al., 2008). As such, it would be informative to 
compare both neutrophilia and the number of IFN-γ and IL-17 producing T cells 
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from WT and p19-/- mice infiltrating different tissues during the course of 
primary infection as well as during secondary challenge. This could provide us 
with useful information about the involvement of IL-23 in some aspects of 
innate immunity and its effect on the recruitment and activation of cells of the 
adaptive arm of immunity. 
Although initial studies on IL-23 and its involvement in IL-17 induction 
showed some interesting links between those two cytokines and autoimmune 
disease, recent work utilising both infection and autoimmune disease models 
has revealed some interesting immunological aspects of this IL-12 p70 
homologue related to the IL-12 p70/IFN-γ axis. While some of the work 
presented in this chapter supports the consensus that IL-23 is required for IL-17 
maintenance, but not induction, the implications of IL-17 responses in our hands 
and others using infection models seem to be localised to preferentially infected 
tissues. Importantly, whereas IL-12 p70 is clearly involved in the induction of 
IFN-γ effector responses, the work outlined in this chapter adds strength to the 
growing idea that IL-23 also plays an important role in providing survival 
signals and recruitment signals to IFN-γ secreting T cells.  
Perhaps it would be interesting to repeat the experiments preformed for 
the purposes of this chapter by immunising mice via the oral route. Since IL-23 
seems to be linked to localised responses, it might be useful to try and elicit 
immunity at the site of pathogen invasion. Such an approach might reveal more 
emphatically the role of IL-23 in localised responses. 
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The implication of IL-23, however, in lymphocyte recruitment provides 
good reasons for further investigations on this cytokine. Harnessing these 
recruiting functions of this APC derived cytokine might provide us with 
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Figure 5.1. Mesenteric lymph node primary responses. IL-23 is not required 
for the induction of IL-17. WT (white bars) or p19-/- (grey bars) mice were 
immunised i.p with either PBS (3 mice/group) or 1*106 CFU SL3261 (5 mice per 
group). Seven days later lymph nodes were processed into single cell 
suspensions and restimulated for three days in either media or with 10µg/ml 
HK SL1344. IFN-γ, IL-17 and IL-10 production was measured by ELISA.  Bars 
represent mean and standard error mean (SEM) of 3 (naïve) or 5 (immunised) 
mice per group and duplicate wells on ELISA plates per mouse. Data are 
representative of two independent experiments. Statistics were performed using 
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Figure 5.2. Splenocyte primary responses. IL-23 is not required for the 
induction of IL-17. WT (white bars) or p19-/- (grey bars) mice were immunised 
i.p with either PBS (3 mice/group) or 1*106 CFU SL3261 (5 mice per group). 
Seven days spleens were processed into single cell suspensions and 
restimulated for three days in either media or with 10µg/ml HK SL1344. IFN-γ, 
IL-17 and IL-10 production was measured by ELISA.  Bars represent mean and 
standard error mean (SEM) of 3 (naïve) or 5 (immunised) mice per group and 
duplicate wells on ELISA plates per mouse. Data are representative of two 
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Figure 5.3. T cell primary responses. IL-23 deficiency correlates with increased 
IFN-γ  secretion by T cells. WT (closed signs), or p19-/- (open signs) mice were 
immunised i.p with either PBS (squares) (3 mice/group) or 1*106 CFU SL3261 
(circles) (5 mice/group). Seven days later T cells were purified from pooled 
splenocytes from individual groups of mice and stimulated for 3 days (1 day for 
IL-2) in the presence of irradiated APC with 1, 5 10 or 25 µg/ml purified-
sonicated C5. Gray rectangles represent irradiated APCs. IFN-γ, IL-17, IL-10 and 
IL-2 production by purified T cells was measured by ELISA. Geometrical shapes 
represent mean and standard error mean (SEM) of 3 replicate wells on ELISA 
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Figure 5.4. Splenocyte memory responses. IL-23 is required for the 
maintenance of IL-17 responses. WT (white bars) or p19-/- (grey bars) mice were 
immunised i.p with either PBS (3 mice/group) or 1*106 CFU SL3261 (5 mice per 
group). 10 weeks later spleens were processed into single cell suspensions and 
restimulated for three days (1 day for IL-2) in either media or with 10µg/ml HK 
SL1344. IFN-γ, IL-17, IL-10 and IL-2 production was measured by ELISA.  Bars 
represent mean and standard error mean (SEM) of 3 (naïve) or 5 (immunised) 
mice per group and duplicate wells on ELISA plates per mouse. Data are 
representative of two independent experiments. Statistics were performed using 
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Figure 5.5. T cell memory responses. IL-23 is indispensable for the 
maintenance of IL-17 secretion by T cells. WT (closed signs), or p19-/- (open 
signs) mice were immunised i.p with either PBS (squares) (3 mice/group) or 
1*106 CFU SL3261 (circles) (5 mice/group). 10 weeks later T cells were purified 
from pooled splenocytes from individual groups of mice and stimulated for 3 
days (1 day for IL-2) in the presence of irradiated APC with 1, 5 10 or 25 µg/ml 
purified-sonicated C5. Gray rectangles represent irradiated APCs. IFN-γ, IL-17, 
IL-10 and IL-2 production by purified T cells was measured by ELISA. 
Geometrical shapes represent mean and standard error mean (SEM) of 3 
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Figure 5.6. B cell memory responses. IL-23 does not affect memory B cell pro-
inflammatory and anti-inflammatory cytokine secretion. WT (closed signs), or 
p19-/- (open signs) mice were immunised i.p with either PBS (squares)(3 
mice/group) or 1*106 CFU SL3261 (circles) (5 mice/group). 10 weeks later B cells 
were purified from pooled splenocytes from individual groups of mice and 
stimulated with increasing concentrations of HK SL3261. IL-6 and IL-10 
production by purified B cells was measured by ELISA. Geometrical shapes 
represent mean and standard error mean (SEM) of 3 replicate wells on ELISA 
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Figure 5.7. Mesenteric lymph node challenge responses. IL-23 is required for 
the maintenance of IL-17 responses. WT (white bars) or p19-/- (grey bars) mice 
were immunised i.p with either PBS (3 mice/group) or 1*106 CFU SL3261 (5 
mice per group). 10 weeks later all mice were orally challenged with 1*108 CFU 
SL1344. 3 days after challenge lymph nodes were processed into single cell 
suspensions and restimulated for three days (1 day for IL-2) in either media or 
with 10µg/ml HK SL1344. IFN-γ, IL-17, IL-10 and IL-2 production was 
measured by ELISA.  Bars represent mean and standard error mean (SEM) of 3 
(naïve) or 5 (immunised) mice per group and duplicate wells on ELISA plates 
per mouse. Data are representative of two independent experiments. Statistics 
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Figure 5.8. Splenocyte challenge responses. IL-23 is required for IFN-γ  
responses at the site of infection. WT (white bars) or p19-/- (grey bars) mice 
were immunised i.p with either PBS (3 mice/group) or 1*106 CFU SL3261 (5 
mice per group). 10 weeks later all mice were orally challenged with 1*108 CFU 
SL1344. 3 days after challenge spleens were processed into single cell 
suspensions and restimulated for three days (1 day for IL-2) in either media or 
with 10µg/ml HK SL1344. IFN-γ, IL-17, IL-10 and IL-2 cytokine production was 
measured by ELISA.  Bars represent mean and standard error mean (SEM) of 3 
or 5 mice per group and duplicate wells on ELISA plates per mouse. Data are 
representative of two independent experiments. Statistics were performed using 
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Figure 5.9. T cell challenge responses. IL-23 is required for CD4+ IFN-γ  
secretion at the site of infection. WT (closed signs), or p19-/- (open signs) mice 
were immunised i.p with either PBS (squares) (3 mice/group) or 1*106 CFU 
SL3261 (circles) (5 mice/group). 10 weeks later all mice were orally challenged 
with 1*108 CFU SL1344. 3 days after challenge T cells were purified from pooled 
splenocytes from individual groups of mice and stimulated for 3 days (1 day for 
IL-2) in the presence of irradiated APC with 1, 5 10 or 25 µg/ml purified-
sonicated C5. Gray rectangles represent irradiated APCs. IFN-γ, IL-17, IL-10 and 
IL-2 production by purified T cells was measured by ELISA. Geometrical shapes 
represent mean and standard error mean (SEM) of 3 replicate wells on ELISA 
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Figure 5.10. B cell challenge responses. IL-23 does not affect B cell pro-
inflammatory and anti-inflammatory cytokine secretion during secondary 
challenge with S. typhimurium. WT (closed signs), or p19-/- (open signs) mice 
were immunised i.p with either PBS (squares) (3 mice/group) or 1*106 CFU 
SL3261 (circles) (5 mice/group). 10 weeks later all mice were orally challenged 
with 1*108 CFU SL1344. 3 days after challenge B cells were purified from pooled 
splenocytes from individual groups of mice and stimulated with increasing 
concentrations of HK SL3261. IL-6 and IL-10 production by purified B cells was 
measured by ELISA. Geometrical shapes represent mean and standard error 
mean (SEM) of 3 replicate wells on ELISA plates per group. Data are 
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Figure 5.11. Antibody responses. IL-23 deficiency results in early, increased 
Th1 type antibody production by B cells. WT (closed squares), or p19-/- (open 
squares) mice were immunised with PBS. WT (closed circles) or p19-/- (open 
circles) mice were immunised with 1*106 CFU SL3261. Serum was collected from 
individual mice at day 0, 7, 10, 31, 51, 67, 66. All mice were challenged at day 69 
post immunisation and serum was again collected at day 72 (last time point). 
Antibody was determined by ELISA. Geometrical shapes represent mean and 
standard error mean (SEM) for 5 mice per group and two replicate wells on the 
ELISA plate per mouse. Data are representative of 2 independent experiments.  
Statistics were performed using two-way ANOVA analysis.   
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Figure 5.12. Pathology. IL-23 deficiency does not affect immunopathology 
caused by primary or seconday SL1344 Salmonella typhimurium infection. WT 
(white bars) or p19-/- (grey bars) mice were immunised i.p with either PBS (3 
mice/group) or 1*106 CFU SL3261 (7 mice per group). 10 weeks later all mice 
were challenged orally with 1*108 CFU SL1344. Serum, spleens and livers were 
collected from individual mice at day 3 post challenge. Serum IFN-γ was 
determined by ELISA (A). Liver bacterial burdens were determined by serial 
dilutions of liver homogenate (B). Splenomegaly was determined by spleen 
weight/total mouse weight ratio (C). Bars represent mean and standard error 
mean (SEM) for 3 (naïve) or 7 (immunised) mice per group. Data are 
representative of 2 independent experiments. Statistics were performed using a 







































































Figure 5.13. Pathology. IL-23 deficiency affects weight change during primary 
infection but not secondary challenge with Salmonella typhimurium. WT (blue 
squares) or p19-/- (red triangles) mice were immunised i.p with 1*106 CFU 
SL3261.Weight change was monitored at day 1, 3, 5, 7, 11 and 42 post 
immunisation (A). 10 weeks later WT non-immunised (black triangles), p19-/- 
non-immunised (green rectangles), WT immunised (blue squares) and p19-/- 
immunised (red triangles) mice mice were challenged orally with 1*108 CFU 
SL1344. Weights were recorded daily for 3 days after challenge (B). Geometrical 
shapes represent mean and standard error mean from 3 (naïve) or 7 
(immunised) mice per group. Data are representative of 2 independent 
















Days post SL1344 Challenge
Weight change



















6.1 General Discussion 
Our work addressed the role of DCs in the generation of immunity 
against S. typhimurium infections. DCs are of crucial importance in the initiation 
of effective immune responses against pathogens, as well as the establishment of 
peripheral tolerance (Banchereau and Steinman, 1998; Mueller). Understanding 
how this cell type becomes activated by different antigens and pathogens, and 
how it subsequently drives immune responses against the vast range of 
pathogenic organisms may lead to the development of better vaccination 
strategies, as well as potential methods for controlling disease progression and 
autoimmune pathology (Banchereau et al., 2009; Figdor et al., 2004).  
The ability of DCs to translate signal, received in the periphery, into 
message for the initiation of adaptive immune responses, posed them as an 
excellent candidate to investigate the highly controversial and dividing, among 
the medical and scientific community, topic of the biological role of ultra-high 
dilutions of Ag.  
While the mechanisms of the adaptive arm of immunity required for 
protection against Salmonella are well characterised, the involvement of APCs in 
the initiation of protective immune responses against this pathogen are less 
understood. The central aim of this thesis was to reveal aspects of DC biology 
that might be playing a role in the generation of effective immune responses 
against S. typhimurium infections. We approached this by testing whether 
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immune responses developed by DCs, altered immunopathology in Salmonella 
infected animals. Furthermore, we investigated whether the novel APC derived 
cytokine, IL-23, affects the generation of protective immunity in mice.  
 
6.2 Ultra-high dilutions of Ag alter immune response development by DCs  
Our aim was to address the most controversial aspect of homeopathy, 
that of preparations that include no substance. As described in Chapter 3.1, 
homeopathy is an alternative medical discipline, which often uses preparations 
that are diluted to such extend that in theory the final solution should constitute 
of pure water. Our aim was to investigate whether such extreme dilutions of Ag 
have a biological effect on DCs, and whether DCs incubated in such extreme 
dilutions of Ag altered immune response development.  
Our results were striking. We observed a measurable biological effect on 
immune response development conferred by DCs that had been pre-treated 
with ultra-high dilutions of antigen. The reason why in the absence of Ag any 
biological effect should be observed remains unclear. We did not succeed in 
determining a possible mode of action for such extreme dilutions. Although our 
meta analytical study, as well as experiments performed in a “blind” fashion, 
revealed a positive correlation of extreme Ag dilutions with cytokine 
production, our experiments would need to be performed by independent 
laboratories in order to obtain a robust statistical picture of our observations. 
Nevertheless, our results suggested that there is a real possibility that 
extreme dilutions of Ag, which by our own mass-spectrometric investigations 
(Figure 2.3) were found to constitute of nothing but water, may exert a real 
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biological effect. In order to determine a mode of action for such dilutions we 
would need to identify what it is in our preparations that convenes the signal to 
DCs. It might therefore, be interesting to know whether such extreme dilutions 
of antigen exhibit any measurable physical properties that might be different 
than those observed in pure, “untreated”, water.  
  
6.3 Mice vaccinated with S.t-pulsed DCs exhibit less severe 
immunopathology compared to non vaccinated mice. 
Salmonella infections are characterised by bacterial invasion through M 
cells residing at the intestinal tract, followed by dissemination to secondary 
lymphatics, a process facilitated by APCs (Salcedo et al., 2001). Salmonella has 
evolved a number of different mechanisms aimed at hindering immunogenic 
proteins from APCs, such as in the case of Flic and PhoP (Murata et al., 2007) 
(Chapter 1.6). Designing effective vaccines against this pathogen requires both 
understanding the underlying immune mechanisms that confer full protection, 
as well as understanding how different bacterial virulence factors and 
immunogenic molecules evade and induce immunity, respectively.  
Our aim was to investigate the contribution of DCs in conferring effective 
adaptive immune responses against S. typhimurium infections. We found that 
Salmonella causes severe immunopathology in NRAMP deficient mice 
characterised by rapid weight loss and increased serum TNF-α (Figure 4.1, 4.2, 
4.3) Interestingly, we found that memory immune responses induced by S.t-
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pulsed DCs reduced immunopathology caused by Salmonella infections (Figure 
4.8, Figure 4.9.B, 4.10).  
Increased splenocyte IFN-γ, serum IgG2c and IgG2b (Figure 4.11, 4.12) in 
conjunction with reduced serum TNF-α (Figure 4.10) correlated with reduced 
splenomegaly and rate of weight loss (Figure 4.9B, 4.8). Our results suggest that, 
both cell mediated as well as humoral immune responses conferred by DCs 
reduce S. typhimurium induced immunopathology.  
The experimental model of transferring DCs as an immunisation method 
against Salmonella is an attractive system that allows for the dissection of 
immune responses against this pathogen. Identifying the influence individual 
Salmonella-derived proteins have on maturation of different DC subsets, and on 
the potential of those subsets to generate effective immune responses against 
Salmonella, might enable us to both improve the design and the delivery 
methods of Salmonella vaccines.  
 
6.4 IL-23 involvement in immunity 
Disease models, such as the murine models for M. tuberculosis and S. 
typhimurium infections, suggest that IL-23 can partially rescue Th1 responses in 
the absence of IFN-γ and recruit IL-17 and IFN-γ secreting T cells to the site of 
infection (Khader et al., 2007; Khader et al., 2005; Schulz et al., 2008). The 
functional similarities of IL-23 and IL12p70 (Oppmann et al., 2000), its 
production by DCs (Smits et al., 2004), its distinct role in inducing proliferation 
of CD4+ CD45Rblow T cells (Oppmann et al., 2000), its importance in the 
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generation or maintenance of IL-17 responses (Khader et al., 2007) as well as its 
implication in autoimmune disease pathology (O'Connor et al., 2008) and 
immune responses against various pathogens (Happel et al., 2005) posed it as a 
very attractive molecule to study in order to further our understanding of 
immune response induction, development and regulation.  
Our aim was to determine whether the APC-derived cytokine, IL-23, 
played a role in the induction and maintenance of CD4+ T cell and B cell primary 
and memory responses, respectively, during S. typhimurium infections. 
Additionally we wished examine whether IL-23 maintained effective CD4+ T cell 
and B cell responses against secondary challenge with S. typhimurium infections.  
 
6.5 IL-23 induces differential secretion of IFN-γ  by spleens and lymph 
nodes during Salmonella infections  
We found that primary IL-17 responses against S. typhimurium are not 
affected by the lack of IL-23, (Figure 5.1, 5.2, 5.3). Interestingly IFN-γ secretion 
during primary stages of infection is significantly elevated in p19-/- mice 
compared to WT mice in the mesenteric lymph nodes but not the spleens 
(Figure 5.1, 5.2). Given that the live attenuated SL3261 S. typhimurium was 
injected intraperitonealy, it is possible that IL-23 might be exerting its effect 
locally, at the site where the pathogen was introduced. Nevetheless, the 
increased IFN-γ secretion by p19 deficient mice is a surprising observation, since 
it is contrasting to the literature (Kullberg et al., 2006). Type 1 antibody levels in 
the serum of p19-/- mice followed the same trend as IFN-γ responses (Figure 
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5.11), suggesting that the early, exaggerated IFN-γ response in those mice 
contributed towards elevated humoral responses. Live attenuated S.typhimurium 
infections induced mixed type 1 and type 2 responses characterised by IgG2c, 
IgG2b and IgG1 (Figure 5.11), further supporting the observation made in our 
DC transfer experiments, in which heat-killed S. typhimurium-pulsed DCs also 
induced mixed type 1 and type 2 Ab responses (Figure 4.12). IL-23 deficiency 
did not affect, however, IgG1 production, suggesting that this cytokine is not 
involved in the generation of Th2 type Abs. We found that WT mice lost 
statistically more weight during the initial stage of immunisation than p19-/- 
mice (Figure 5.13A). This is in accord with our observation that S.t-DC 
vaccinated animals, which were characterised by increased splenocyte and 
serum IFN-γ compared to naïve mice lost significantly less weight (Figure 4.8, 
4.10, 4.11).  
 
6.6 IL-23 is required for the maintenance of IL-17 responses during S. 
typhimurium infections 
Memory responses in IL-23 deficient mice were characterised by the 
complete impairment of IL-17 secretion by T cells and splenocytes (Figure 5.4, 
5.5). Our data confirm previous reports that have shown that IL-23 promotes 
maintenance of IL-17 producing cells (Stritesky et al., 2008). It is interesting that 
splenocytes from mice that had received DCs pulsed with heat-killed S. 
typhimurium 5 weeks prior to being infected with live S. typhimurium secreted 
IL-17, in comparison to mice that had received unstimulated DCs, which failed 
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to secrete any IL-17 after being infected (Figure 4.11). It is unclear whether 
BMDC transferred into naïve animals can persist for as long as 5 weeks, thereby 
sustaining an IL-17 producing population of T cells, nevertheless an interesting 
possibility. In the DC transfer experiments, memory responses were 
investigated at the 5th week post transfer, while in the live attenuated 
immunisation experiments memory responses were addressed at the 10th week 
post injection of live bacteria. The difference in the time post infection/injection 
might be accounting for the fact that IL-23 deficient mice were unable to elicit 
memory IL-17 responses. Perhaps investigating for the presence of IL-17 in the 
live bacterial immunisation experiments at earlier time points might give us a 
clearer picture about when IL-17 responses collapse in the absence of IL-23. 
 
6.7 IL-23 is required for the induction of tissue specific IFN-γ  responses 
during secondary challenge responses against Salmonella typhimurium 
infections  
Surprisingly, and in stark contrast to primary immune responses, we 
found that during secondary challenge with SL1344, IL-23 deficient mice 
showed impaired IFN-γ responses in the spleens but not lymph nodes, 
compared to WT mice (Figure 5.7, 5.8). It is possible that preferential bacterial 
dissemination to and survival within different tissues is imposing differential 
immunological strain to different sites, hence contributing towards the observed 
differences in tissue specific immune responses.  
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6.8 In conclusion 
The work presented in this thesis illustrates the contribution of DCs in 
the generation of effective immune responses against S. typhimurium infections, 
and the importance of the APC derived cytokine, IL-23, in localised immune 
responses. Further work addressing IL-23 involvement in localised immune 
responses against S. typhimurium  and the role of DCs in generating such tissue 
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